UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                   to                  

 

Commission File No. 001-38909

 

AGBA GROUP HOLDING LIMITED
(Exact name of registrant as specified in its charter)

 

British Virgin Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

AGBA Tower

68 Johnston Road

Wan Chai, Hong Kong SAR

  N/A
(Address of Principal Executive Offices)   (Zip Code)

 

+852 3601 8000
(Registrant’s telephone number, including area code)

 

 
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares   AGBA   NASDAQ Capital Market
Warrants   AGBAW   NASDAQ Capital Market

 

As of July 17, 2023, there were 67,461,998 ordinary shares, par value $0.001 per share, issued and outstanding.

 

 

 

 

 

 

AGBA GROUP HOLDING LIMITED

 

Quarterly Report on Form 10-Q

 

TABLE OF CONTENTS

 

    Page
     
PART I – FINANCIAL INFORMATION 1
     
Item 1. Financial Statements  
     
  Unaudited Condensed Consolidated Balance Sheets F-1
   
  Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss F-2
     
  Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity F-3
     
  Unaudited Condensed Consolidated Statements of Cash Flows F-4
     
  Notes to Unaudited Condensed Consolidated Financial Statements F-5 to F-32
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 2
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 16
     
Item 4. Control and Procedures 16
     
PART II – OTHER INFORMATION 17
     
Item 1. Legal Proceedings 17
     
Item 1A. Risk Factors 17
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17
     
Item 3. Defaults Upon Senior Securities 18
     
Item 4. Mine Safety Disclosures 18
     
Item 5. Other Information 18
     
Item 6. Exhibits 18
     
SIGNATURES 19

 

i

 

 

PART I – FINANCIAL INFORMATION

 

AGBA GROUP HOLDING LIMITED

 

INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

    Page
     
Unaudited Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022   F-1
     
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2023 and 2022   F-2
     
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three and Six Months Ended June 30, 2023 and 2022   F-3
     
Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022   F-4
     
Notes to Unaudited Condensed Consolidated Financial Statements   F-5 to F-32

 

1

 

 

AGBA GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   June 30,
2023
   December 31,
2022
 
ASSETS      (Audited) 
Current assets:        
Cash and cash equivalents  $3,783,780   $6,449,876 
Restricted cash   27,454,651    44,844,196 
Accounts receivable, net   3,430,780    2,822,162 
Accounts receivable, net, related parties   601,576    272,546 
Loans receivable, net   516,237    517,479 
Notes receivable, net   601,490     
Asset held for sale   5,459,822     
Income tax recoverable   397,655    260,120 
Deposits, prepayments, and others receivable, net   2,997,021    589,786 
Total current assets   45,243,012    55,756,165 
           
Non-current assets:          
Rental deposit, net   957,814     
Loans receivable, net   1,059,776    1,072,392 
Property and equipment, net   1,733,464    7,359,416 
Right-of-use asset, net   12,361,125     
Long-term investments, net   33,947,066    37,033,360 
Total non-current assets   50,059,245    45,465,168 
           
TOTAL ASSETS  $95,302,257   $101,221,333 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued liabilities  $19,088,631   $20,274,429 
Escrow liabilities   27,454,651    29,487,616 
Borrowings   6,255,238    4,477,254 
Amounts due to the holding company   4,539,168    6,289,743 
Lease liabilities   1,186,200     
Forward share purchase liability       13,491,606 
Income tax payable and provision   23,000,000    23,000,000 
Total current liabilities   81,523,888    97,020,648 
           
Non-current liabilities:          
Lease liabilities   11,227,185     
Warrant liabilities   2,173    4,548 
Deferred tax liabilities   45,680    45,858 
Total non-current liabilities   11,275,038    50,406 
           
TOTAL LIABILITIES   92,798,926    97,071,054 
           
Commitments and contingencies (Note 21)        
           
Shareholders’ equity:          
Ordinary shares, $0.001 par value; 200,000,000 shares authorized, 67,461,998 and 58,376,985 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively   67,462    58,377 
Ordinary shares to be issued       1,665 
Additional paid-in capital   64,973,808    43,870,308 
Accumulated other comprehensive loss   (484,907)   (384,938)
Accumulated deficit   (62,053,032)   (39,395,133)
Total shareholders’ equity   2,503,331    4,150,279 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $95,302,257   $101,221,333 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

F-1

 

 

AGBA GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
Revenues:                
Interest income:                
Loans  $38,175   $37,871   $76,333   $99,194 
Total interest income   38,175    37,871    76,333    99,194 
Non-interest income:                    
Commissions   16,323,056    2,937,080    26,338,683    3,764,157 
Recurring service fees   768,014    873,396    1,548,976    1,821,376 
Total non-interest income   17,091,070    3,810,476    27,887,659    5,585,533 
Total revenues from others   17,129,245    3,848,347    27,963,992    5,684,727 
                     
Non-interest income:                    
Recurring service fees   241,688    241,325    480,621    481,268 
Total revenues from related parties   241,688    241,325    480,621    481,268 
Total revenues   17,370,933    4,089,672    28,444,613    6,165,995 
                     
Operating cost and expenses:                    
Interest expense   (247,680)       (412,776)    
Commission expense   (11,984,437)   (2,480,271)   (19,279,929)   (3,181,313)
Sales and marketing expense   (514,984)   (391,301)   (2,371,887)   (631,652)
Technology expense   (1,058,812)   (149,230)   (1,937,798)   (283,097)
Personnel and benefit expense   (5,302,270)   (3,404,039)   (14,907,460)   (5,409,018)
Other general and administrative expenses   (8,655,884)   (1,173,217)   (14,511,705)   (2,081,618)
Total operating cost and expenses   (27,764,067)   (7,598,058)   (53,421,555)   (11,586,698)
                     
Loss from operations   (10,393,134)   (3,508,386)   (24,976,942)   (5,420,703)
                     
Other income (expense):                    
Interest income   197,255    8,976    367,781    16,615 
Foreign exchange gain (loss), net   349,539    (2,126,882)   905,850    (2,607,456)
Investment income (loss), net   (441,568)   (5,683,988)   1,281,496    (3,535,053)
Change in fair value of warrant liabilities   1,695        2,375     
Change in fair value of forward share purchase liability           (82,182)    
Loss on settlement of forward share purchase agreement   (378,895)       (378,895)    
Rental income   78,764    78,647    138,271    157,714 
Sundry income   27,423    26,175    84,067    155,528 
Total other income (expense), net   (165,787)   (7,697,072)   2,318,763    (5,812,652)
                     
Loss before income taxes   (10,558,921)   (11,205,458)   (22,658,179)   (11,233,355)
                     
Income tax (expense) benefit   (26,368)   314,143    280    (105,354)
                     
NET LOSS  $(10,585,289)  $(10,891,315)  $(22,657,899)  $(11,338,709)
                     
Other comprehensive income (loss):                    
Foreign currency translation adjustment   33,235    (106,008)   (99,969)   (380,359)
                     
TOTAL COMPREHENSIVE LOSS  $(10,552,054)  $(10,997,323)  $(22,757,868)  $(11,719,068)
                     
Weighted average number of ordinary shares outstanding – basic and diluted   64,953,238    55,500,000    62,823,549    55,500,000 
                     
Net loss per ordinary share – basic and diluted  $(0.16)  $(0.20)  $(0.36)  $(0.20)

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

F-2

 

 

AGBA GROUP HOLDING LIMITED

UNAUDITED CONDESED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   Three and six Months ended June 30, 2023 
   Ordinary shares   Ordinary shares to
be issued
   Additional
paid-in
   Accumulated other comprehensive   Accumulated   Total shareholders’ 
   No. of shares   Amount   No. of shares   Amount   capital   income (loss)   deficit   equity 
Balance as of January 1, 2023   58,376,985   $58,377    1,665,000   $1,665   $43,870,308   $(384,938)  $(39,395,133)  $4,150,279 
                                         
Issuance of ordinary shares to settle finder fee   2,173,913    2,174            3,997,826            4,000,000 
Share-based compensation   1,200,000    1,200            3,905,400            3,906,600 
Forgiveness of amounts due to the holding company                   3,000,000            3,000,000 
Foreign currency translation adjustment                       (133,204)       (133,204)
Net loss for the period                           (12,072,610)   (12,072,610)
Balance as of March 31, 2023   61,750,898    61,751    1,665,000    1,665    54,773,534    (518,142)   (51,467,743)   2,851,065 
                                         
Issuance of holdback shares   1,665,000    1,665    (1,665,000)   (1,665)                
Share-based compensation   4,046,100    4,046            4,600,274            4,604,320 
Forgiveness of amounts due to the holding company                   5,600,000            5,600,000 
Foreign currency translation adjustment                       33,235        33,235 
Net loss for the period                           (10,585,289)   (10,585,289)
                                         
Balance as of June 30, 2023   67,461,998   $67,462       $   $64,973,808   $(484,907)  $(62,053,032)  $2,503,331 

 

   Three and six Months ended June 30, 2022 
   Ordinary shares   Ordinary shares to
be issued
   Additional
paid-in
   Receivable
from the
   Accumulated
other
comprehensive
   Retained
earnings
(accumulated
   Total
shareholders’
 
   No. of shares   Amount   No. of shares   Amount   capital   Shareholder   loss   deficit)   equity 
Balance as of January 1, 2022   53,835,000   $53,835    1,665,000   $1,665   $38,706,226   $(29,562,195)  $(179,461)  $52,125,502   $61,145,572 
                                              
Special dividend to the holding company                       29,562,195        (47,000,000)   (17,437,805)
Foreign currency translation adjustment                           (274,351)       (274,351)
Net loss for the period                               (447,394)   (447,394)
Balance as of March 31, 2022   53,835,000    53,835    1,665,000    1,665    38,706,226        (453,812)   4,678,108    42,986,022 
                                              
Foreign currency translation adjustment                           (106,008)       (106,008)
Net loss for the period                               (10,891,315)   (10,891,315)
                                              
Balance as of June 30, 2022   53,835,000   $53,835    1,665,000   $1,665   $38,706,226   $   $(559,820)  $(6,213,207)  $31,988,699 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

F-3

 

 

AGBA GROUP HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Currency expressed in United States Dollars (“US$”))

 

    Six months ended
June 30,
 
    2023     2022  
Cash flows from operating activities:            
Net loss   $(22,657,899)     $(11,338,709)  
Adjustments to reconcile net loss to net cash used in operating activities                
Share-based compensation expense     8,510,920        
Non-cash lease expense     213,550        
Depreciation on property and equipment     215,494       192,352  
Interest income on notes receivable     (11,778 )      
Foreign exchange (gain) loss, net     (905,850 )     2,607,456  
Investment (income) loss, net     (1,281,496 )     3,535,053  
Allowance for credit loss on financial instruments     333,276        
Change in fair value of warrant liabilities     (2,375 )      
Change in fair value of forward share purchase liability     82,182        
Loss on settlement of forward share purchase agreement     378,895        
Reversal of annual bonus accrued in prior year     (3,763,847 )      
                 
Change in operating assets and liabilities:                
Accounts receivable     (1,005,597 )     40,992  
Loans receivable     13,319       2,320,527  
Deposit, prepayments, and others receivables     (3,629,837 )     (420,678 )
Accounts payable and accrued liabilities     6,578,049     (124,238 )
Escrow liabilities     (2,032,965 )     633,539  
Lease liabilities     (161,274 )      
Income tax payable     (138,590 )     104,890  
Net cash used in operating activities     (19,265,823 )     (2,448,816 )
                 
Cash flows from investing activities:                
Proceeds from sale of long-term investments     3,976,657       1,861,348  
Purchase of notes receivable     (589,086 )      
Dividends received from long-term investments     1,167,433        
Addition in long-term investments           (7,849,676 )
Purchase of property and equipment     (77,969 )     (864,961 )
Net cash provided by (used in) investing activities     4,477,035       (6,853,289 )
                 
Cash flows from financing activities:                
Advances from holding company     6,849,425       4,298,479  
Settlement of forward share purchase agreement     (13,952,683 )      
Proceeds from borrowings     1,786,640        
Dividend paid to holding company           (17,437,805 )
Net cash used in financing activities     (5,316,618 )     (13,139,326 )
                 
Effect on exchange rate change on cash, cash equivalents and restricted cash     49,765       (310,995 )
                 
Net change in cash, cash equivalent and restricted cash     (20,055,641 )     (22,752,426 )
                 
BEGINNING OF PERIOD     51,294,072       73,081,407  
                 
END OF PERIOD   $ 31,238,431     $ 50,328,981  
                 
SUPPLEMENTAL CASH FLOW INFORMATION:                
Cash paid for income taxes   $ 138,310     $  
Cash paid for interest   $ 412,776     $  
Cash received for interest   $ 356,003     $  
                 
Reconciliation to amounts on consolidated balance sheets:                
Cash and cash equivalents   $ 3,783,780     $ 15,209,645  
Restricted cash     27,454,651       35,119,336  
                 
Total cash, cash equivalents and restricted cash   $ 31,238,431     $ 50,328,981  
                 
SUPPLEMENTAL NON-CASH DISCLOSURES                
Issuance of ordinary shares to settle finder fee   $ 4,000,000     $  
Forgiveness of amount due to holding company   $ 8,600,000     $  
Operating lease right-of-use asset obtained in exchange for operating lease liabilities   $ 12,512,585     $  
Purchase of property and equipment, through earnest deposit   $     $ 7,205,118  
Special dividend to the holding company offset with amount due from the holding company   $     $ 29,562,195  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

F-4

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

NOTE 1 - NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

AGBA Group Holding Limited (“AGBA” or the “Company”) was incorporated on October 8, 2018 in British Virgin Islands.

 

The Company, through its subsidiaries, is operating a wealth and health platform, offering a wide range of financial service and products, covering life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, lending, and real estate in overseas. AGBA is also engaged in financial technology business and financial investments, managing an ensemble of fintech investments and healthcare investment and operating a health and wealth management platform with a broad spectrum of services and value-added information in health, insurance, investments and social sharing.

 

The accompanying unaudited condensed consolidated financial statements of the Company are presented in United State dollars (“US$” or “$”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities Exchange Commission. Certain information and footnote disclosures normally included in consolidated financial statements have been omitted pursuant to such rules and regulations. The consolidated balance sheet as of December 31, 2022 derived from the audited consolidated financial statements at that date, but does not include all the information and footnotes required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

The unaudited condensed consolidated financial statements as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and 2022, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition, results of operations and cash flows. The results of operations for the three and six months ended June 30, 2023 and 2022 are not necessarily indicative of the results to be expected for any other interim period or for the entire year.

 

Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

These accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying unaudited condensed consolidated financial statements and notes.

 

Principal of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the financial statements of AGBA and its subsidiaries. A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. All intercompany transactions and balances between AGBA and its subsidiaries are eliminated upon consolidation.

 

F-5

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Use of Estimates and Assumptions

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property and equipment, impairment of long-lived assets, allowance for doubtful accounts, notes receivable, share-based compensation, warrant liabilities, forward share purchase liability, provision for contingent liabilities, revenue recognition, income tax provision, deferred taxes and uncertain tax position, and allocation of expenses from holding company.

 

The inputs into the management’s judgments and estimates consider the economic implications of COVID-19 on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates.

 

Foreign Currency Translation and Transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

 

The reporting currency of the Company is US$ and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company and subsidiaries are operating in Hong Kong maintain their books and record in their local currency, Hong Kong dollars (“HK$”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, Translation of Financial Statement, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the unaudited condensed consolidated statements of changes in shareholders’ equity.

 

Translation of amounts from HK$ into US$ has been made at the following exchange rates for the six months ended June 30, 2022 and 2021:

 

   June 30,
2023
   June 30,
2022
 
Period-end HK$:US$ exchange rate   0.12761    0.12744 
Period average HK$:US$ exchange rate   0.12757    0.12779 

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist primarily of cash in readily available checking and saving accounts. They consist of highly liquid investments that are readily convertible to cash and that mature within three months or less from the date of purchase. The carrying amounts approximate fair value due to the short maturities of these instruments. The Company maintains most of its bank accounts in Hong Kong.

 

Restricted Cash

 

Restricted cash consist of funds held in escrow accounts reflecting (i) the restricted cash and cash equivalents maintained in certain bank accounts that are held for the exclusive interest of the Company’s customers and (ii) the full obligation to an investor in connection with the Meteora Backstop Agreement (see Note 4).

 

The Company restricts the use of the assets underlying the funds held in escrow to meet with regulatory or contractual requirements and classifies the assets as current based on their purpose and availability to fulfill its direct obligation under current liabilities.

 

F-6

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Accounts Receivable, net

 

Accounts receivable include trade accounts due from customers in insurance brokerage and asset management businesses.

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms. The normal settlement terms of accounts receivable from insurance companies in the provision of brokerage agency services are within 30 days upon the execution of the insurance policies. Credit terms with the products providers of investment, unit and mutual funds and asset portfolio are mainly 90 days or a credit period mutually agreed between the contracting parties. The Company seeks to maintain strict control over its outstanding receivables to minimize credit risk. Overdue balances are reviewed regularly by senior management. Management reviews its receivables on a regular basis to determine if the bad debt allowance is adequate, and provides allowance when necessary.

 

The Company does not hold any collateral or other credit enhancements over its accounts receivable balances.

 

Loans Receivable, net

 

Loans receivable are real estate mortgage loans that carried at unpaid principal balances, less the allowance for credit losses on loans receivable and charge-offs.

 

Loans are placed on nonaccrual status when they are past due 180 days or more as to contractual obligations or when other circumstances indicate that collection is not probable. When a loan is placed on nonaccrual status, any interest accrued but not received is reversed against interest income. Payments received on a nonaccrual loan are either applied to protective advances, the outstanding principal balance or recorded as interest income, depending on an assessment of the ability to collect the loan. A nonaccrual loan may be restored to accrual status when principal and interest payments have been brought current and the loan has performed in accordance with its contractual terms for a reasonable period (generally six months).

 

If the Company determines that a loan is impaired, the Company next determines the amount of the impairment. The amount of impairment on collateral dependent loans is charged off within the given fiscal quarter. Generally, the amount of the loan and negative escrow in excess of the appraised value less estimated selling costs, for the fair value of collateral valuation method, is charged off. For all other loans, impairment is measured as described below in Allowance for Credit Losses on Financial Instruments.

 

Allowance for Credit Losses on Financial Instruments

 

In accordance with ASC Topic 326 “Credit Losses – Measurement of Credit Losses on Financial Instruments” (ASC Topic 326), the Company utilizes the current expected credit losses (“CECL”) model to determine an allowance that reflects its best estimate of the lifetime expected credit losses on accounts receivable, loans receivable, notes receivable and deposits, prepayments, and others receivable which is recorded as a liability to offset the receivables. The CECL model is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Accounts receivable, loans receivable, notes receivables and deposits, prepayments, and others receivable are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded as a reduction of bad debt expense.

 

Long-Term Investments, net

 

The Company invests in equity securities with readily determinable fair values and equity securities that do not have readily determinable fair values.

 

Equity securities with readily determinable fair values are carried at fair value with any unrealized gains or losses reported in earnings.

 

F-7

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Equity securities that do not have readily determinable fair values mainly consist of investments in privately-held companies. They are accounted for, at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.

 

At each reporting period, the Company makes a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired.

 

Asset Held For Sale

 

Assets to be disposed of by sale are reported at the lower of the carrying value or fair value less cost to sell when the Company has committed to a sale agreement and would be reported separately as assets held for sale in the unaudited condensed consolidated balance sheets.  

 

Property and Equipment, net

 

Property and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational:

 

   Expected useful life
Land and building  Shorter of 50 years or lease term
Office improvement  3 years
Furniture, fixtures and equipment  5 years
Computer equipment  3 years
Motor vehicle  3 years

 

Expenditure for repairs and maintenance is expensed as incurred. When assets have retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Impairment of Long-Lived Assets

 

In accordance with the provisions of ASC Topic 360, Impairment or Disposal of Long-Lived Assets, all long-lived assets such as property and equipment owned and held by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. No impairment losses were recognized for the three and six months ended June 30, 2023 and 2022.

 

Revenue Recognition

 

The Company receives certain portion of its non-interest income from contracts with customers, which are accounted for in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASC Topic 606").

 

ASC Topic 606 provided the following overview of how revenue is recognized from the Company’s contracts with customers. The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.

 

Step 1: Identify the contract(s) with a customer.

 

Step 2: Identify the performance obligations in the contract.

 

F-8

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Step 3: Determine the transaction price – The transaction price is the amount of consideration in a contract to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer.

 

Step 4: Allocate the transaction price to the performance obligations in the contract – Any entity typically allocates the transaction price to each performance obligation on the basis of the relative standalone selling prices of each distinct good or service promised in the contract.

 

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation – An entity recognizes revenue when (or as) it satisfies a performance obligation by transferring a promised good or service to a customer (which is when the customer obtains control of that good or service). The amount of revenue recognized is the amount allocated to the satisfied performance obligation. A performance obligation may be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically for promises to transfer service to a customer).

 

Certain portion of the Company's income is derived from contracts with customers, and as such, the revenue recognized depicts the transfer of promised goods or services to its customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company considers the terms of the contract and all relevant facts and circumstances when applying this guidance. The Company’s revenue recognition policies are in compliance with ASC Topic 606, as follows:

 

Commissions

 

The Company earns commissions from the sale of investment products to customers. The Company enters into commission agreements with customers which specify the key terms and conditions of the arrangement. Commissions are separately negotiated for each transaction and generally do not include rights of return, credits or discounts, rebates, price protection or other similar privileges, and typically paid on or shortly after the transaction is completed. Upon the purchase of an investment product, the Company earns a commission from customers, calculated as a fixed percentage of the investment products acquired by its customers. The Company defines the “purchase of an investment product” for its revenue recognition purpose as the time when the customers referred by the Company has entered into a subscription contract with the relevant product provider and, if required, the customer has transferred a deposit to an escrow account designated by the Company to complete the purchase of the investment products. After the contract is established, there are no significant judgments made when determining the one-time commission price. Therefore, commissions are recorded at point in time when the investment product is purchased.

 

The Company also facilitates the arrangement between insurance providers and individuals or businesses by providing insurance placement services to the insureds, and is compensated in the form of one-time commissions from the respective insurance providers. The Company primarily facilitates the placement of life, general and MPF insurance products. The Company determines that insurance providers are the customers.

 

The Company primarily earns commission income arising from the facilitation of the placement of an effective insurance policy, which is recognized at a point in time when the performance obligation has been satisfied upon execution of the insurance policy as the Company has no future or ongoing obligation with respect to such policies. The commission fee rate, which is paid by the insurance providers, based on the terms specified in the service contract which are agreed between the Company and insurance providers for each insurance product being facilitated through the Company. The commission earned is equal to a percentage of the premium paid to the insurance provider. Commission from renewed policies is variable consideration and is recognized in subsequent periods when the uncertainty around variable consideration is subsequently resolved (e.g., when customer renews the policy).

 

In accordance with ASC Topic 606, Revenue Recognition: Principal Agent Considerations, the Company evaluates the terms in the agreements with its channels and independent contractors to determine whether or not the Company acts as the principal or as an agent in the arrangement with each party respectively. The determination of whether to record the revenue in a gross or net basis depends upon whether the Company has control over the services prior to transferring it. Control is demonstrated by the Company which is primarily responsible for fulfilling the provision of placement services through the Company’s licensed insurance brokers to provide agency services. The commissions from insurance providers are recorded on a gross basis and commission paid to independent contractors or channel costs are recorded as commission expense in the statements of operations.

 

F-9

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

The Company also offers the sale solicitation of real estate property to the final customers and is compensated in the form of commissions from the corresponding property developers pursuant to the service contracts. Commission income is recognized at a point of time upon the sale contracts of real estate property is signed and executed.

 

Recurring service fees

 

The Company provides asset management services to investment funds or investment product providers in exchange for recurring service fees. Recurring service fees are determined based on the types of investment products the Company distributes and are calculated as a fixed percentage of the fair value of the total investment of the investment products, calculated daily. These customer contracts require the Company to provide investment management services, which represents a performance obligation that the Company satisfies over time. After the contract is established, there are no significant judgments made when determining the transaction price. As the Company provides these services throughout the contract term, for the method of calculating recurring service fees, revenue is calculated on a daily basis over the contract term, quarterly billed and recognized. Recurring service agreements do not include rights of return, credits or discounts, rebates, price protection, performance component or other similar privileges and the circumstances under which the fixed percentage fees, before determined, could be not subject to clawback. Payment of recurring service fees are normally on a regular basis (typically monthly or quarterly).

 

Interest income

 

The Company offers money lending services from loan origination in form of mortgage and personal loans. Interest income is recognized monthly in accordance with their contractual terms and recorded as interest income in the unaudited condensed consolidated statement of operations. The Company does not charge prepayment penalties from its customers. Interest income on mortgage and personal loans is recognized as it accrued using the effective interest method. Accrual of interest income on mortgage loans is suspended at the earlier of the time at which collection of an account becomes doubtful or the account becomes 180 days delinquent.

 

Disaggregation of Revenue

 

The Company has disaggregated its revenue from contracts with customers into categories based on the nature of the revenue. The following table presents the revenue streams by segments, with the presentation revenue categories presented on the statements of operation for the periods indicated:

 

   For the three months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $38,175   $-   $38,175 
                          
Non-interest income:                         
Commissions   16,005,608    277,960    -    39,488    16,323,056 
Recurring service fees   -    1,009,702    -    -    1,009,702 
                          
   $16,005,608   $1,287,662   $38,175   $39,488   $17,370,933 

 

F-10

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

   For the three months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $37,871   $-   $37,871 
                          
Non-interest income:                         
Commissions   2,373,898    518,277    -    44,905    2,937,080 
Recurring service fees   -    1,114,721    -    -    1,114,721 
                          
   $2,373,898   $1,632,998   $37,871   $44,905   $4,089,672 

 

   For the six months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $76,333   $-   $76,333 
                          
Non-interest income:                         
Commissions   25,693,427    601,722    -    43,534    26,338,683 
Recurring service fees   -    2,029,597    -    -    2,029,597 
                          
   $25,693,427   $2,631,319   $76,333   $43,534   $28,444,613 

 

   For the six months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $99,194   $-   $99,194 
                          
Non-interest income:                         
Commissions   2,553,829    1,094,812    -    115,516    3,764,157 
Recurring service fees   -    2,302,644    -    -    2,302,644 
                          
   $2,553,829   $3,397,456   $99,194   $115,516   $6,165,995 

 

Rental income

 

Rental income represents monthly rental received from the Company’s tenants. The Company recognizes rental income on a straight-line basis over the lease term in accordance with the lease agreement.

 

F-11

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Comprehensive Loss

 

ASC Topic 220, Comprehensive Income, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income (loss), as presented in the accompanying statement of shareholder’s equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive loss is not included in the computation of income tax expense or benefit.

 

Income Taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC Topic 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC Topic 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

For the three and six months ended June 30, 2023 and 2022, the Company did not have any interest and penalties associated with tax positions. As of June 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions.

 

The Company is subject to tax in local and foreign jurisdictions. As a result of its business activities, the Company files tax returns that are subject to examination by the relevant tax authorities.

 

Share-Based Compensation

 

The Company accounts for share-based compensation in accordance with the fair value recognition provision of ASC Topic 718, Stock Compensation. The Company grants share awards, including ordinary shares and restricted share units, to eligible participants. Share-based compensation expense for share awards is measured at fair value on the grant date. The fair value of restricted stock with either solely a service requirement or with the combination of service and performance requirements is based on the closing fair market value of the ordinary shares on the date of grant. Share-based compensation expense is recognized over the awards requisite service period. For awards with graded vesting that are subject only to a service condition, the expense is recognized on a straight-line basis over the service period for the entire award.

 

Net Loss Per Share

 

The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, Earnings per Share (“ASC Topic 260”). ASC Topic 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net (loss) income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Segment Reporting

 

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for details on the Company’s business segments.

 

F-12

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

The Company uses the management approach to determine reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making decisions, allocating resources and assessing performance. The Company’s CODM has been identified as the CEO, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. Based on management’s assessment, the Company determined that it has the following operating segments:

 

Segments   Scope of Service   Business Activities
Distribution Business   Insurance Brokerage
Business
  - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
         
Platform Business   - Asset Management Business  

- Providing access to financial products and services to licensed brokers.

- Providing operational support for the submission and processing of product applications.

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

- Providing training resources and materials.

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

         
    - Money Lending Service   - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
         
    - Real Estate Agency Service   - Solicitation of real estate sales for the developers, in exchange for commissions.
         
Fintech Business   Investment Holding   Managing an ensemble of fintech investments.
         
Healthcare Business   Investment Holding   Managing an ensemble of healthcare-related investments.

 

All of the Company’s revenues were generated in Hong Kong.

 

Leases

 

The Company follows ASC Topic 842, Leases (“ASC Topic 842”), utilizing the modified retrospective transition method with no adjustments to comparative periods presented. On February 25, 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (ASC Topic 842), to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. ASC Topic 842 requires that lessees recognize right-of-use asset and lease liabilities calculated based on the present value of lease payments for all lease agreements with terms that are greater than twelve months. It requires for leases longer than one year, a lessee to recognize in the statement of financial condition a right-of-use asset, representing the right to use the underlying asset for the lease term, and a lease liability, representing the liability to make lease payments. ASC Topic 842 distinguishes leases as either a finance lease or an operating lease that affects how the leases are measured and presented in the statement of operations and statement of cash flows. ASC Topic 842 supersedes nearly all existing lease accounting guidance under GAAP issued by the Financial Accounting Standards Board (“FASB”) including ASC Topic 840, Leases.

 

When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company used an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected to adopt the following lease policies in conjunction with the adoption of ASU 2016-02: (i) for leases that have lease terms of 12 months or less and does not include a purchase option that is reasonably certain to exercise, the Company elected not to apply ASC 842 recognition requirements; and (ii) the Company elected to apply the package of practical expedients for existing arrangements entered into prior to January 1, 2021 to not reassess (a) whether an arrangement is or contains a lease, (b) the lease classification applied to existing leases, and (c) initial direct costs.

 

F-13

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

The accounting update also requires that for finance leases, a lessee recognize interest expense on the lease liability, separately from the amortization of the right-of-use asset in the statements of earnings, while for operating leases, such amounts should be recognized as a combined expense. In addition, this accounting update requires expanded disclosures about the nature and terms of lease agreements.

 

Related Parties

 

The Company follows the ASC Topic 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Commitments And Contingencies

 

The Company follows the ASC Topic 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

F-14

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Fair Value Measurement

 

The Company follows the guidance of the ASC Topic 820-10, Fair Value Measurements and Disclosures ("ASC Topic 820-10"), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 : Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets;

 

  Level 2 : Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. Black-Scholes Option-Pricing model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs; and

 

  Level 3 : Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the assets or liabilities. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models.

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, restricted cash, accounts receivable, deposits, prepayments, and others receivable, amounts due to the holding company, accounts payable and accrued liabilities, escrow liabilities and borrowings approximate at their fair values because of the short-term nature of these financial instruments.

 

Management believes, based on the current market prices or interest rates for similar debt instruments, the fair value of loans receivable and notes receivable approximate the carrying amount. They are accounted at amortized cost, subject to impairment testing.

 

The following table presents information about the Company’s assets that were measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

 

   June 30,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2023   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $524   $    524   $         -   $- 
Non-marketable equity securities  $33,946,542   $-   $-   $33,946,542 
                     
Liabilities:                    
Warrant liabilities  $2,173   $-   $-   $2,173 

 

   December 31,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2022   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $2,443,593   $2,443,593   $     -   $- 
Non-marketable equity securities  $34,589,767   $-   $-   $34,589,767 
                     
Liabilities:                    
Forward share purchase liability  $13,491,606   $-   $-   $13,491,606 
Warrant liabilities  $4,548   $-   $-   $4,548 

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

F-15

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Recently Issued Accounting Pronouncements

 

There were no new standards or updates during the six months ended June 30, 2023 that had a material impact on the unaudited condensed consolidated financial statements.

 

NOTE 3 — LIQUIDITY AND GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements were prepared assuming the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

For the six months ended June 30, 2023, the Company reported $22,657,899 net loss and $19,265,823 net cash outflows from operating activities. As of June 30, 2023, the Company had an accumulated deficit of $62,053,032 and cash and cash equivalents of $3,783,780.

 

The ability to continue as a going concern is dependent on the Company’s ability to successfully implement its plans. The Company believes that it will be able to continue to grow the Company’s revenue base and control expenditures. In parallel, the Company continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance the Company’s business development activities, general and administrative expenses and growth strategy. These alternatives include external borrowings, raising funds through public equity or debt markets. Although there is no assurance that, if needed, the Company will be successful with its fundraising initiatives, the Company believes that the Business Combination transaction significantly increases its ability to access the capital going forward. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Without realization of additional capital, there is substantial doubt about the Company can continue as a going concern until such time, as the Company is able to secure adequate financial resources and capital that provides the required capital to continue to settle its debts as they fall due and sustain the operation through the next 12 months from the date that these unaudited condensed consolidated financial statements were made available to issue.

 

NOTE 4 — RESTRICTED CASH

 

Pursuant to the Meteora Backstop Agreement dated November 9, 2022, the fund held in the escrow account for the forward share purchase is restricted to the Company for the nine months following the consummation of the Business Combination in November 2022, unless the investors sell the shares in the market or redeems the shares. Notwithstanding the sale of shares by the investors, the restricted cash will be used to settle any of the Company’s repurchase obligations.

 

During the six months ended June 30, 2023, the investors sold 1,191,016 shares in the open market at a price ranging from $1.51 to $1.61 per share.

 

On June 29, 2023, the Company and the investors entered into an agreement to early terminate the Meteora Backstop Agreement.

 

Pursuant to the early termination clauses of Meteora Backstop Agreement, the Company released $14.0 million from restricted cash to settle the obligation to investors and retained $1.7 million which is reflected in the cash and cash equivalents on the unaudited condensed consolidated balance sheets.

 

Pursuant to the termination agreement, the Company is not obligated to purchase the remaining 124,949 shares (the “Shares”) from the investors and the investors shall have no obligation to sell the Shares to the Company. In addition, the investors may dispose the Shares at its discretion in the open market at a sales price not less than $2 per share within the first three months following the date of the termination agreement and there is no condition or restrictions on the sales price thereafter. As a result, the Company released the remaining $1.5 million from restricted cash to settle the obligation to investors.

 

With the early termination and sale of shares by investors, the forward share purchase liability (“FSP liability”) was fully settled as of June 30, 2023 and a loss on settlement of $378,895 was recorded in the unaudited condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2023.

 

F-16

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

NOTE 5 - ACCOUNTS RECEIVABLE, NET

 

Accounts receivable, net consisted of the following:

 

   As of 
   June 30,
2023
   December 31,
2022
 
Accounts receivable  $3,592,789   $2,916,609 
Accounts receivable – related parties   601,576    272,546 
Less: allowance for estimated credit losses   (162,009)   (94,447)
Accounts receivable, net  $4,032,356   $3,094,708 

 

The accounts receivable due from related parties represented the management service rendered to the portfolio assets of a related companies, which are controlled by the holding company, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers. The amount is unsecured, interest-free and with a credit term mutually agreed.

 

The Company generally conducts its business with creditworthy third parties. The Company determines, on a quarterly basis, the probable losses and an allowance for credit losses determined in accordance with the CECL model, based on historical losses, current economic conditions, forecasted future economic and market considerations, and in some cases, evaluating specific customer accounts for risk of loss. Accounts receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. In addition, receivable balances are monitored on an ongoing basis and its exposure to bad debts is not significant.

 

For the three and six months ended June 30, 2023, the Company has assessed the probable loss and made an allowance for estimated credit losses of $67,949 and $67,949 on accounts receivable, respectively.

 

For the three and six months ended June 30, 2022, there was no estimated credit losses to accounts receivable.

 

NOTE 6 - LOANS RECEIVABLE, NET

 

The Company’s loans receivable, net was as follows:

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Mortgage loans (residential)  $1,576,013   $1,589,871 
           
Reclassifying as:          
Current portion  $516,237   $517,479 
Non-current portion   1,059,776    1,072,392 
Loans receivable, net  $1,576,013   $1,589,871 

 

The interest rates on loans issued ranged between 9.00% and 10.50% per annum for the six months ended June 30, 2023 and 2022. Mortgage loans are secured by collateral in the pledge of the underlying real estate properties owned by the borrowers.

 

Mortgage loans are made to either business or individual customers in Hong Kong for a period of 1 to 25 years, which are fully collateralized and closely monitored for counterparty creditworthiness, with such collateral having a fair value in excess of the carrying amount of the loans as of June 30, 2023 and December 31, 2022.

 

Estimated allowance for credit losses is determined on quarterly basis, in accordance with the CECL model, for general credit risk of the overall portfolio, which is relied on an assessment of specific evidence indicating doubtful collection, historical loss experience, loan balance aging and prevailing economic conditions. If there is an unexpected deterioration of a customer’s financial condition or an unexpected change in economic conditions, including macroeconomic events, the Company will assess the need to adjust the allowance for credit losses. Any such resulting adjustments would affect earnings in the period that adjustments are made.

 

For the three and six months ended June 30, 2023 and 2022, the Company has evaluated the probable losses on the loans receivable and no estimated credit losses is determined.

 

F-17

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

NOTE 7 - ASSET HELD FOR SALE

 

On June 28, 2023, the Company entered into a provisional purchase and sale agreement with an independent third party to sell one of its office premises at a consideration of $6.15 million. The Company received a deposit of $0.3 million and the transaction is expected to be completed in October 2023. As of June 30, 2023, the carrying amount of the asset held for sale was $5.46 million which reclassified from the property and equipment, net.

 

NOTE 8 - NOTES RECEIVABLE, NET

 

On February 24, 2023, the Company entered into a Subscription Agreement and a Convertible Loan Note Instrument (the “Note”) (collectively the “Agreements”) with Investment A. Pursuant to the Agreements, the Company agrees to subscribe an aggregate amount of $1,673,525 notes, in batches, which are payable on or before January 31, 2024 and bears a fixed interest rate of 8% per annum. The maturity of the notes receivable is on April 30, 2024.

 

As of June 30, 2023, the carrying amount of the notes receivable was $601,490, including an interest receivable of $11,778.

 

In accordance with ASC Topic 326, the Company accounts for its allowance for credit losses on notes receivable using the CECL model. Periodic changes to the allowance for credit losses are recognized in the unaudited condensed consolidated statements of operations. For the three and six months ended June 30, 2023, the Company has evaluated the probable losses on the notes receivable and no estimated credit losses is determined.

 

NOTE 9 - LONG-TERM INVESTMENTS, NET

 

Long-term investments consisted of the following:

 

   As of 
   Ownership
interest
   June 30,
2023
   Ownership
interest
   December 31,
2022
 
                 
Marketable equity securities                
Investment C   0.00%*  $524    0.46%  $2,443,593 
                     
Non-marketable equity securities:                    
Investment A   8.37%   5,740,036    8.37%   5,717,678 
Investment B   3.63%   511,003    3.63%   513,000 
Investment D   4.49%   16,784,183    4.92%   16,030,943 
Investment E   4.00%   520,523    4.00%   522,557 
Investment F   4.00%   10,390,797    4.00%   11,805,589 
Total        33,946,542         34,589,767 
Net carrying value       $33,947,066        $37,033,360 

 

*Less than 0.001%

 

Investments in Marketable Equity Securities

 

Investments in marketable securities are accounted for at its current market value with the changes in fair value recognized in statements of operations. Investment C was listed and publicly traded on Nasdaq Stock Exchange.

 

During the six months ended June 30, 2023, the Company sold 993,108 shares of Investment C at the average market price of $4.01 per share, resulting with a realized gain of $1,541,736.

 

As of June 30, 2023 and December 31, 2022, Investment C was recorded at fair value of $524 and $2,443,593, which were traded at a closing price of $8.06 and $2.46 per share, respectively.

 

F-18

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Investments in Non-Marketable Equity Securities

 

Investments in non-marketable equity securities consist of investments in limited liability companies in which the Company’s interests are deemed minor and long-term, strategic investments in companies that are in various stages of development, and investments in a close-ended partnership funds which concentrated in the healthcare sector. These investments do not have readily determinable fair values and, therefore, are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.

 

Management assesses each of these investments on an individual basis, subject to a periodic impairment review and considers qualitative and quantitative factors including the investee’s financial condition, the business outlook for its products and technology, its projected results and cash flow, financing transactions subsequent to the acquisition of the investment, the likelihood of obtaining subsequent rounds of financing and cash usage. The Company is not required to determine the fair value of these investments unless impairment indicators existed. When an impairment exists, the investment will be written down to its fair value by recording the corresponding charge as a component of other income (expense), net. Fair value is estimated using the best information available, which may include cash flow projections or other available market data.

 

The following table presents the changes in fair value of non-market equity securities which are measured using Level 3 inputs as of June 30, 2023 and December 31, 2022:

 

   As of 
   June 30,
2023
   December 31,
2022
 
Balance at beginning of period/year  $34,589,767   $25,496,534 
Additions   -    16,228,690 
Adjustments:          
Downward adjustments   (1,427,904)   (6,898,549)
Upward adjustments   -    2,137,021 
Foreign exchange adjustment   784,679    (2,373,929)
Balance at end of period/year  $33,946,542   $34,589,767 

 

Cumulative unrealized gains and losses, included in the carrying value of the Company’s non-marketable equity securities:

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Downward adjustments (including impairment)  $(28,682,504)  $(27,254,600)
Upward adjustments  $6,209,357   $6,209,357 

 

Investment income (loss) is recorded as other income (expense) and consisted of the following:

 

   For the three months ended
June 30,
 
   2023   2022 
Marketable equity securities:        
Unrealized loss from the changes in fair value – Investment C  $(168)  $(5,683,988)
Realized gain from sale of Investment C   -    - 
           
Non-marketable equity securities:          
Unrealized loss (including impairment) – Investment F   (1,000,119)   - 
Dividend income   558,719    - 
Investment loss, net  $(441,568)  $(5,683,988)

 

F-19

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

   For the six months ended
June 30,
 
   2023   2022 
Marketable equity securities:        
Unrealized gain (loss) from the changes in fair value – Investment C  $98   $(3,535,053)
Realized gain from sale of Investment C   1,541,736    - 
           
Non-marketable equity securities:          
Unrealized loss (including impairment) – Investment F   (1,427,771)   - 
Dividend income   1,167,433    - 
Investment income (loss), net  $1,281,496   $(3,535,053)

 

NOTE 10 - PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

   As of 
   June 30,
2023
   December 31,
2022
 
At cost:        
Land and building  $1,878,538   $7,881,202 
Furniture, fixtures and equipment   13,360    13,412 
Computer equipment   241,842    164,536 
Motor vehicles   108,570    108,994 
    2,242,310    8,168,144 
Less: accumulated depreciation   (508,846)   (808,728)
Property and equipment, net  $1,733,464   $7,359,416 

 

Depreciation expenses for the three months ended June 30, 2023 and 2022 were $114,322 and $95,673, respectively.

 

Depreciation expenses for the six months ended June 30, 2023 and 2022 were $215,494 and $192,352, respectively.

 

As of June 30, 2023, the carrying amount of an office premises of $5.46 million was reclassified to asset held for sale as the Company entered a provisional purchase and sale agreement with an independent third party to sale the office premises in October 2023 (see Note 7).

 

NOTE 11 - BORROWINGS

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Mortgage borrowings  $6,255,238   $4,477,254 

 

In September 2022, the Company obtained a mortgage loan from a finance company in Hong Kong, which bears interest at a fixed rate of 10.85% per annum, is repayable in September 2023.

 

In February 2023, the Company obtained another mortgage loan from another finance company in Hong Kong, which bears an average interest rate at 13.75% per annum, is repayable in February 2024.

 

As of June 30, 2023, the mortgage loans are secured by the office premises of the Company, located in Hong Kong, with the aggregate carrying amount of $7.0 million (December 31, 2022: $5.7 million), of which $5.5 million (December 31, 2022: nil) is asset held for sale.

 

F-20

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

NOTE 12 - FORWARD SHARE PURCHASE LIABILITY

 

For the three and six months ended June 30, 2023, subject to the sale of shares by investors and early termination of the Meteora Backshop Agreement, the forward share purchase liability (“FSP liability”) was fully settled and a loss on settlement of $378,895 was recorded in the unaudited condensed consolidated statements of operations and comprehensive loss.

 

The FSP liability under the Meteora Backstop Agreement is valued by an independent valuer using a Black-Scholes model, which is considered to be Level 3 fair value measurement. The following table present the quantitative information regarding Level 3 fair value measurement of the FSP liability:

 

Input   December 31,
2022
 
Share price   $1.54 
Risk-free interest rate    4.16%
Volatility    52.19%
Exercise price   $12.34 
Term    0.61 years 

 

For the three and six months ended June 30, 2023, the change in fair value of FSP liability was $0 and $82,182, respectively.

 

NOTE 13 - LEASES

 

Operating lease right-of-use (“ROU”) asset and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU asset represents the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest (“discount rate”) in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

 

During the six months ended June 30, 2023, the Company has entered into a commercial operating lease with an independent third party for the use of an office in Hong Kong. The lease has an original term exceeding 1 year, but not more than 3 years with an option to renew a further term of 3 years. The operating lease is included in “Right-of-use asset” on the unaudited condensed consolidated balance sheet and represents the Company’s right to use the underlying asset during the lease term. The Company’s obligation to make lease payments are included in “Lease liabilities” on the unaudited condensed consolidated balance sheet.

 

Supplemental balance sheet information related to the operating lease was as follows:

 

   June 30,
2023
 
Operating lease:    
Right-of-use asset, net  $12,361,125 
      
Lease liabilities:     
Current lease liabilities   1,186,200 
Non-current lease liabilities   11,227,185 
Total lease liabilities  $12,413,385 

 

Operating lease expense for the three and six months ended June 30, 2023 was $213,550 and $213,550, respectively. There was no operating lease for the three and six months ended June 30, 2022.

 

Other supplemental information about the Company’s operating lease as of June 30, 2023 are as follow:

 

Weighted average discount rate   6.58%
Weighted average remaining lease term (years)   5.92 

 

F-21

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Maturities of operating lease liabilities as of June 30, 2023 were as follows:

 

For the period ending June 30,  Operating
lease
 
2024  $1,934,715 
2025   1,934,715 
2026   2,039,234 
2027   3,188,945 
2028   3,188,945 
Thereafter   2,923,199 
Total future minimum lease payments   15,209,753 
Less: imputed interest   (2,796,368)
Present value of operating lease liabilities  $12,413,385 

 

NOTE 14 - WARRANT LIABILITIES

 

The private warrants are accounted for as liabilities in accordance with ASC 480 and are presented as liabilities on the unaudited condensed consolidated balance sheets. As of June 30, 2023 and December 31, 2022, there were 225,000 private warrants outstanding.

 

The fair value of the private warrants are valued by an independent valuer using a Binominal pricing model. The warrants were classified as Level 3 due to the use of unobservable inputs.

 

The key inputs into the Binominal pricing model were as follows at their measurement dates:

 

Input  June 30,
2023
   December 31,
2022
 
Share price  $1.44   $1.54 
Risk-free interest rate   4.51%   4.16%
Volatility   51.83%   52.19%
Exercise price  $11.50   $11.50 
Term   4.4 years    4.9 years 

 

As of June 30, 2023 and December 31, 2022, the aggregate value of the private warrants was $2,173 and $4,548, respectively. The changes in fair value for the three and six months ended June 30, 2023 was $1,695 and $2,375, respectively.

 

NOTE 15 - SHAREHOLDERS’ EQUITY

 

Ordinary shares

 

As of June 30, 2023 and December 31, 2022, the Company has authorized share of 200,000,000 ordinary shares with a par value $0.001.

 

On March 21, 2023, the Company issued 2,173,913 ordinary shares to Apex Twinkle Limited to partially settle the finder fee payable.

 

On May 22, 2023, the Company issued 946,100 ordinary shares to the directors and officers of the Company under the Share Award Scheme (the “Scheme”) for compensating the contributions of prior services and performance. The shares were approved and granted previously in December 2022.

 

On June 6, 2023, the holdback shares of 1,665,000 ordinary shares were fully released and issued.

 

F-22

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

During the six months ended June 30, 2023, pursuant to the Scheme, the Company issued in aggregate of 4,300,000 ordinary shares to certain consultants to compensate the services rendered.

 

As of June 30, 2023 and December 31, 2022, there were 67,461,998 and 58,376,985 ordinary shares issued and outstanding, respectively.

 

Public Warrants

 

Each public warrant entitles the holder thereof to purchase one-half (1/2) of one ordinary share at a price of $11.50 per full share, subject to adjustment as discussed herein. The warrants became exercisable 90 days after the Closing of the Business Combination and will expire five years after the Closing of the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares. This means that only an even number of warrants may be exercised at any given time by a warrant holder.

 

Once the warrants become exercisable, the Company may call the outstanding warrants (including any outstanding warrants issued upon exercise of the unit purchase option issued to Maxim Group LLC) for redemption:

 

  in whole and not in part;

 

  at a price of $0.01 per warrant;

 

  upon a minimum of 30 days’ prior written notice of redemption,

 

  if, and only if, the last sales price of the ordinary shares equals or exceeds $16.50 per share for any 20 trading days within a 30 trading day period ending three business days before the Company send the notice of redemption, and

 

  if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

 

If the Company calls the warrants for redemption as described above, the management of the Company will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Whether the Company will exercise our option to require all holders to exercise their warrants on a “cashless basis” will depend on a variety of factors including the price of our ordinary shares at the time the warrants are called for redemption, the Company’s cash needs at such time and concerns regarding dilutive share issuances.

 

Private Warrants

 

The private warrants are identical to the public warrants, except that the private warrants and the ordinary shares issuable upon the exercise of the private warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the private warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private warrants are held by someone other than the initial purchasers or their permitted transferees, the private warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.

 

The private warrants are accounted as liabilities, remeasured to fair value on a recurring basis, with changes in fair value recorded to the unaudited condensed consolidated statements of operations (see Note 14).

 

As of June 30, 2023 and December 31, 2022, there were 4,600,000 public warrants and 225,000 private warrants outstanding.

 

F-23

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Share Award Scheme

 

On February 24, 2023, pursuant to the Scheme, the Company registered 11,675,397 ordinary shares to be issued. As of June 30, 2023, the Company issued 5,246,100 ordinary shares under the Scheme.

 

The fair value of the ordinary shares granted under the scheme is measured based on the closing price of the Company’s ordinary shares as reported by Nasdaq Exchange on the date of grant.

 

For those vested immediately on the date of grant, the fair value is recognized as share-based compensation expense in the consolidated statements of operations.

 

For the restricted share units (“RSUs”), the fair value is recognized over the period based on the derived service period (usually the vesting period), on a straight-line basis. The valuations assume no dividends will be paid. The Company has assumed 10% forfeitures.

 

During the three and six months ended June 30, 2023, the Company recorded $4,604,320 and $8,510,920 share-based compensation expense, respectively which is included in the operating expenses in the unaudited condensed consolidated statements of operations.

 

As of June 30, 2023, total unrecognized compensation remaining to be recognized in future periods for RSUs totaled $8.5 million. They are expected to be recognized over the weighted average period of 2.2 years.

 

A summary of the activities for the Company’s RSUs for the three and six months ended June 30, 2023 is as follow:

 

   As of 
   June 30, 2023   December 31, 2022 
   Number of
RSUs
   Weighted
Average
Grant Price
   Number of
RSUs
   Weighted
Average
Grant Price
 
                 
Outstanding, beginning of period/year   5,000,000   $2.47    -   $- 
Granted   -   $-    5,000,000   $2.47 
Outstanding, end of period/year   5,000,000   $2.47    5,000,000   $2.47 

 

Forgiveness of Amounts Due to the Holding Company

 

During the three and six months ended June 30, 2023, TAG agreed to forgive the Company $5.6 million and $8.6 million, in aggregate, respectively representing certain amount due to it and treat as additional paid-in capital.

 

NOTE 16 - OPERATING COST AND EXPENSES

 

Commission Expense

 

Pursuant to the terms of respective contracts, commission expense represents certain premiums from insurance or investment products paid to agents. Commission rates vary by market due to local practice, competition, and regulations. The Company charged commission expense on a systematic basis that is consistent with the revenue recognition.

 

During the three months ended June 30, 2023 and 2022, the Company recorded $11,984,437 and $2,480,271 commission expenses, respectively.

 

During the six months ended June 30, 2023 and 2022, the Company recorded $19,279,929 and $3,181,313 commission expenses, respectively.

 

Personnel and Benefit Expense

 

Personnel and benefit expense mainly consisted of salaries and bonus paid and payable to the employees of the Company. During the six months ended June 30, 2023, the Company reversed the annual bonus of $3.8 million that was already accrued for the year ended December 31, 2022.

 

F-24

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

During the three months ended June 30, 2023 and 2022, the Company recorded $5,302,270 and $3,404,039 personnel and benefit expense, respectively.

 

During the six months ended June 30, 2023 and 2022, the Company recorded $14,907,460 and $5,409,018 personnel and benefit expense, respectively.

 

Other General and Administrative Expenses

 

The Company incurred different types of expenditures under other general and administrative expenses. They primarily consist of depreciation of property and equipment, legal and professional fees and management fee expenses which are allocated for certain corporate office expenses.

 

During the three months ended June 30, 2023 and 2022, the Company recorded $8,655,884 and $1,173,217 other general and administrative expenses, respectively.

 

During the six months ended June 30, 2023 and 2022, the Company recorded $14,511,705 and $2,081,618 other general and administrative expenses, respectively.

 

NOTE 17 - INCOME TAXES

 

The provision for income taxes consisted of the following:

 

   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
Current tax (including over provision of income tax)  $26,368   $40,431   $(280)  $105,354 
Deferred tax   -    (354,574)   -    - 
Income tax expense (benefit)  $26,368   $(314,143)  $(280)  $105,354 

 

The Company’s subsidiaries mainly operate in Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

British Virgin Islands

 

The Company is incorporated in the British Virgin Islands and is not subject to taxation. In addition, upon payments of dividends by these entities to their shareholder, no British Virgin Islands withholding tax will be imposed.

 

Hong Kong

 

The Company’s subsidiaries operating in Hong Kong is subject to the Hong Kong Profits Tax at the income tax rates ranging from 8.25% to 16.5% on the assessable income arising in Hong Kong during its tax year. During the six months ended June 30, 2023, income tax benefit is primarily attributable to the over provision of income taxes for prior year of $40,151.   

 

The following table sets forth the significant components of the deferred tax liabilities and assets of the Company as of June 30, 2023 and December 31, 2022:

 

   June 30,
2023
   December 31,
2022
 
Deferred tax liabilities:        
- Accelerated depreciation  $45,680   $45,858 
    45,680    45,858 
           
Deferred tax assets, net:          
Net operating loss carryforwards   7,747,627    5,461,370 
Less: valuation allowance   (7,747,627)   (5,461,370)
    -    - 
           
Deferred tax liabilities, net  $45,680   $45,858 

 

F-25

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

As of June 30, 2023 and December 31, 2022, the operations incurred $47.0 million and $33.1 million, respectively of cumulative net operating losses which can be carried forward to offset future taxable income. Net operating loss can be carried forward indefinitely but cannot be carried back to prior years. There are no group relief provisions for losses or transfers of assets under Hong Kong tax regime. Each company within a corporate group is taxed as a separate entity. The Company has provided for a full valuation allowance against the deferred tax assets on the expected future tax benefits from the net operating loss carryforwards as the management believes that it is more likely than not that these assets will not be realized in the future. The valuation allowance is reviewed annually.

 

Uncertain tax positions

 

The Company evaluates the uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of June 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the six months ended June 30, 2023 and 2022 and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from June 30, 2023.

 

NOTE 18 - SEGMENT INFORMATION

 

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for detailing the Company’s business segments.

 

Currently, the Company has four business segments comprised of the following products and services:

 

Segments   Scope of Business Activities
Distribution Business   - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
     
Platform Business  

- Providing access to financial products and services to licensed brokers.

 

- Providing operational support for the submission and processing of product applications.

 

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

 

- Providing training resources and materials.

 

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

     
    - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
     
    - Solicitation of real estate sales for the developers, in exchange for commissions.
     
Fintech Business   Managing an ensemble of fintech investments.
     
Healthcare Business   Managing an ensemble of healthcare-related investments.

 

The four business segments were determined based primarily on how the chief operating decision maker views and evaluates the operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services are considered in determining the formation of these operating segments.

 

F-26

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

The following tables present the summary information by segment for the three and six months ended June 30, 2023 and 2022:

 

   For the three months ended June 30, 2023 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue                    
- Interest income  $-   $38,175   $-   $-   $38,175 
- Non-interest income   16,005,608    1,327,150    -    -    17,332,758 

Total revenue  

   16,005,608    1,365,325    -    -    17,370,933 
                          
Commission expense   11,628,412    356,025    -    -    11,984,437 
Depreciation on property and equipment   261    105,892    8,169    -    114,322 
Income (loss) from operations   2,734,753    6,785,460    (19,913,347)   -    (10,393,134)
Investment loss, net   -    -    (441,568)   -    (441,568)
Total assets  $18,065,731   $42,202,217   $34,513,786   $520,523   $95,302,257 

 

   For the three months ended June 30, 2022 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue, net                    
- Interest income  $-   $37,871   $-   $-   $37,871 
- Non-interest income   2,373,898    1,677,903    1,188    -    4,052,989 
Less: inter-segment   -    -    (1,188)   -    (1,188)

Total revenue, net  

   2,373,898    1,715,774    -    -    4,089,672 
                          
Commission expense   1,906,944    573,327    -    -    2,480,271 
Depreciation on property and equipment   239    95,342    92    -    95,673 
Income (loss) from operations   (1,321,333)   (2,591,456)   404,403    -    (3,508,386)
Investment loss, net   -    -    (5,683,988)   -    (5,683,988)
Total assets  $4,427,863   $52,241,241   $37,746,196   $522,557   $94,937,857 

 

   For the six months ended June 30, 2023 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue                    
- Interest income  $-   $76,333   $-   $-   $76,333 
- Non-interest income   25,693,427    2,674,853    -    -    28,368,280 

Total revenue  

   25,693,427    2,751,186    -    -    28,444,613 
                          
Commission expense   18,540,477    739,452    -    -    19,279,929 
Depreciation on property and equipment   522    201,514    13,458    -    215,494 
Income (loss) from operations   3,187,190    (4,401,856)   (23,762,276)   -    (24,976,942)
Investment income, net   -    -    1,281,496    -    1,281,496 
Total assets  $18,065,731   $42,202,217   $34,513,786   $520,523   $95,302,257 

 

F-27

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

   For the six months ended June 30, 2022 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue, net                    
- Interest income  $-   $99,194   $-   $-   $99,194 
- Non-interest income   2,553,829    3,512,972    2,767    -    6,069,568 
Less: inter-segment   -    -    (2,767)   -    (2,767)
Total revenue, net   2,553,829    3,612,166    -    -    6,165,995 
                          
Commission expense   1,975,138    1,206,175    -    -    3,181,313 
Depreciation on property and equipment   372    191,285    695    -    192,352 
Loss from operations   (2,768,395)   (2,045,873)   (606,435)   -    (5,420,703)
Investment loss, net   -    -    (3,535,053)   -    (3,535,053)
Total assets  $4,427,863   $52,241,241   $37,746,196   $522,557   $94,937,857 

 

All of the Company’s customers and operations are based in Hong Kong.

 

NOTE 19 - RELATED PARTY BALANCES AND TRANSACTIONS

 

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by the holding company. Amounts represent advances or amounts paid in satisfaction of liabilities.

 

Related party balances consisted of the following:

 

      As of 
      June 30,
2023
   December 31,
2022
 
            
Accounts receivable  (a)  $601,576   $272,546 
Amounts due to the holding company  (b)  $4,539,168   $6,289,743 

 

(a)Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the holding company.

 

(b) Amounts due to the holding company are those nontrade payables arising from transactions between the Company and the holding company, such as advances made by the holding company on behalf of the Company, advances made by the Company on behalf of the holding company, and allocated shared expenses paid by the holding company.

 

F-28

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

In the ordinary course of business, during the three and six months ended June 30, 2023 and 2022, the Company involved with transactions, either at cost or current market prices and on the normal commercial terms among related parties. The following table provides the transactions with these parties for the periods as presented (for the portion of such period that they were considered related):

 

      Three months ended
June 30,
   Six months ended
June 30,
 
      2023   2022   2023   2022 
Asset management service income  (c)  $241,688   $241,325   $480,621   $481,268 
Commission expenses  (d)       7,183        56,017 
Office and operating fee charge  (e)   1,742,332    499,161    3,772,045    1,004,307 
General and administrative expense allocated  (f)   1,722    272,190    1,722    545,836 
Purchase of investment from holding company  (g)       6,560,122        6,560,122 
Purchase of office building from holding company  (h)               5,896,301 
Payment of special dividends to holding company  (k)  $   $   $   $47,000,000 

 

(c) Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the holding company, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers.

 

(d)Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee.

 

(e)Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the holding company for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the holding company. Also, the holding company charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business.

 

(f)Certain amounts of general and administrative expenses were allocated by the holding company.

 

(g)The Company purchased 4,158,963 shares of Investment A from the holding company and the transaction was completed on April 20, 2022 based on the historical cost to the holding company.

 

(h)The Company purchased an office building from the holding company in January 2022, based on its historical carrying amount.

 

(i)On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from holding company and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021.

 

Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented.

 

F-29

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

NOTE 20 - CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

(a)Major customers

 

For the three and six months ended June 30, 2023, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivable balances at period-end dates, are presented as follows:

 

   Three months ended
June 30, 2023
   Six months ended
June 30, 2023
   June 30,
2023
 
Customer  Revenues   Percentage
of revenues
   Revenues   Percentage
of revenues
   Accounts
receivable
 
Customer A  $3,849,161    22%  $6,566,059    23%  $- 
Customer B  $3,055,295    18%  $4,425,921    16%  $139 
Customer C  $1,874,473    11%  $3,105,629    11%  $- 
Customer D  $2,029,613    12%  $3,051,903    11%  $49,223 

 

For the three and six months ended June 30, 2022, there was no single customer who accounted for 10% or more of the Company’s revenues.

 

All of the Company’s major customers are located in Hong Kong.

 

(b)Credit risk

 

Financial instruments that potentially subject the Company to credit risk consist of cash equivalents, restricted cash, accounts receivable, loans receivable, and notes receivable. Cash equivalents are maintained with high credit quality institutions, the composition and maturities of which are regularly monitored by management. The Hong Kong Deposit Protection Board pays compensation up to a limit of HK$500,000 (approximately $63,805) if the bank with which an individual/a company hold its eligible deposit fails. As of June 30, 2023, cash balance of $3.8 million and fund held in escrow of $27.5 million were maintained at financial institutions in Hong Kong, of which approximately $28.7 million was subject to credit risk. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.

 

For accounts receivable, loans receivable, and notes receivable, the Company determines, on a continuing basis, the probable losses and sets up an allowance for doubtful accounts based on the estimated realizable value. Credit of money lending business is controlled by the application of credit approvals, limits and monitoring procedures.

 

The Company uses internally-assigned risk grades to estimate the capability of borrowers to repay the contractual obligations of their loan agreements as scheduled or at all. The Company’s internal risk grade system is based on experiences with similarly graded loans and the assessment of borrower credit quality, such as, credit risk scores, collateral and collection history. Individual credit scores are assessed by credit bureau, such as TransUnion. Internal risk grade ratings reflect the credit quality of the borrower, as well as the value of collateral held as security. To minimize credit risk, the Company requires collateral arrangements to all mortgage loans and has policies and procedures for validating the reasonableness of the collateral valuations on a regular basis. Management believes that these policies effectively manage the credit risk from advances.

 

F-30

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

The Company’s third-party customers that represent more than 10% of total combined loans receivable, and their related net loans receivable balance as a percentage of total combined loans receivable, as of June 30, 2023 and December 31, 2022 were as follows:

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Customer E   37.3%   37.4%
Customer F   31.6%   31.6%
Customer G   31.1%   31.0%

 

(c)Economic and political risk

 

The Company’s major operations are conducted in Hong Kong. Accordingly, the political, economic, and legal environments in Hong Kong, as well as the general state of Hong Kong’s economy may influence the Company’s business, financial condition, and results of operations.

 

(d)Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of HKD converted to US$ and Sterling on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

For the three months ended June 30, 2023 and 2022, the Company recorded the foreign exchange gain of $349,539 and exchange loss of $2,126,882, respectively, mainly attributable from the long-term investments which are mostly denominated in Sterling.

 

For the six months ended June 30, 2023 and 2022, the Company recorded the foreign exchange gain of $905,850 and exchange loss of $2,607,456, respectively, mainly attributable from the long-term investments which are mostly denominated in Sterling.

 

(e)Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company’s policy is to ensure that it has sufficient cash to meet its liabilities when they become due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation. A key risk in managing liquidity is the degree of uncertainty in the cash flow projections. If future cash flows are fairly uncertain, the liquidity risk increases.

 

NOTE 21 - COMMITMENTS AND CONTINGENCIES

 

Litigation — From time to time, the Company is involved in various legal proceedings and claims in the ordinary course of business. The Company currently is not aware of any legal proceedings or claims that it believes will have, individually or in the aggregate, a material adverse effect on its business, financial condition, operating results, or cash flows.

 

As at June 30, 2023, the Company involved with various legal proceedings:-

 

Action Case: HCA702/2018 On March 27, 2018, the writ of summons was issued against the Company and seven related companies of the former shareholder by the Plaintiff. This action alleged the infringement of certain registered trademarks currently registered under the Plaintiff. In February 2023, the Court granted leave for this action be set down for trial of 13 days. The trial will take place from November 25 to December 11, 2024. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

F-31

 

 

AGBA GROUP HOLDING LIMITED

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

 

Action Case: HCA765/2019 On April 30, 2019, the writ of summons was issued against the Company’s subsidiary, three related companies and the former directors, shareholders and financial consultant by the Plaintiff. This action alleged the deceit and misrepresentation from an inducement of the fund subscription and claimed for compensatory damage of approximately $2 million (equal to HK$17.1 million). In April 2023, the Court fixed a case management conference with 30 minutes reserved. The conference will be held on November 2, 2023. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

Action Case: HCA2097 and 2098/2020 On December 15, 2020, the writs of summons were issued against the Company and the former consultant by the Plaintiff. This action alleged the misrepresentation and conspiracy causing the loss from the investment in corporate bond and claimed for compensatory damage of approximately $1.67 million (equal to HK$13 million). The Company previously made $0.84 million as contingency loss during the year ended December 31, 2021. In March 2022, parties participated in a mediation but no settlement reached. A case management summons will be held on February 5, 2024. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

The Company makes a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least each fiscal quarter and adjusted to reflect the impacts of negotiations, estimate settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. Legal fees are expensed in the period in which they are incurred.

 

Notes Receivable Agreement — Pursuant to the Agreements, subject to demand, the Company is committed to subscribe the notes of Investment A with an aggregate amount of $1,673,525, in batches, which are payable on or before January 31, 2024. As of June 30, 2023, the remaining committed subscription amount was $1,084,439.

 

Capital Contribution in Investment F — As of June 30, 2023, the remaining committed capital amount in Investment F was $331,432.

 

Share-based Compensation — Pursuant to the Scheme, the Company is committed to issue 2,000,000 ordinary shares to a consultant to compensate the services rendered subsequently.

 

NOTE 22 - SUBSEQUENT EVENTS

 

On July 20, 2023, the Company entered into a purchase and sale agreement with an independent third party to sell one of its office premises for a consideration of $6.15 million. The transaction is expected to be completed in October 2023. As of June 30, 2023, the Company has accounted for the relevant office premises as asset held for sale in the unaudited condensed consolidated balance sheets. For the related disclosure, please refer to Note 7 of these financial statements.

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2023, up to August 11, 2023 that the unaudited condensed consolidated financial statements were available to be issued.

 

F-32

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this report (the “Quarterly Report”) to “we,” “us”, “the Group” or the “Company” refer to AGBA Group Holding Limited. References to our “management” or our “management team” refer to our officers and directors. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section included in our 2022 Annual Report filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Business Overview

 

We are a leading one-stop financial supermarket based in Hong Kong servicing over 400,000 individual and corporate customers. We offer the broadest set of financial services and healthcare products in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) through a tech-led ecosystem, enabling clients to unlock the choices that best suit their needs.

 

We currently operate four major areas of businesses, comprising of:

 

1.Distribution Business: The Group’s powerful financial advisor business is the largest in the market, it engages in the personal financial advisory business (including advising and sales of a full range of financial services products including long-term life insurance, savings and mortgages), with additional internal and external channels being developed and added.

 

2.Platform Business: The Group operates as a “financial supermarket” offering over 1,800 financial products to a large universe of retail and corporate customers.

 

3.Healthcare Business: Through the Group’s 4% stake in and a strategic partnership with HCMPS, operating as one of the largest healthcare management organizations in the Hong Kong and Macau region, with over 800 doctors in its network. Established in 1979, it is one of the most reputed healthcare brands in Hong Kong.

 

4.Fintech Business: The Group has an ensemble of leading FinTech assets and businesses in Europe and Hong Kong. In addition to financial gains, the Group also derives substantial knowledge transfers from its investee companies, supporting the development and growth of the Group’s new business models.

 

Distribution Business

 

The Distribution Business comprises a variety of captive financial services distribution channels. We have built a market leading financial advisors distribution channel in Hong Kong. We have also built other distribution channels alongside our market leading financial advisors business.

 

Our combined captive distribution channels enable us to directly access one of the largest pools of customers accessible to independent financial services providers in Hong Kong.

 

2

 

 

Channel   Description
Financial Advisors Business (“FA Business”)   “Focus” is engaged in the distribution of life insurance, asset management, property-casualty and Mandatory Provident Fund products through its teams of independent financial advisors (brokers).
     
Alternative Distribution Business   A collection of distribution channels, including salaried financial planners targeting HNWI, development teams pursuing corporate partnerships and incubating financial advisors teams.
     
Digital Business   AGBA Money is a direct-to-consumer digital app that provides various financial products and services to retail customers.

 

Our largest distribution channel is the FA Business, operating under the brand name Focus. With its large salesforce of financial advisors, “Focus” provides a wide range of financial products and independent advisory services to individual and corporate customers, primarily in connection with life insurance products. Our FA Business has been the clear market leader in the insurance brokerage industry in Hong Kong for decades, building up a large and highly productive salesforce. As of June 30, 2023, there were around 1,354 financial advisors at “Focus”, organized into 29 sales teams. Each team is led by a “tree head”, responsible for managing the financial advisors within their teams.

 

In addition to the FA Business, we continue to expand our distribution footprint with the establishment and expansion of a number of additional distribution channels, collectively known as our Alternative Distribution Business. These distribution channels are targeted at specific customer segments and/or capturing specific distribution opportunities.

 

Combined with our Digital Business, we now have a well-diversified range of distribution channels and capabilities.

 

During 2022, we continued to make significant investments into developing and expanding our financial advisors salesforce, broadening and deepening the product range, as well as upgrading the supporting infrastructure. Our infrastructure not only supports the financial consultants in engaging with their customers, it also provides extensive operational support in relation to the processing of transactions, associated payment flows, as well as after-sales services. Building our infrastructure required substantial investments into technological, operational and financial systems, as well as the development of comprehensive operational and support teams (operations support, customer services, payments, etc.). Since many of the financial products offered to our customers are regulated, on top of the various operational requirements, we have built significant internal capabilities in the areas of risk and internal control, as well as legal and compliance to ensure an appropriate level of regulatory compliance and supervision.

 

As a result of our efforts to expand our distribution capabilities and improve our supporting infrastructure, we have successfully developed these inter-related strategic assets:

 

Vast customer base in Hong Kong and growing customer base in Mainland China.

 

State-of-the-art supporting infrastructure.

 

Relationships with and access to a broad range of leading global financial product providers.

 

Deep market knowledge and understanding.

 

Highly productive and well-trained salesforce.

 

We will continue to capitalize on these core strategic assets and match them with the emerging opportunities in our three core industries (life insurance, wealth management and healthcare).

 

For the three and six months ended June 30, 2023, the Company made $16.0 million and $25.7 million, respectively from commission in the Distribution Business. The revenue attributed to the Company during the first quarter of 2023 only captured an insignificant portion of the revenues actually generated by the financial advisors currently associated with Focus.

 

Upon the re-opening of China Border, we will continue to widen our distribution footprint and actively explore further opportunities to develop partnerships and generate customer leads on the ground in Mainland China, as well as refining our abilities to service our customer base. We expect sales volumes to return to the levels previously recorded, prior to the pandemic period, especially with the re-opening of the Mainland border and the ongoing integration of Hong Kong into the Greater Bay area.

 

Platform Business

 

The Platform business, through OPH and its subsidiaries, is a one-stop financial supermarket with a breadth of products and services that is unrivaled in Hong Kong sourced from leading global product providers.

 

3

 

 

The Platform Business was set up to take advantage of the decades-long experience we built up in supporting the largest financial advisors salesforce in Hong Kong. We were already servicing a large pool of customers and in the process, built up a wide library of world class financial products and constructed a state-of-the-art technological and operational infrastructure.

 

The Platform Business now operates this full-service platform under its “OnePlatform” brand and has opened it up to banks, other financial institutions, family offices, brokers, and individual independent financial advisors that are looking for support in advising and serving their retail clients.

 

Our technology-enabled Platform Business offers a wide range of financial products, covering life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, money lending and real estate agency.

 

In addition to its unrivaled product-shelf, the Platform Business offers digital-enabled sales management and support solutions, business operations support, comprehensive customer services, and training support.

 

Currently, our platform financial services and investment products mainly comprise mutual fund distributions, portfolio management, money lending, insurance and Mandatory Provident Fund (MPF) products, and international real estate referral and brokerage services, as discussed below:-

 

The OnePlatform brand currently covers 44 insurance providers selling 657 products, and 40 asset management fund houses with over 1,000 products.

 

Fintech Business

 

The Fintech Business has collected an ensemble of valuable fintech assets in its investment portfolio. Fintech Business’ management team has strived to establish the business as a leading name in the fintech investment sector.

 

Core Fintech investments held under the Fintech Business as of June 30, 2023 include:

 

1.An investment in Tandem Money Limited, a UK digital bank.

 

2.An investment in CurrencyFair Limited, a B2B and B2C payments company.

 

3.An investment in Oscar Health Inc., a US direct-to-consumer digital health insurer.

 

4.An investment in Goxip Inc., a fashion media platform based in Hong Kong.

 

5.An investment in LC Healthcare Fund I, L.P., a PRC healthcare and healthtech investment fund.

 

   Carrying amount in
US$ thousands (1)
 
   June 30,
2023
   December 31,
2022
 
Tandem Money Limited   16,784    16,031 
CurrencyFair Limited   5,740    5,718 
Oscar Health Inc.(2)   -    2,443 
Goxip Inc.   511    513 
LC Healthcare Fund I, L.P.   10,391    11,805 

 

Notes:

 

(1)Carrying amount represents Fintech’s attributable interest in the investment portfolio asset.

(2) During the six months ended June 30, 2023, the Company partially sold 993,108 shares of Oscar Health Inc. on Nasdaq Stock Exchange with an average current market price of $4.01 per share, resulting with a realized gain of $1.5 million.

 

Healthcare Business

 

We currently hold a 4% equity stake in HCMPS, one of the leading healthcare management organizations in Hong Kong.

 

Founded in 1979 and currently operating under the Dr. Jones Fok & Associates Medical Scheme Management Limited (“JFA”) brand, JFA is one of the most reputed healthcare brands in Hong Kong. It has four self-operated medical centers and a network of over 700 healthcare service providers – providing healthcare schemes for more than 500 corporate clients with over 300,000 scheme members. JFA’s clients include blue chip companies from various industry and leading insurers. Apart from Hong Kong, JFA is the largest operator in Macau with around 70 clinics.

 

4

 

 

JFA operates a city-wide medical network that includes 340 general practitioners (“GP”), 11 laboratories and imaging centers, 273 specialist doctors, 25 physiotherapy centers, 12 Chinese medicine practitioner clinics, all based in Hong Kong, and 69 GP clinics in Macau. Over 380,000 out-patient and in-patient visits are recorded annually through HCMPS’s medical network. JFA offers its patients a full range of medical services, including general services, specialist services, physiotherapy, Chinese medicine, dental, vaccination, X-ray, laboratories and imaging services.

 

We believe that the future of healthcare is in “Smart Health” – technology that offers improved patient-care management and leverages data as the new tool for solving complex healthcare challenges with reduced operating costs. We will focus on technology/digitalization and consumerization of healthcare to create an ecosystem empowering customers to proactively manage their health and well-being and to improve their access to healthcare at a lower cost – with connectivity across the care continuum. We believe that JFA has the captive customer base, infrastructure and product/service offerings to optimize customer experience to further grab market share.

 

We are currently working to transform JFA into the best medical care institution in Asia by 2025, redefining industry standards in the Greater Bay Area and offering market-leading customer care and best-in-class infrastructure empowered by data analytics.

 

Results of Operations

 

Three months ended June 30, 2023 vs. three months ended June 30, 2022

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Revenues:                
Interest income:                
Loans  $38   $38         
Total interest income   38    38         
Non-interest income:                    
Commissions   16,323    2,937    13,386    455.77 
Recurring service fees   768    873    (105)   (12.03)
Total non-interest income   17,091    3,810    13,281    348.58 
Total revenues from others   17,129    3,848    13,281    345.14 
Non-interest income:                    
Recurring service fees   242    241    1    0.41 
Total revenues from related parties   242    241    1    0.41 
Total revenues   17,371    4,089    13,282    324.82 
Operating cost and expenses:                    
Interest expense   (248)       248    N/A 
Commission expense   (11,984)   (2,480)   9,504    383.23 
Sales and marketing expense   (515)   (391)   124    31.71 
Technology expense   (1,059)   (149)   910    610.74 
Personnel and benefit expense   (5,302)   (3,404)   1,898    55.76 
Other general and administrative expenses   (8,656)   (1,173)   7,483    637.94 
Total operating cost and expenses   (27,764)   (7,597)   20,167    265.46 
Loss from operations   (10,393)   (3,508)   6,885    196.27 
Other income (expense):                    
Other interest income   197    9    188    2,088.89 
Foreign exchange gain (loss), net   349    (2,127)   2,476    116.41 
Investment loss, net   (441)   (5,684)   (5,243)   (92.24)
Change in fair value of warrant liabilities   2        2    N/A 
Loss on settlement of forward share purchase agreement   (379)       379    N/A 
Rental income   79    79         
Sundry income   27    26    (1)   (3.85)
Total other expense, net   (166)   (7,697)   (7,531)   (97.84)
Loss before income taxes   (10,559)   (11,205)   (646)   (5.77)
Income tax (expense) benefit   (26)   314    340    108.28 
NET LOSS  $(10,585)  $(10,891)   (306)   (2.81)

 

5

 

 

Revenue

 

The following table summarizes the major operating revenues for the three months ended June 30, 2023 and 2022:

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Business segment                
Distribution Business  $16,006   $2,374    13,632    574.22 
Platform Business   1,365    1,715    (350)   (20.41)
Fintech Business                
Healthcare Business                
TOTAL  $17,371   $4,089    13,282    324.82 

 

Distribution Business

 

The Distribution Business contributed 92.14% and 58.06% of the total revenue for the three months ended June 30, 2023 and 2022, respectively. Income from the Distribution Business mainly related to commissions earned, which significantly increased by US$13.6 million, or 574.22%, from US$2.4 million in 2022 to US$16.0 million in 2023. The largest segment of the Distribution Business is our FA Business, operated under the “Focus” brand name. Commissions generated by the financial advisors currently associated with Focus, along with associated potential platform commissions and fees, were attributable to the Legacy Group and as such not reflected in the results for the Distribution Business for 2022.

 

Summarized revenue breakdown by product and type of contracts:

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
By product:                
Life insurance  $15,214   $2,353    12,861    546.58 
Property-casualty insurance   552    47    505    1,074.47 
Mandatory provident fund and related revenues   240    (26)   266    1,023.08 
    16,006    2,374    13,632    574.22 
                     
By the type of contracts:                    
- New and or current year   15,930    2,230    13,700    614.35 
- Recurring   76    144    (68)   (47.22)
TOTAL  $16,006   $2,374    13,632    574.22 

 

Platform Business

 

The Platform Business contributed 7.86% and 41.94% of the total revenue for the three months ended June 30, 2023 and 2022, respectively. 

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Commission  $317   $563    (246)   (43.69)
Recurring service fees   1,010    1,114    (104)   (9.34)
Loans   38    38         
TOTAL  $1,365   $1,715    (350)   (20.41)

 

6

 

 

Operating Expenses

 

Commission Expense

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Business segment                
Distribution Business  $11,628   $1,907    9,721    509.75 
Platform Business   356    573    (217)   (37.87)
Fintech Business                
Healthcare Business                
TOTAL  $11,984   $2,480    9,504    383.23 

 

The Distribution Business contributed 97.03% and 76.90% of the total commission expense for the three months ended June 30, 2023 and 2022, respectively. Commission expense for the Distribution Business increased by US$9.7 million, or 509.75%, from US$1.9 million in 2022 to US$11.6 million in 2023. As a result of the increase in revenue associated with the Distribution Business, commission expense significantly increased.

 

Sales and Marketing Expense

 

Sales and Marketing expense increased by US$0.1 million for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022. The slight increase in sales and marketing expense mainly reflects the Company has closely monitor and control in the spending.

 

Technology Expense

 

Technology expense increased by US$0.9 million for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022. The increase was primarily due to increased headcount to support anticipated growth in the business and platform expansion.

 

Personnel and Benefit Expense

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Personnel and benefit  $3,984   $3,404    580    17.04 
Share-based compensation to employees   1,318        1,318    N/A 
TOTAL  $5,302   $3,404    1,898    55.76 

 

Personnel and benefit cost increased by US$0.6 million for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022. The increase was primarily due to the increased headcount to support the continuing growth of the Platform Business and Distribution Business.

 

Share-Based Compensation

 

Pursuant to the Share Award Scheme (the “Scheme”), the Company filed S-8 registration statement to register 11,675,397 ordinary shares on February 24, 2023.

 

During the three months ended June 30, 2023, the Company recorded US$1.3 million in share-based compensation expense on the restricted share units. There was no such expense during the three months ended June 30, 2022. The fair value of the restricted share units is recognized over the period based on the derived service period (usually the vesting period), on a straight-line basis.

 

7

 

 

Other General and Administrative Expenses

 

   Three months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Depreciation  $114   $95    19    20.00 
Financial data subscription expense   45    139    (94)   (67.63)
Legal and professional fees   2,289    357    1,932    541.18 
Management fee expense   1,668    499    1,169    234.27 
Share-based compensation (service related)   3,286        3,286    N/A 
Other operating expenses   1,254    83    1,171    1,410.84 
TOTAL  $8,656   $1,173    7,483    637.94 

 

Total other general and administrative expenses increased by US$7.5 million, or 637.94%, for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022. The net increase was mainly due to the increase in legal and professional fees of US$1.9 million, management fee expense of US$1.2 million, and share-based compensation of $3.3 million. Upon the consummation of Business Combination, the post-combination entity has expensed more as a listed company, with a significant increase in the legal and professional fees and management fee expense increased were primarily attributed to 1) the US legal counsel fee incurred and 2) the office and administrative expenses pay to the holding company for the use of office premises in Trust Tower and Hopewell Centre, including building management fees, government rates and rent, office rent, lease-related interest, and depreciation actually incurred by the holding company, with the increased occupancy from business expansion. Share-based compensation for the three months ended June 30, 2023 was mainly related to marketing consultancy service rendered by a third party consultant, payable by 2,000,000 ordinary shares at the market price of $1.578 per share.

 

Loss from Operations

 

Loss from operations increased by US$6.9 million, or 196.27%, for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022. The increase was mainly attributable to the increase in operating expenses of US$20.2 million, offset by the increase in revenues of US$13.3 million.

 

Other Income (Expense), Net

 

Other Interest Income

 

Other interest income increased by US$0.2 million for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022.

 

Foreign Exchange Gain (Loss), Net

 

Foreign exchange gain (loss) mainly represented the unrealized net foreign exchange gain (loss) from the translation of long-term investments which are mostly denominated in Sterling. The net foreign exchange gain increased by US$2.5 million or 116.41% for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022, due to the stronger Sterling exchange rate.

 

Investment Loss, Net

 

   Three month ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Unrealized loss in marketable equity securities  $   $(5,684)   (5,684)   (100)
Unrealized loss in non-marketable equity securities   (1,000)       1,000    N/A 
Dividend income   559        559    N/A 
TOTAL  $(441)  $(5,684)   (5,243)   (92.24)

 

Investment loss decreased by US$5.2 million, or 92.24%, for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022, mainly as a result of the unrealized loss in non-marketable equity securities of US$1.0 million, offset by dividend income of US$0.6 million for the three months ended June 30, 2023 as compared to $5.7 million unrealized loss in marketable equity securities for the same period ended in 2022.

 

Loss on settlement of forward share purchase agreement

 

Loss on settlement of forward share purchase agreement was resulted from the early termination of the Meteora Backstop Agreement on June 29, 2023. For the three months ended June 30, 2023, the loss on settlement of forward share purchase agreement was $0.4 million recognized in the unaudited condensed consolidated statements of operation.

 

8

 

 

Income Tax (Expense) Benefit

 

Income tax expense increased by US$0.3 million, or 108.28% for the three months ended June 30, 2023, as compared to the three months ended June 30, 2022, primarily attributable to the over provision of income tax for prior years.

 

Net Loss

 

Net loss decreased by US$0.3 million, or 2.81% for the three months ended June 30, 2023, as compared to June 30, 2022, primarily due to the increase in revenues of US$13.3 million and decrease in other expense, net of US$7.5 million, offset by the increase in operating cost and expenses of US$20.2 million.

 

Six months ended June 30, 2023 vs six months ended June 30, 2022

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Revenues:                
Interest income:                
Loans  $76   $99    (23)   (23.23)
Total interest income   76    99    (23)   (23.23)
Non-interest income:                    
Commissions   26,339    3,764    22,575    599.76 
Recurring service fees   1,549    1,821    (272)   (14.94)
Total non-interest income   27,888    5,585    22,303    399.34 
Total revenues from others   27,964    5,684    22,280    391.98 
Non-interest income:                    
Recurring service fees   481    481         
Total revenues from related parties   481    481         
Total revenues   28,445    6,165    22,280    361.39 
Operating cost and expenses:                    
Interest expense   (413)       413    N/A 
Commission expense   (19,280)   (3,181)   16,099    506.10 
Sales and marketing expense   (2,372)   (632)   1,740    275.32 
Technology expense   (1,938)   (283)   1,655    584.81 
Personnel and benefit expense   (14,907)   (5,409)   9,498    175.60 
Other general and administrative expenses   (14,512)   (2,082)   12,430    597.02 
Total operating cost and expenses   (53,422)   (11,587)   41,835    361.05 
Loss from operations   (24,977)   (5,422)   19,555    360.66 
Other income (expense):                    
Other interest income   368    17    351    2,064.71 
Foreign exchange gain (loss), net   906    (2,607)   3,513    134.75 
Investment income (loss), net   1,282    (3,535)   4,817    136.27 
Change in fair value of warrant liabilities   2        2    N/A 
Change in fair value of forward share purchase liability   (82)       82    N/A 
Loss on settlement of forward share purchase agreement   (379)       379    N/A 
Rental income   138    158    (20)   (12.66)
Sundry income   84    155    (71)   (45.81)
Total other income (expense), net   2,319    (5,812)   8,131    139.90 
Loss before income taxes   (22,658)   (11,234)   11,424    101.69 
Income tax expense       (105)   (105)   (100.00)
NET LOSS  $(22,658)  $(11,339)   11,319    99.82 

 

9

 

 

Revenue

 

The following table summarizes the major operating revenues for the six months ended June 30, 2023 and 2022:

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Business segment                
Distribution Business  $25,693   $2,554    23,139    905.99 
Platform Business   2,752    3,611    (859)   (23.79)
Fintech Business       -—         
Healthcare Business                
TOTAL  $28,445   $6,165    22,280    361.39 

 

Distribution Business

 

The Distribution Business contributed 90.33% and 41.43% of the total revenue for the six months ended June 30, 2023 and 2022, respectively. Income from the Distribution Business mainly related to commissions earned, which significantly increased by US$23.1 million, or 905.99%, from US$2.6 million in 2022 to US$25.7 million in 2023. The largest segment of the Distribution Business is our FA Business, operated under the “Focus” brand name. Commissions generated by the financial advisors currently associated with Focus, along with associated potential platform commissions and fees, were attributable to the Legacy Group and as such not reflected in the results for the Distribution Business for 2022.

 

Summarized revenue breakdown by product and type of contracts:

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
By product:                
Life insurance  $24,139   $2,498    21,641    866.33 
Property-casualty insurance   1,056    48    1,008    2,100.00 
Mandatory provident fund and related revenues   498    8    490    6,125.00 
    25,693    2,554    23,139    905.99 
                     
By the type of contracts:                    
- New and or current year   25,448    2,300    23,148    1,006.43 
- Recurring   245    254    (9)   (3.54)
TOTAL  $25,693   $2,554    23,139    905.99 

 

Platform Business

 

The Platform Business contributed 9.67% and 58.57% of the total revenue for the six months ended June 30, 2023 and 2022, respectively. 

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Commission  $646   $1,209    (563)   (46.57)
Recurring service fees   2,030    2,303    (273)   (11.85)
Loans   76    99    (23)   (23.23)
TOTAL  $2,752   $3,611    (859)   (23.79)

 

10

 

 

Operating Expenses

 

Commission Expense

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Business segment                
Distribution Business  $18,541   $1,975    16,566    838.78 
Platform Business   739    1,206    (467)   (38.72)
Fintech Business       -—         
Healthcare Business                
TOTAL  $19,280   $3,181    16,099    506,10 

 

The Distribution Business contributed 96.17% and 62.09% of the total commission expense for the six months ended June 30, 2023 and 2022, respectively. Commission expense for the Distribution Business increased by US$16.6 million, or 838.78%, from US$2.0 million in 2022 to US$18.5 million in 2023. As a result of the increase in revenue associated with the Distribution Business, commission expense significantly increased.

 

Sales and Marketing Expense

 

Sales and Marketing expense increased by US$1.7 million for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The increase in sales and marketing expense mainly reflects spending associated with “AGBA” corporate branding and associated product campaigns, celebrating it’s the successful listing, through public relations, corporate video and campaigns, digital marketing and public advertisements.

 

Technology Expense

 

Technology expense increased by US$1.7 million for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The increase was primarily due to increased headcount to support anticipated growth in the business and platform expansion.

 

Personnel and Benefit Expense

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Personnel and benefit  $12,271   $5,409    6,862    126.86 
Share-based compensation to employees   2,636        2,636    N/A 
TOTAL  $14,907   $5,409    9,498    175.60 

 

Personnel and benefit cost increased by US$6.9 million for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The increase was primarily due to the increased headcount to support the continuing growth of the Platform Business and Distribution Business.

 

Share-Based Compensation

 

Pursuant to the Share Award Scheme (the “Scheme”), the Company filed S-8 registration statement to register 11,675,397 ordinary shares on February 24, 2023.

 

During the six months ended June 30, 2023, the Company recorded US$2.6 million in share-based compensation expense on the restricted share units. There was no such expense during the six months ended June 30, 2022. The fair value of the restricted share units is recognized over the period based on the derived service period (usually the vesting period), on a straight-line basis.

 

Other General and Administrative Expenses

 

   Six months ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Depreciation on property and equipment  $215   $192    23    11.98 
Financial data subscription expense   139    269    (130)   (48.33)
Legal and professional fees   3,095    466    2,629    564.16 
Management fee expense   3,868    1,004    2,864    285.26 
Share-based compensation (service related)   5,875        5,875    N/A 
Other operating expenses   1,320    151    1,169    774.17 
TOTAL  $14,512   $2,082    12,430    597.02 

 

11

 

 

Total other general and administrative expenses increased by US$12.4 million, or 597.02%, for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The net increase was mainly due to the increase in legal and professional fees of US$2.6 million, management fee expense of US$2.9 million, share-based compensation of US$5.9 million, offset by a decrease in financial data subscription expense of US$0.1 million. Upon the consummation of Business Combination, the post-combination entity has expensed more as a listed company, with a significant increase in the legal and professional fees and management fee expense increased were primarily attributed to 1) the US legal counsel fee incurred and 2) the office and administrative expenses pay to the holding company for the use of office premises in Trust Tower and Hopewell Centre, including building management fees, government rates and rent, office rent, lease-related interest, and depreciation actually incurred by the holding company, with the increased occupancy from business expansion. Share-based compensation for the three months ended June 30, 2023 was mainly related to marketing consultancy service rendered by a third party consultant, payable by 2,000,000 ordinary shares at the market price of $1.578 per share.

 

Loss from Operations

 

Loss from operations increased by US$19.6 million, or 360.66%, for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The increase was mainly attributable to the increase in operating expenses of US$41.8 million and offset by the increase in revenues of US$22.3 million.

 

Other Income (Expense), Net

 

Other Interest Income

 

Other interest income increased by US$0.4 million for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022.

 

Foreign Exchange Gain (Loss), Net

 

Foreign exchange gain (loss) mainly represented the unrealized net foreign exchange gain (loss) from the translation of long-term investments which are mostly denominated in Sterling. The net foreign exchange gain increased by US$3.5 million or 134.75% for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022, due to the stronger Sterling exchange rate.

 

Investment Income (Loss), Net

 

   Six month ended June 30,         
   2023   2022   Variance 
   (US$ in thousands)   $   % 
Unrealized loss in marketable equity securities  $   $(3,535)   (3,535)   (100)
Realized gain in marketable equity securities   1,542        1,542    N/A 
Unrealized loss in non-marketable equity securities   (1,427)       (1,427)   N/A 
Dividend income   1,167        1,167    N/A 
TOTAL  $1,282   $(3,535)   4,817    136.27 

 

Investment income increased by US$4.8 million, or 136.27%, for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022, mainly as a result of the realized gain of US$1.5 million on the sale of the shares of Oscar Health Inc. in the open market at the average market price of $4.01 per shares and dividend income of US$1.2 million, offset by unrealized loss in non-marketable equity securities of US$1.4 million, which was fewer than the unrealized loss in marketable securities of US$3.5 million.

 

Loss on settlement of forward share purchase agreement

 

Loss on settlement of forward share purchase agreement was resulted from the early termination of the Meteora Backstop Agreement on June 29, 2023. For the six months ended June 30, 2023, the loss on settlement of forward share purchase agreement was $0.4 million recognized in the unaudited condensed consolidated statements of operation.

 

12

 

 

Income Tax Expense

 

Income tax expense decreased by US$0.1 million, or 100.00% for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022, primarily attributable to the over provision of income tax for prior years.

 

Net Loss

 

Net loss decreased by US$11.3 million, or 99.82% for the six months ended June 30, 2023, as compared to six months ended June 30, 2022, primarily due to the increase in operating cost and expenses of US$41.8 million, offset by the increase in revenues of US$22.3 million and increase in other income, net of US$8.1 million.

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

We have a history of operating losses and negative cash flow. During the six months ended June 30, 2023, we reported a net loss of US$22.7 million and reported a negative operating cash flow of US$19.3 million. As of June 30, 2023, our cash balance was US$3.8 million for working capital use. Our management estimates that currently available cash will not be able to provide sufficient funds to meet the planned obligations for the next 12 months starting June 30, 2023.

 

Our ability to continue as a going concern is dependent on our ability to successfully implement our plans. Our management believes that it will be able to continue to grow our revenue base and control expenditures. In parallel, AGBA continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance our business development activities, general and administrative expenses, and growth strategy. These alternatives include external borrowings, raising funds through public equity, or tapping debt markets. Although there is no assurance that, if needed, we will be able to pursue these fundraising initiatives and have access to the capital markets going forward. The unaudited condensed consolidated financial statements attached to this Form 10-Q do not include any adjustments that might result from the outcome of these uncertainties.

 

Future Liquidity

 

On a recurring basis, the primary future cash needs of the Company will be focused on operating activities, working capital, capital expenditures, investment, regulatory and compliance costs. The ability of the Company to fund these needs will depend, in part, on its ability to generate or raise cash in the future, which is subject to general economic, financial, competitive, regulatory, and other factors that are beyond its control.

 

The ability to fund our operating needs will depend on its future ability to continue to generate positive cash flow from operations and raise capital in the capital markets. Our management believe that we will meet known or reasonably likely future cash requirements through the combination of cash flows from operating activities, available cash balances, and external borrowings and fund raising. Our management expects that the primary cash requirements in 2023 will be to fund capital expenditures for (i) expansion of the Distribution Business and (ii) Platform Business.

 

If our sources of liquidity need to be augmented, additional cash requirements would likely need to be financed through the issuance of debt or equity securities; however, there can be no assurances that we will be able to obtain additional debt or equity financing on acceptable terms, or at all, in the future.

 

We expect that operating losses could continue into the foreseeable future as we continue to invest in growing our businesses. Based upon our current operating plans, our management believes that cash and cash equivalents will not be able to provide sufficient funds to its operations for at least the next 12 months from the date of its unaudited condensed consolidated financial statements provided with this Form 10-Q. However, these forecasts involve risks and uncertainties, and actual results could vary materially.

 

Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenues growth, the timing and extent of spending on sales and marketing, the expansion of sales and marketing activities, the timing of new product introductions, market acceptance of our brand, and overall economic conditions. We may also seek additional capital to fund our operations, including through the sale of equity or debt financings. To the extent that we raise additional capital through the future sale of equity, the ownership interest of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our existing shareholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations.

 

13

 

 

Cash Flows

 

As of June 30, 2023, we had cash and cash equivalents totalling US$3.8 million, and US$27.5 million in restricted cash.

 

As of December 31, 2022, we had cash and cash equivalents totalling US$6.4 million, and US$44.8 million in restricted cash.

 

The following table summarizes our cash flows for the periods presented:

 

   Six months ended March 31, 
   2023   2022 
   (US$ in thousands) 
Net cash used in operating activities  $(19,265)  $(2,449)
Net cash provided by (used in) investing activities   4,477    (6,853)
Net cash used in financing activities   (5,317)   (13,139)
Effect on exchange rate change on cash and cash equivalents   49    (311)
Net change in cash, cash equivalents and restricted cash   (20,056)   (22,752)
Cash, cash equivalents and restricted cash, at the beginning   51,294    73,081 
Cash, cash equivalents and restricted cash, at the end   31,238    50,329 
Representing as:          
Cash and cash equivalents   3,784    15,210 
Restricted cash – fund held in escrow   27,454    35,119 
   $31,238   $50,329 

 

The following table sets forth a summary of our working capital:

 

   June 30,
2023
   December 31,
2022
   Variance 
   (US$ in thousands)   $   % 
Total Current Assets  $45,243   $55,756    (10,513)   (18.86)
Total Current Liabilities   81,524    97,021    (15,497)   (15.97)
Working Deficit   (36,281)   (41,265)   (4,984)   (12.08)

 

Working Deficit

 

The working deficit as of June 30, 2023 and December 31, 2022 was amounted to approximately US$36.3 million and US$41.3 million, respectively, a decline of US$5.0 million or 12.08%.

 

Cash Flows from Operating Activities

 

Net cash used in operating activities was US$19.3 million and US$2.4 million for the six months ended June 30, 2023 and 2022, respectively.

 

Net cash used in operating activities for the six months ended June 30, 2023 was primarily the result of the net loss of US$22.7 million, an increase in accounts receivable of US$1.0 million, increase in deposits, prepayments, and others receivable of US$3.6 million, decrease in accounts payable and accrued liabilities of US$6.6 million, decrease in escrow liabilities of US$2.0 million, decrease in lease liabilities of US$0.2 million and decrease in income tax payable of US$0.1 million. These amounts were partially offset by the decrease in loans receivable of US$0.01 million, and non-cash adjustments consisting of share-based compensation expense of US$8.5 million, non-cash lease expense of US$0.2 million, depreciation of property and equipment of US$0.2 million, interest income on note receivables of US$0.01 million, net foreign exchange gain of US$0.9 million, net investment income of US$1.3 million, allowance for credit loss on financial instruments of US$0.3 million, loss on settlement of forward share purchase agreement of US$0.4 million and reversal of annual bonus accrued in prior year of US$3.8 million.

 

Net cash used in operating activities for the six months ended June 30, 2022 was primarily the result of the net loss of US$11.3 million, a decrease in accounts receivable of US$0.04 million, decrease in loans receivable of US$2.3 million, an increase in escrow liabilities of US$0.6 million, and an increase in income tax payable of US$0.1 million. These amounts were partially offset by the increase in deposits, prepayments, and others receivable of US$0.4 million, decrease in accounts payable and accrued liabilities of US$0.1 million, and non-cash adjustments consisting of unrealized investment loss of US$3.5 million, net foreign exchange loss of US$2.6 million, and depreciation on property and equipment of US$0.2 million.

 

14

 

 

Cash Flows from Investing Activities

 

Net cash provided by investing activities for the six months ended June 30, 2023 of US$4.5 million was primarily due to proceeds from sale of investments of US$4.0 million, dividend received from long-term investments of US$1.2 million, offset by the purchase of notes receivable of US$0.6 million and purchase of property and equipment of US$0.08 million.

 

Net cash used in investing activities for the six months ended June 30, 2022 of US$6.9 million was primarily due to the proceeds from sale of investments of US$1.9 million, offset by the purchase of property and equipment of US$0.9 million, and payment of earnest deposit of US$7.8 million for the purchase of an office premise from the shareholder.

 

Cash Flows from Financing Activities

 

Net cash used in financing activities for the six months ended June 30, 2023 of US$5.3 million was primarily due to advances from holding company of US$6.8 million, proceeds from borrowings of US$1.8 million, offset by the settlement of forward share purchase agreement of US$14.0 million.

 

Net cash used in financing activities for the six months ended June 30, 2022 of US$13.1 million was primarily due to advances from the holding company of US$4.3 million, offset by the dividend distribution of US$17.4 million to the holding company.

 

Liquidity and Going Concern

 

Our unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. The management of the Company estimates that currently available cash will not be able to provide sufficient funds to meet the Company’s planned obligations for the next 12 months from the date that these unaudited condensed consolidated financial statements were made available to be issued.

 

For the six months ended June 30, 2023, we reported a net loss of approximately US$22.7 million. With a significant increase in our operating costs, described in the paragraph below, we had an accumulated deficit of approximately US$62.1 million as of June 30, 2023.

 

However, coupled with its business expansion, we reported significant sales growth with total revenue of approximately US$28.4 million for the six months ended June 30, 2023 (2022: US$6.2 million), and resulted with an operating loss of approximately US$25.0 million (2022: US$5.4 million). We expect to continue our business growth, while closely monitoring our future spending.

 

Our ability to continue as a going concern is dependent on the management’s ability to successfully implement its plans. Our management team believes that we will be able to continue to grow our revenue base and control our expenditures. In parallel, our management team will continually monitor our capital structure and operating plans and evaluate various potential funding alternatives that may be needed in order to finance our business development activities, general and administrative expenses and growth strategy.

 

We intend to raise additional capital through private placements of debt and equity securities, but there can be no assurance that these funds will be available on terms acceptable, or will be sufficient to enable us to fully complete its development activities or sustain operations. If we are unable to raise sufficient additional funds, we will have to develop and implement a plan to further extend payables, reduce overhead, or scale back our current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.

 

Capital Commitments

 

Notes Receivable Agreement — Pursuant to the Agreements, subject to demand, the Company is committed to subscribe the notes of Investment A with an aggregate amount of $1,673,525, in batches, which are payable on or before January 31, 2024. As of June 30, 2023, the remaining committed subscription amount was $1,084,439.

 

Capital Contribution in L.C. Healthcare Fund I, L.P. — As of June 30, 2023, the remaining committed capital amount in Investment F was $331,432.

 

Share-based Compensation — Pursuant to the Scheme, the Company is committed to issue 2,000,000 ordinary shares to a consultant to compensate the services rendered subsequently.

 

Off-Balance Sheet Arrangements

 

We are not party to any off-balance sheet transactions. We have no guarantees or obligations other than those which arise out of normal business operations.

 

We have not engaged in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, net revenue or expenses, results of operations, liquidity, capital expenditures, or capital resources.

 

15

 

 

Stock Repurchase Program

 

On April 18, 2023, our Board of Directors approved the repurchase of 1,000,000 ordinary shares (the “2023 Share Repurchase Program”). Under the 2023 Share Repurchase Program, we are authorized to re-purchase up to 1,000,000 ordinary shares at a maximum price of $10 per share from the open market, for a term of one year, no later than April 18, 2024.

 

Critical Accounting Policies, Judgements and Estimates

 

The preparation of financial statements in conformity with GAAP requires us to make judgments, estimates, and assumptions in the preparation of our unaudited condensed consolidated financial statements. Actual results could differ from those estimates. There have been no material changes to our critical accounting policies and estimates as reported in our 2022 Annual Report.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation and supervision of our Chief Executive Officer and our Chief Financial Officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures are effective   to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on Effectiveness of Controls and Procedures

 

The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurances. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but there can be no assurance that such improvements will be sufficient to provide us with effective internal control over financial reporting.

 

16

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

As at June 30, 2023, the Company involved with various legal proceedings:-

 

Action Case: HCA702/2018 On March 27, 2018, the writ of summons was issued against the Company and seven related companies of the former shareholder by the Plaintiff. This action alleged the infringement of certain registered trademarks currently registered under the Plaintiff. In February 2023, the Court granted leave for this action be set down for trial of 13 days. The trial will take place from November 25, 2024 to December 11, 2024. Legal counsel of the Company will continue to handle in this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

Action Case: HCA765/2019 On April 30, 2019, the writ of summons was issued against the Company’s subsidiary, three related companies and the former directors, shareholders and financial consultant by the Plaintiff. This action alleged the deceit and misrepresentation from an inducement of the fund subscription and claimed for compensatory damage of approximately $2 million (equal to HK$17.1million). In April 2023, the Court fixed a case management conference within 30 minutes reserved. The conference will be held on November 2, 2023. Legal counsel of the Company will continue to handle in this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

Action Case: HCA2097 and 2098/2020 On December 15, 2020, the writs of summons were issued against the Company and the former consultant by the Plaintiff. This action alleged the misrepresentation and conspiracy causing the loss from the investment in corporate bond and claimed for compensatory damage of approximately $1.67 million (equal to HK$13 million). The Company previously made $0.84 million as contingency loss for the year ended December 31, 2021. In March 2022, parties participated in a mediation but no settlement reached. A case management summons will be held on February 5, 2024. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or any further potential loss, if any.

 

ITEM 1A. RISK FACTORS.

 

As smaller reporting company we are not required to make disclosures under this Item.

  

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Issuer Purchases of Equity Securities

 

The Company approved a share repurchase program on April 18, 2023 authorizing to purchase up to 1,000,000 ordinary shares at a maximum price of $10 per share from the open market, for a term of one year, expiry in April 2024.

 

The following table summarizes the ordinary shares repurchase activity during the second quarter of fiscal 2023 under our ordinary share repurchase program:

 

   (a)
Total
Number of
Shares 
Purchased
   (b)
Average Price
Paid Per Share
   (c)
Total
Number of
Shares Purchased
as Part of Publicly
Announced
Plans
   (d)
Maximum
Dollar
Value of
Shares
that May
Yet Be
Purchased
Under the
Plans at
Period End
(in  thousands)
 
April 1-30            -   $         -             -   $    - 
May 1-31   -    -    -    - 
June 1-30   -    -    -                  - 
Total   -   $-    -   $- 

 

17

 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

Not applicable.

 

ITEM 6. EXHIBITS.

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32**   Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.
** Furnished.

 

18

 

 

SIGNATURES

 

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AGBA GROUP HOLDING LIMITED
     
Date: August 11, 2023 By: /s/ Ng Wing Fai
  Name: Ng Wing Fai
  Title: Chief Executive Officer
    (Principal Executive Officer)
     
Date: August 11, 2023 By: /s/ Shu Pei Huang, Desmond
  Name:  Shu Pei Huang, Desmond
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

19

 
00-0000000 55500000 55500000 62823549 64953238 0.16 0.20 0.20 0.36 false --12-31 Q2 0001769624 0001769624 2023-01-01 2023-06-30 0001769624 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001769624 agba:WarrantsMember 2023-01-01 2023-06-30 0001769624 2023-07-17 0001769624 2023-06-30 0001769624 2022-12-31 0001769624 2023-04-01 2023-06-30 0001769624 2022-04-01 2022-06-30 0001769624 2022-01-01 2022-06-30 0001769624 us-gaap:CommonStockMember 2022-12-31 0001769624 agba:OrdinarySharesToBeIssuedMember 2022-12-31 0001769624 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001769624 us-gaap:RetainedEarningsMember 2022-12-31 0001769624 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001769624 agba:OrdinarySharesToBeIssuedMember 2023-01-01 2023-03-31 0001769624 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001769624 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001769624 2023-01-01 2023-03-31 0001769624 us-gaap:CommonStockMember 2023-03-31 0001769624 agba:OrdinarySharesToBeIssuedMember 2023-03-31 0001769624 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001769624 us-gaap:RetainedEarningsMember 2023-03-31 0001769624 2023-03-31 0001769624 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001769624 agba:OrdinarySharesToBeIssuedMember 2023-04-01 2023-06-30 0001769624 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001769624 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001769624 us-gaap:CommonStockMember 2023-06-30 0001769624 agba:OrdinarySharesToBeIssuedMember 2023-06-30 0001769624 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001769624 us-gaap:RetainedEarningsMember 2023-06-30 0001769624 us-gaap:CommonStockMember 2021-12-31 0001769624 agba:OrdinarySharesToBeIssuedMember 2021-12-31 0001769624 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001769624 agba:ReceivableFromTheShareholderMember 2021-12-31 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001769624 us-gaap:RetainedEarningsMember 2021-12-31 0001769624 2021-12-31 0001769624 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001769624 agba:OrdinarySharesToBeIssuedMember 2022-01-01 2022-03-31 0001769624 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001769624 agba:ReceivableFromTheShareholderMember 2022-01-01 2022-03-31 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001769624 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001769624 2022-01-01 2022-03-31 0001769624 us-gaap:CommonStockMember 2022-03-31 0001769624 agba:OrdinarySharesToBeIssuedMember 2022-03-31 0001769624 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001769624 agba:ReceivableFromTheShareholderMember 2022-03-31 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001769624 us-gaap:RetainedEarningsMember 2022-03-31 0001769624 2022-03-31 0001769624 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001769624 agba:OrdinarySharesToBeIssuedMember 2022-04-01 2022-06-30 0001769624 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001769624 agba:ReceivableFromTheShareholderMember 2022-04-01 2022-06-30 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001769624 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001769624 us-gaap:CommonStockMember 2022-06-30 0001769624 agba:OrdinarySharesToBeIssuedMember 2022-06-30 0001769624 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001769624 agba:ReceivableFromTheShareholderMember 2022-06-30 0001769624 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001769624 us-gaap:RetainedEarningsMember 2022-06-30 0001769624 2022-06-30 0001769624 us-gaap:LandAndBuildingMember 2023-01-01 2023-06-30 0001769624 us-gaap:OfficeEquipmentMember 2023-06-30 0001769624 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001769624 us-gaap:ComputerEquipmentMember 2023-06-30 0001769624 us-gaap:VehiclesMember 2023-06-30 0001769624 us-gaap:LoansMember 2023-04-01 2023-06-30 0001769624 us-gaap:OneTimeTerminationBenefitsMember 2023-04-01 2023-06-30 0001769624 agba:RecurringServiceFeesMember 2023-04-01 2023-06-30 0001769624 us-gaap:LoansMember 2022-04-01 2022-06-30 0001769624 us-gaap:OneTimeTerminationBenefitsMember 2022-04-01 2022-06-30 0001769624 agba:RecurringServiceFeesMember 2022-04-01 2022-06-30 0001769624 us-gaap:LoansMember 2023-01-01 2023-06-30 0001769624 us-gaap:OneTimeTerminationBenefitsMember 2023-01-01 2023-06-30 0001769624 agba:RecurringServiceFeesMember 2023-01-01 2023-06-30 0001769624 us-gaap:LoansMember 2022-01-01 2022-06-30 0001769624 us-gaap:OneTimeTerminationBenefitsMember 2022-01-01 2022-06-30 0001769624 agba:RecurringServiceFeesMember 2022-01-01 2022-06-30 0001769624 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember agba:DistributionBusinessMember 2023-01-01 2023-06-30 0001769624 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember agba:PlatformBusinessMember 2023-01-01 2023-06-30 0001769624 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember agba:PlatformBusinessTwoMember 2023-01-01 2023-06-30 0001769624 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember agba:PlatformBusinessThreeMember 2023-01-01 2023-06-30 0001769624 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember agba:FintechBusinessMember 2023-01-01 2023-06-30 0001769624 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember agba:HealthcareBusinessMember 2023-01-01 2023-06-30 0001769624 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001769624 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001769624 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001769624 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001769624 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001769624 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001769624 srt:MinimumMember 2023-06-30 0001769624 srt:MaximumMember 2023-06-30 0001769624 2023-06-29 0001769624 srt:MaximumMember 2022-06-30 0001769624 srt:MaximumMember country:HK 2022-12-31 0001769624 2022-01-01 2022-12-31 0001769624 2023-06-28 0001769624 2023-02-24 0001769624 agba:InvestmentCMember 2023-06-30 0001769624 agba:InvestmentCMember 2022-12-31 0001769624 agba:InvestmentAMember 2023-06-30 0001769624 agba:InvestmentAMember 2022-12-31 0001769624 agba:InvestmentBMember 2023-06-30 0001769624 agba:InvestmentBMember 2022-12-31 0001769624 agba:InvestmentDMember 2023-06-30 0001769624 agba:InvestmentDMember 2022-12-31 0001769624 agba:InvestmentEMember 2023-06-30 0001769624 agba:InvestmentEMember 2022-12-31 0001769624 agba:InvestmentFMember 2023-06-30 0001769624 agba:InvestmentFMember 2022-12-31 0001769624 us-gaap:LandAndBuildingMember 2023-06-30 0001769624 us-gaap:LandAndBuildingMember 2022-12-31 0001769624 agba:FurnitureFixturesAndEquipmentMember 2023-06-30 0001769624 agba:FurnitureFixturesAndEquipmentMember 2022-12-31 0001769624 us-gaap:ComputerEquipmentMember 2022-12-31 0001769624 agba:MotorVehiclesMember 2023-06-30 0001769624 agba:MotorVehiclesMember 2022-12-31 0001769624 country:HK 2022-09-30 0001769624 country:HK 2023-02-28 0001769624 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001769624 agba:PrivateWarrantsMember 2023-06-30 0001769624 agba:PrivateWarrantsMember 2022-12-31 0001769624 2022-07-01 2022-12-31 0001769624 agba:ApexTwinkleLimitedMember 2023-03-01 2023-03-21 0001769624 2023-05-01 2023-05-03 0001769624 2023-06-06 0001769624 agba:PublicWarrantsMember 2023-06-30 0001769624 srt:MinimumMember country:HK 2023-01-01 2023-06-30 0001769624 srt:MaximumMember country:HK 2023-01-01 2023-06-30 0001769624 agba:DistributionBusinessMember 2023-01-01 2023-06-30 0001769624 agba:PlatformBusinessMember 2023-01-01 2023-06-30 0001769624 agba:PlatformBusinessTwoMember 2023-01-01 2023-06-30 0001769624 agba:PlatformBusinessThreeMember 2023-01-01 2023-06-30 0001769624 agba:FintechBusinessMember 2023-01-01 2023-06-30 0001769624 agba:HealthcareBusinessMember 2023-01-01 2023-06-30 0001769624 agba:DistributionBusinessMember 2023-04-01 2023-06-30 0001769624 agba:PlatformBusinessMember 2023-04-01 2023-06-30 0001769624 agba:FintechBusinessMember 2023-04-01 2023-06-30 0001769624 agba:HealthcareBusinessMember 2023-04-01 2023-06-30 0001769624 agba:TotalMember 2023-04-01 2023-06-30 0001769624 agba:DistributionBusinessMember 2023-06-30 0001769624 agba:PlatformBusinessMember 2023-06-30 0001769624 agba:FintechBusinessMember 2023-06-30 0001769624 agba:HealthcareBusinessMember 2023-06-30 0001769624 agba:TotalMember 2023-06-30 0001769624 agba:DistributionBusinessMember 2022-04-01 2022-06-30 0001769624 agba:PlatformBusinessMember 2022-04-01 2022-06-30 0001769624 agba:FintechBusinessMember 2022-04-01 2022-06-30 0001769624 agba:HealthcareBusinessMember 2022-04-01 2022-06-30 0001769624 agba:TotalMember 2022-04-01 2022-06-30 0001769624 agba:DistributionBusinessMember 2022-06-30 0001769624 agba:PlatformBusinessMember 2022-06-30 0001769624 agba:FintechBusinessMember 2022-06-30 0001769624 agba:HealthcareBusinessMember 2022-06-30 0001769624 agba:TotalMember 2022-06-30 0001769624 agba:TotalMember 2023-01-01 2023-06-30 0001769624 agba:DistributionBusinessMember 2022-01-01 2022-06-30 0001769624 agba:PlatformBusinessMember 2022-01-01 2022-06-30 0001769624 agba:FintechBusinessMember 2022-01-01 2022-06-30 0001769624 agba:HealthcareBusinessMember 2022-01-01 2022-06-30 0001769624 agba:TotalMember 2022-01-01 2022-06-30 0001769624 2022-04-20 0001769624 2022-01-18 2022-01-18 0001769624 agba:CustomerAMember 2023-04-01 2023-06-30 0001769624 agba:CustomerAMember 2023-01-01 2023-06-30 0001769624 agba:CustomerAMember 2023-06-30 0001769624 agba:CustomerBMember 2023-04-01 2023-06-30 0001769624 agba:CustomerBMember 2023-01-01 2023-06-30 0001769624 agba:CustomerBMember 2023-06-30 0001769624 agba:CustomerCMember 2023-04-01 2023-06-30 0001769624 agba:CustomerCMember 2023-01-01 2023-06-30 0001769624 agba:CustomerCMember 2023-06-30 0001769624 agba:CustomerDMember 2023-04-01 2023-06-30 0001769624 agba:CustomerDMember 2023-01-01 2023-06-30 0001769624 agba:CustomerDMember 2023-06-30 0001769624 agba:CustomerEMember 2023-01-01 2023-06-30 0001769624 agba:CustomerEMember 2022-01-01 2022-12-31 0001769624 agba:CustomerFMember 2023-01-01 2023-06-30 0001769624 agba:CustomerFMember 2022-01-01 2022-12-31 0001769624 2019-04-01 2019-04-30 0001769624 2020-12-01 2020-12-15 0001769624 srt:ScenarioForecastMember 2024-01-01 2024-01-31 0001769624 2023-07-20 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:HKD

Exhibit 31.1

 

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Ng Wing Fai, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of AGBA Group Holding Limited;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 11, 2023 By: /s/ Ng Wing Fai
  Name:  Ng Wing Fai
  Title: Chief Executive Officer and President
    (Principal Executive Officer)

 

 

Exhibit 31.2

 

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Shu Pei Huang, Desmond, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of AGBA Group Holding Limited;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 11, 2023 By: /s/ Shu Pei Huang, Desmond
  Name:  Shu Pei Huang, Desmond
  Title: Chief Financial Officer
    (Principal Financial Officer)

 

 

Exhibit 32

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of AGBA Group Holding Limited (the “Company”) on Form 10-Q for the quarter ended June 30, 2023 as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: August 11, 2023

 

/s/ Ng Wing Fai  
Ng Wing Fai  
Chief Executive Officer  
(Principal executive officer)  

 

Date: August 11, 2023

 

/s/ Shu Pei Huang, Desmond  
Shu Pei Huang, Desmond  
Chief Financial Officer  
(Principal financial and accounting officer)  

  

 

 

v3.23.2
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2023
Jul. 17, 2023
Document Information Line Items    
Entity Registrant Name AGBA GROUP HOLDING LIMITED  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   67,461,998
Amendment Flag false  
Entity Central Index Key 0001769624  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Jun. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-38909  
Entity Incorporation, State or Country Code D8  
Entity Tax Identification Number 00-0000000  
Entity Address, Address Line One AGBA Tower  
Entity Address, Address Line Two 68 Johnston Road  
Entity Address, City or Town Wan Chai  
Entity Address, Country HK  
Entity Address, Postal Zip Code N/A  
City Area Code +852  
Local Phone Number 3601 8000  
Entity Interactive Data Current Yes  
Ordinary Shares    
Document Information Line Items    
Trading Symbol AGBA  
Title of 12(b) Security Ordinary Shares  
Security Exchange Name NASDAQ  
Warrants    
Document Information Line Items    
Trading Symbol AGBAW  
Title of 12(b) Security Warrants  
Security Exchange Name NASDAQ  
v3.23.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,783,780 $ 6,449,876
Restricted cash 27,454,651 44,844,196
Accounts receivable, net 3,430,780 2,822,162
Accounts receivable, net, related parties 601,576 272,546
Loans receivable, net 516,237 517,479
Notes receivable, net 601,490
Asset held for sale 5,459,822
Income tax recoverable 397,655 260,120
Deposits, prepayments, and others receivable, net 2,997,021 589,786
Total current assets 45,243,012 55,756,165
Non-current assets:    
Rental deposit, net 957,814
Loans receivable, net 1,059,776 1,072,392
Property and equipment, net 1,733,464 7,359,416
Right-of-use asset, net 12,361,125
Long-term investments, net 33,947,066 37,033,360
Total non-current assets 50,059,245 45,465,168
TOTAL ASSETS 95,302,257 101,221,333
Current liabilities:    
Accounts payable and accrued liabilities 19,088,631 20,274,429
Escrow liabilities 27,454,651 29,487,616
Borrowings 6,255,238 4,477,254
Amounts due to the holding company 4,539,168 6,289,743
Lease liabilities 1,186,200
Forward share purchase liability 13,491,606
Income tax payable and provision 23,000,000 23,000,000
Total current liabilities 81,523,888 97,020,648
Non-current liabilities:    
Lease liabilities 11,227,185
Warrant liabilities 2,173 4,548
Deferred tax liabilities 45,680 45,858
Total non-current liabilities 11,275,038 50,406
TOTAL LIABILITIES 92,798,926 97,071,054
Commitments and contingencies (Note 21)
Shareholders’ equity:    
Ordinary shares, $0.001 par value; 200,000,000 shares authorized, 67,461,998 and 58,376,985 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 67,462 58,377
Ordinary shares to be issued 1,665
Additional paid-in capital 64,973,808 43,870,308
Accumulated other comprehensive loss (484,907) (384,938)
Accumulated deficit (62,053,032) (39,395,133)
Total shareholders’ equity 2,503,331 4,150,279
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 95,302,257 $ 101,221,333
v3.23.2
Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Ordinary shares, par value (in Dollars per share) $ 0.001 $ 0.001
Ordinary shares, shares authorized 200,000,000 200,000,000
Ordinary shares, shares issued 67,461,998 58,376,985
Ordinary shares, shares outstanding 67,461,998 58,376,985
v3.23.2
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Interest income:        
Loans $ 38,175 $ 37,871 $ 76,333 $ 99,194
Total interest income 38,175 37,871 76,333 99,194
Non-interest income:        
Commissions 16,323,056 2,937,080 26,338,683 3,764,157
Recurring service fees 768,014 873,396 1,548,976 1,821,376
Total non-interest income 17,091,070 3,810,476 27,887,659 5,585,533
Total revenues from others 17,129,245 3,848,347 27,963,992 5,684,727
Non-interest income:        
Recurring service fees 241,688 241,325 480,621 481,268
Total revenues from related parties 241,688 241,325 480,621 481,268
Total revenues 17,370,933 4,089,672 28,444,613 6,165,995
Operating cost and expenses:        
Interest expense (247,680) (412,776)
Commission expense (11,984,437) (2,480,271) (19,279,929) (3,181,313)
Sales and marketing expense (514,984) (391,301) (2,371,887) (631,652)
Technology expense (1,058,812) (149,230) (1,937,798) (283,097)
Personnel and benefit expense (5,302,270) (3,404,039) (14,907,460) (5,409,018)
Other general and administrative expenses (8,655,884) (1,173,217) (14,511,705) (2,081,618)
Total operating cost and expenses (27,764,067) (7,598,058) (53,421,555) (11,586,698)
Loss from operations (10,393,134) (3,508,386) (24,976,942) (5,420,703)
Other income (expense):        
Interest income 197,255 8,976 367,781 16,615
Foreign exchange gain (loss), net 349,539 (2,126,882) 905,850 (2,607,456)
Investment income (loss), net (441,568) (5,683,988) 1,281,496 (3,535,053)
Change in fair value of warrant liabilities 1,695 2,375
Change in fair value of forward share purchase liability (82,182)
Loss on settlement of forward share purchase agreement (378,895) (378,895)
Rental income 78,764 78,647 138,271 157,714
Sundry income 27,423 26,175 84,067 155,528
Total other income (expense), net (165,787) (7,697,072) 2,318,763 (5,812,652)
Loss before income taxes (10,558,921) (11,205,458) (22,658,179) (11,233,355)
Income tax (expense) benefit (26,368) 314,143 280 (105,354)
NET LOSS (10,585,289) (10,891,315) (22,657,899) (11,338,709)
Other comprehensive income (loss):        
Foreign currency translation adjustment 33,235 (106,008) (99,969) (380,359)
TOTAL COMPREHENSIVE LOSS $ (10,552,054) $ (10,997,323) $ (22,757,868) $ (11,719,068)
Weighted average number of ordinary shares outstanding – basic (in Shares) 64,953,238 55,500,000 62,823,549 55,500,000
Net loss per ordinary share – basic (in Dollars per share) $ (0.16) $ (0.2) $ (0.36) $ (0.2)
v3.23.2
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Weighted average number of ordinary shares outstanding diluted 64,953,238 55,500,000 62,823,549 55,500,000
Net loss per ordinary share diluted $ (0.16) $ (0.20) $ (0.36) $ (0.20)
v3.23.2
Unaudited Condesed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Ordinary shares
Ordinary shares to be issued
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Receivable from the shareholder
Total
Balance at Dec. 31, 2021 $ 53,835 $ 1,665 $ 38,706,226 $ (179,461) $ 52,125,502 $ (29,562,195) $ 61,145,572
Balance (in Shares) at Dec. 31, 2021 53,835,000 1,665,000          
Special dividend to the holding company (47,000,000) 29,562,195 (17,437,805)
Foreign currency translation adjustment (274,351) (274,351)
Net loss for the period (447,394) (447,394)
Balance at Mar. 31, 2022 $ 53,835 $ 1,665 38,706,226 (453,812) 4,678,108 42,986,022
Balance (in Shares) at Mar. 31, 2022 53,835,000 1,665,000          
Balance at Dec. 31, 2021 $ 53,835 $ 1,665 38,706,226 (179,461) 52,125,502 (29,562,195) 61,145,572
Balance (in Shares) at Dec. 31, 2021 53,835,000 1,665,000          
Net loss for the period             (11,338,709)
Balance at Jun. 30, 2022 $ 53,835 $ 1,665 38,706,226 (559,820) (6,213,207) 31,988,699
Balance (in Shares) at Jun. 30, 2022 53,835,000 1,665,000          
Balance at Mar. 31, 2022 $ 53,835 $ 1,665 38,706,226 (453,812) 4,678,108 42,986,022
Balance (in Shares) at Mar. 31, 2022 53,835,000 1,665,000          
Foreign currency translation adjustment (106,008) (106,008)
Net loss for the period (10,891,315) (10,891,315)
Balance at Jun. 30, 2022 $ 53,835 $ 1,665 38,706,226 (559,820) (6,213,207) 31,988,699
Balance (in Shares) at Jun. 30, 2022 53,835,000 1,665,000          
Balance at Dec. 31, 2022 $ 58,377 $ 1,665 43,870,308 (384,938) (39,395,133)   4,150,279
Balance (in Shares) at Dec. 31, 2022 58,376,985 1,665,000          
Issuance of ordinary shares to settle finder fee $ 2,174 3,997,826   4,000,000
Issuance of ordinary shares to settle finder fee (in Shares) 2,173,913          
Share-based compensation $ 1,200 3,905,400   3,906,600
Share-based compensation (in Shares) 1,200,000          
Forgiveness of amounts due to the holding company 3,000,000   3,000,000
Foreign currency translation adjustment (133,204)   (133,204)
Net loss for the period (12,072,610)   (12,072,610)
Balance at Mar. 31, 2023 $ 61,751 $ 1,665 54,773,534 (518,142) (51,467,743)   2,851,065
Balance (in Shares) at Mar. 31, 2023 61,750,898 1,665,000          
Balance at Dec. 31, 2022 $ 58,377 $ 1,665 43,870,308 (384,938) (39,395,133)   $ 4,150,279
Balance (in Shares) at Dec. 31, 2022 58,376,985 1,665,000          
Issuance of holdback shares (in Shares)             4,300,000
Net loss for the period             $ (22,657,899)
Balance at Jun. 30, 2023 $ 67,462 64,973,808 (484,907) (62,053,032)   2,503,331
Balance (in Shares) at Jun. 30, 2023 67,461,998          
Balance at Mar. 31, 2023 $ 61,751 $ 1,665 54,773,534 (518,142) (51,467,743)   2,851,065
Balance (in Shares) at Mar. 31, 2023 61,750,898 1,665,000          
Issuance of holdback shares $ 1,665 $ (1,665)  
Issuance of holdback shares (in Shares) 1,665,000 (1,665,000)          
Share-based compensation $ 4,046 4,600,274   4,604,320
Share-based compensation (in Shares) 4,046,100          
Forgiveness of amounts due to the holding company 5,600,000   5,600,000
Foreign currency translation adjustment 33,235   33,235
Net loss for the period (10,585,289)   (10,585,289)
Balance at Jun. 30, 2023 $ 67,462 $ 64,973,808 $ (484,907) $ (62,053,032)   $ 2,503,331
Balance (in Shares) at Jun. 30, 2023 67,461,998          
v3.23.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (22,657,899) $ (11,338,709)
Adjustments to reconcile net loss to net cash used in operating activities    
Share-based compensation expense 8,510,920
Non-cash lease expense 213,550
Depreciation on property and equipment 215,494 192,352
Interest income on notes receivable (11,778)
Foreign exchange (gain) loss, net (905,850) 2,607,456
Investment (income) loss, net (1,281,496) 3,535,053
Allowance for credit loss on financial instruments 333,276
Change in fair value of warrant liabilities (2,375)
Change in fair value of forward share purchase liability 82,182
Loss on settlement of forward share purchase agreement 378,895
Reversal of annual bonus accrued in prior year (3,763,847)
Accounts receivable (1,005,597) 40,992
Loans receivable 13,319 2,320,527
Deposit, prepayments, and others receivables (3,629,837) (420,678)
Accounts payable and accrued liabilities 6,578,049 (124,238)
Escrow liabilities (2,032,965) 633,539
Lease liabilities (161,274)  
Income tax payable (138,590) 104,890
Net cash used in operating activities (19,265,823) (2,448,816)
Proceeds from sale of long-term investments 3,976,657 1,861,348
Purchase of notes receivable (589,086)
Dividends received from long-term investments 1,167,433
Addition in long-term investments (7,849,676)
Purchase of property and equipment (77,969) (864,961)
Net cash provided by (used in) investing activities 4,477,035 (6,853,289)
Advances from holding company 6,849,425 4,298,479
Settlement of forward share purchase agreement (13,952,683)
Proceeds from borrowings 1,786,640
Dividend paid to holding company (17,437,805)
Net cash used in financing activities (5,316,618) (13,139,326)
Effect on exchange rate change on cash, cash equivalents and restricted cash 49,765 (310,995)
Net change in cash, cash equivalent and restricted cash (20,055,641) (22,752,426)
BEGINNING OF PERIOD 51,294,072 73,081,407
END OF PERIOD 31,238,431 50,328,981
Cash paid for income taxes 138,310
Cash paid for interest 412,776
Cash received for interest 356,003
Reconciliation to amounts on consolidated balance sheets:    
Cash and cash equivalents 3,783,780 15,209,645
Restricted cash 27,454,651 35,119,336
Total cash, cash equivalents and restricted cash 31,238,431 50,328,981
SUPPLEMENTAL NON-CASH DISCLOSURES    
Issuance of ordinary shares to settle finder fee 4,000,000
Forgiveness of amount due to holding company 8,600,000
Operating lease right-of-use asset obtained in exchange for operating lease liabilities 12,512,585
Purchase of property and equipment, through earnest deposit 7,205,118
Special dividend to the holding company offset with amount due from the holding company $ 29,562,195
v3.23.2
Nature of Business and Basis of Presentation
6 Months Ended
Jun. 30, 2023
Nature of Business and Basis of Presentation [Abstract]  
NATURE OF BUSINESS AND BASIS OF PRESENTATION

NOTE 1 - NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

AGBA Group Holding Limited (“AGBA” or the “Company”) was incorporated on October 8, 2018 in British Virgin Islands.

 

The Company, through its subsidiaries, is operating a wealth and health platform, offering a wide range of financial service and products, covering life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, lending, and real estate in overseas. AGBA is also engaged in financial technology business and financial investments, managing an ensemble of fintech investments and healthcare investment and operating a health and wealth management platform with a broad spectrum of services and value-added information in health, insurance, investments and social sharing.

 

The accompanying unaudited condensed consolidated financial statements of the Company are presented in United State dollars (“US$” or “$”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities Exchange Commission. Certain information and footnote disclosures normally included in consolidated financial statements have been omitted pursuant to such rules and regulations. The consolidated balance sheet as of December 31, 2022 derived from the audited consolidated financial statements at that date, but does not include all the information and footnotes required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

The unaudited condensed consolidated financial statements as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and 2022, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition, results of operations and cash flows. The results of operations for the three and six months ended June 30, 2023 and 2022 are not necessarily indicative of the results to be expected for any other interim period or for the entire year.

 

Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

v3.23.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

These accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying unaudited condensed consolidated financial statements and notes.

 

Principal of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the financial statements of AGBA and its subsidiaries. A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. All intercompany transactions and balances between AGBA and its subsidiaries are eliminated upon consolidation.

 

Use of Estimates and Assumptions

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property and equipment, impairment of long-lived assets, allowance for doubtful accounts, notes receivable, share-based compensation, warrant liabilities, forward share purchase liability, provision for contingent liabilities, revenue recognition, income tax provision, deferred taxes and uncertain tax position, and allocation of expenses from holding company.

 

The inputs into the management’s judgments and estimates consider the economic implications of COVID-19 on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates.

 

Foreign Currency Translation and Transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

 

The reporting currency of the Company is US$ and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company and subsidiaries are operating in Hong Kong maintain their books and record in their local currency, Hong Kong dollars (“HK$”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, Translation of Financial Statement, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the unaudited condensed consolidated statements of changes in shareholders’ equity.

 

Translation of amounts from HK$ into US$ has been made at the following exchange rates for the six months ended June 30, 2022 and 2021:

 

   June 30,
2023
   June 30,
2022
 
Period-end HK$:US$ exchange rate   0.12761    0.12744 
Period average HK$:US$ exchange rate   0.12757    0.12779 

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist primarily of cash in readily available checking and saving accounts. They consist of highly liquid investments that are readily convertible to cash and that mature within three months or less from the date of purchase. The carrying amounts approximate fair value due to the short maturities of these instruments. The Company maintains most of its bank accounts in Hong Kong.

 

Restricted Cash

 

Restricted cash consist of funds held in escrow accounts reflecting (i) the restricted cash and cash equivalents maintained in certain bank accounts that are held for the exclusive interest of the Company’s customers and (ii) the full obligation to an investor in connection with the Meteora Backstop Agreement (see Note 4).

 

The Company restricts the use of the assets underlying the funds held in escrow to meet with regulatory or contractual requirements and classifies the assets as current based on their purpose and availability to fulfill its direct obligation under current liabilities.

 

Accounts Receivable, net

 

Accounts receivable include trade accounts due from customers in insurance brokerage and asset management businesses.

 

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms. The normal settlement terms of accounts receivable from insurance companies in the provision of brokerage agency services are within 30 days upon the execution of the insurance policies. Credit terms with the products providers of investment, unit and mutual funds and asset portfolio are mainly 90 days or a credit period mutually agreed between the contracting parties. The Company seeks to maintain strict control over its outstanding receivables to minimize credit risk. Overdue balances are reviewed regularly by senior management. Management reviews its receivables on a regular basis to determine if the bad debt allowance is adequate, and provides allowance when necessary.

 

The Company does not hold any collateral or other credit enhancements over its accounts receivable balances.

 

Loans Receivable, net

 

Loans receivable are real estate mortgage loans that carried at unpaid principal balances, less the allowance for credit losses on loans receivable and charge-offs.

 

Loans are placed on nonaccrual status when they are past due 180 days or more as to contractual obligations or when other circumstances indicate that collection is not probable. When a loan is placed on nonaccrual status, any interest accrued but not received is reversed against interest income. Payments received on a nonaccrual loan are either applied to protective advances, the outstanding principal balance or recorded as interest income, depending on an assessment of the ability to collect the loan. A nonaccrual loan may be restored to accrual status when principal and interest payments have been brought current and the loan has performed in accordance with its contractual terms for a reasonable period (generally six months).

 

If the Company determines that a loan is impaired, the Company next determines the amount of the impairment. The amount of impairment on collateral dependent loans is charged off within the given fiscal quarter. Generally, the amount of the loan and negative escrow in excess of the appraised value less estimated selling costs, for the fair value of collateral valuation method, is charged off. For all other loans, impairment is measured as described below in Allowance for Credit Losses on Financial Instruments.

 

Allowance for Credit Losses on Financial Instruments

 

In accordance with ASC Topic 326 “Credit Losses – Measurement of Credit Losses on Financial Instruments” (ASC Topic 326), the Company utilizes the current expected credit losses (“CECL”) model to determine an allowance that reflects its best estimate of the lifetime expected credit losses on accounts receivable, loans receivable, notes receivable and deposits, prepayments, and others receivable which is recorded as a liability to offset the receivables. The CECL model is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Accounts receivable, loans receivable, notes receivables and deposits, prepayments, and others receivable are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded as a reduction of bad debt expense.

 

Long-Term Investments, net

 

The Company invests in equity securities with readily determinable fair values and equity securities that do not have readily determinable fair values.

 

Equity securities with readily determinable fair values are carried at fair value with any unrealized gains or losses reported in earnings.

 

Equity securities that do not have readily determinable fair values mainly consist of investments in privately-held companies. They are accounted for, at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.

 

At each reporting period, the Company makes a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired.

 

Asset Held For Sale

 

Assets to be disposed of by sale are reported at the lower of the carrying value or fair value less cost to sell when the Company has committed to a sale agreement and would be reported separately as assets held for sale in the unaudited condensed consolidated balance sheets.  

 

Property and Equipment, net

 

Property and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational:

 

   Expected useful life
Land and building  Shorter of 50 years or lease term
Office improvement  3 years
Furniture, fixtures and equipment  5 years
Computer equipment  3 years
Motor vehicle  3 years

 

Expenditure for repairs and maintenance is expensed as incurred. When assets have retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

 

Impairment of Long-Lived Assets

 

In accordance with the provisions of ASC Topic 360, Impairment or Disposal of Long-Lived Assets, all long-lived assets such as property and equipment owned and held by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. No impairment losses were recognized for the three and six months ended June 30, 2023 and 2022.

 

Revenue Recognition

 

The Company receives certain portion of its non-interest income from contracts with customers, which are accounted for in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASC Topic 606").

 

ASC Topic 606 provided the following overview of how revenue is recognized from the Company’s contracts with customers. The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.

 

Step 1: Identify the contract(s) with a customer.

 

Step 2: Identify the performance obligations in the contract.

 

Step 3: Determine the transaction price – The transaction price is the amount of consideration in a contract to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer.

 

Step 4: Allocate the transaction price to the performance obligations in the contract – Any entity typically allocates the transaction price to each performance obligation on the basis of the relative standalone selling prices of each distinct good or service promised in the contract.

 

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation – An entity recognizes revenue when (or as) it satisfies a performance obligation by transferring a promised good or service to a customer (which is when the customer obtains control of that good or service). The amount of revenue recognized is the amount allocated to the satisfied performance obligation. A performance obligation may be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically for promises to transfer service to a customer).

 

Certain portion of the Company's income is derived from contracts with customers, and as such, the revenue recognized depicts the transfer of promised goods or services to its customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company considers the terms of the contract and all relevant facts and circumstances when applying this guidance. The Company’s revenue recognition policies are in compliance with ASC Topic 606, as follows:

 

Commissions

 

The Company earns commissions from the sale of investment products to customers. The Company enters into commission agreements with customers which specify the key terms and conditions of the arrangement. Commissions are separately negotiated for each transaction and generally do not include rights of return, credits or discounts, rebates, price protection or other similar privileges, and typically paid on or shortly after the transaction is completed. Upon the purchase of an investment product, the Company earns a commission from customers, calculated as a fixed percentage of the investment products acquired by its customers. The Company defines the “purchase of an investment product” for its revenue recognition purpose as the time when the customers referred by the Company has entered into a subscription contract with the relevant product provider and, if required, the customer has transferred a deposit to an escrow account designated by the Company to complete the purchase of the investment products. After the contract is established, there are no significant judgments made when determining the one-time commission price. Therefore, commissions are recorded at point in time when the investment product is purchased.

 

The Company also facilitates the arrangement between insurance providers and individuals or businesses by providing insurance placement services to the insureds, and is compensated in the form of one-time commissions from the respective insurance providers. The Company primarily facilitates the placement of life, general and MPF insurance products. The Company determines that insurance providers are the customers.

 

The Company primarily earns commission income arising from the facilitation of the placement of an effective insurance policy, which is recognized at a point in time when the performance obligation has been satisfied upon execution of the insurance policy as the Company has no future or ongoing obligation with respect to such policies. The commission fee rate, which is paid by the insurance providers, based on the terms specified in the service contract which are agreed between the Company and insurance providers for each insurance product being facilitated through the Company. The commission earned is equal to a percentage of the premium paid to the insurance provider. Commission from renewed policies is variable consideration and is recognized in subsequent periods when the uncertainty around variable consideration is subsequently resolved (e.g., when customer renews the policy).

 

In accordance with ASC Topic 606, Revenue Recognition: Principal Agent Considerations, the Company evaluates the terms in the agreements with its channels and independent contractors to determine whether or not the Company acts as the principal or as an agent in the arrangement with each party respectively. The determination of whether to record the revenue in a gross or net basis depends upon whether the Company has control over the services prior to transferring it. Control is demonstrated by the Company which is primarily responsible for fulfilling the provision of placement services through the Company’s licensed insurance brokers to provide agency services. The commissions from insurance providers are recorded on a gross basis and commission paid to independent contractors or channel costs are recorded as commission expense in the statements of operations.

 

The Company also offers the sale solicitation of real estate property to the final customers and is compensated in the form of commissions from the corresponding property developers pursuant to the service contracts. Commission income is recognized at a point of time upon the sale contracts of real estate property is signed and executed.

 

Recurring service fees

 

The Company provides asset management services to investment funds or investment product providers in exchange for recurring service fees. Recurring service fees are determined based on the types of investment products the Company distributes and are calculated as a fixed percentage of the fair value of the total investment of the investment products, calculated daily. These customer contracts require the Company to provide investment management services, which represents a performance obligation that the Company satisfies over time. After the contract is established, there are no significant judgments made when determining the transaction price. As the Company provides these services throughout the contract term, for the method of calculating recurring service fees, revenue is calculated on a daily basis over the contract term, quarterly billed and recognized. Recurring service agreements do not include rights of return, credits or discounts, rebates, price protection, performance component or other similar privileges and the circumstances under which the fixed percentage fees, before determined, could be not subject to clawback. Payment of recurring service fees are normally on a regular basis (typically monthly or quarterly).

 

Interest income

 

The Company offers money lending services from loan origination in form of mortgage and personal loans. Interest income is recognized monthly in accordance with their contractual terms and recorded as interest income in the unaudited condensed consolidated statement of operations. The Company does not charge prepayment penalties from its customers. Interest income on mortgage and personal loans is recognized as it accrued using the effective interest method. Accrual of interest income on mortgage loans is suspended at the earlier of the time at which collection of an account becomes doubtful or the account becomes 180 days delinquent.

 

Disaggregation of Revenue

 

The Company has disaggregated its revenue from contracts with customers into categories based on the nature of the revenue. The following table presents the revenue streams by segments, with the presentation revenue categories presented on the statements of operation for the periods indicated:

 

   For the three months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $38,175   $-   $38,175 
                          
Non-interest income:                         
Commissions   16,005,608    277,960    -    39,488    16,323,056 
Recurring service fees   -    1,009,702    -    -    1,009,702 
                          
   $16,005,608   $1,287,662   $38,175   $39,488   $17,370,933 

 

   For the three months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $37,871   $-   $37,871 
                          
Non-interest income:                         
Commissions   2,373,898    518,277    -    44,905    2,937,080 
Recurring service fees   -    1,114,721    -    -    1,114,721 
                          
   $2,373,898   $1,632,998   $37,871   $44,905   $4,089,672 

 

   For the six months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $76,333   $-   $76,333 
                          
Non-interest income:                         
Commissions   25,693,427    601,722    -    43,534    26,338,683 
Recurring service fees   -    2,029,597    -    -    2,029,597 
                          
   $25,693,427   $2,631,319   $76,333   $43,534   $28,444,613 

 

   For the six months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $99,194   $-   $99,194 
                          
Non-interest income:                         
Commissions   2,553,829    1,094,812    -    115,516    3,764,157 
Recurring service fees   -    2,302,644    -    -    2,302,644 
                          
   $2,553,829   $3,397,456   $99,194   $115,516   $6,165,995 

 

Rental income

 

Rental income represents monthly rental received from the Company’s tenants. The Company recognizes rental income on a straight-line basis over the lease term in accordance with the lease agreement.

 

Comprehensive Loss

 

ASC Topic 220, Comprehensive Income, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income (loss), as presented in the accompanying statement of shareholder’s equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive loss is not included in the computation of income tax expense or benefit.

 

Income Taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC Topic 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC Topic 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

For the three and six months ended June 30, 2023 and 2022, the Company did not have any interest and penalties associated with tax positions. As of June 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions.

 

The Company is subject to tax in local and foreign jurisdictions. As a result of its business activities, the Company files tax returns that are subject to examination by the relevant tax authorities.

 

Share-Based Compensation

 

The Company accounts for share-based compensation in accordance with the fair value recognition provision of ASC Topic 718, Stock Compensation. The Company grants share awards, including ordinary shares and restricted share units, to eligible participants. Share-based compensation expense for share awards is measured at fair value on the grant date. The fair value of restricted stock with either solely a service requirement or with the combination of service and performance requirements is based on the closing fair market value of the ordinary shares on the date of grant. Share-based compensation expense is recognized over the awards requisite service period. For awards with graded vesting that are subject only to a service condition, the expense is recognized on a straight-line basis over the service period for the entire award.

 

Net Loss Per Share

 

The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, Earnings per Share (“ASC Topic 260”). ASC Topic 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net (loss) income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Segment Reporting

 

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for details on the Company’s business segments.

 

The Company uses the management approach to determine reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making decisions, allocating resources and assessing performance. The Company’s CODM has been identified as the CEO, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. Based on management’s assessment, the Company determined that it has the following operating segments:

 

Segments   Scope of Service   Business Activities
Distribution Business   Insurance Brokerage
Business
  - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
         
Platform Business   - Asset Management Business  

- Providing access to financial products and services to licensed brokers.

- Providing operational support for the submission and processing of product applications.

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

- Providing training resources and materials.

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

         
    - Money Lending Service   - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
         
    - Real Estate Agency Service   - Solicitation of real estate sales for the developers, in exchange for commissions.
         
Fintech Business   Investment Holding   Managing an ensemble of fintech investments.
         
Healthcare Business   Investment Holding   Managing an ensemble of healthcare-related investments.

 

All of the Company’s revenues were generated in Hong Kong.

 

Leases

 

The Company follows ASC Topic 842, Leases (“ASC Topic 842”), utilizing the modified retrospective transition method with no adjustments to comparative periods presented. On February 25, 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (ASC Topic 842), to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. ASC Topic 842 requires that lessees recognize right-of-use asset and lease liabilities calculated based on the present value of lease payments for all lease agreements with terms that are greater than twelve months. It requires for leases longer than one year, a lessee to recognize in the statement of financial condition a right-of-use asset, representing the right to use the underlying asset for the lease term, and a lease liability, representing the liability to make lease payments. ASC Topic 842 distinguishes leases as either a finance lease or an operating lease that affects how the leases are measured and presented in the statement of operations and statement of cash flows. ASC Topic 842 supersedes nearly all existing lease accounting guidance under GAAP issued by the Financial Accounting Standards Board (“FASB”) including ASC Topic 840, Leases.

 

When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company used an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected to adopt the following lease policies in conjunction with the adoption of ASU 2016-02: (i) for leases that have lease terms of 12 months or less and does not include a purchase option that is reasonably certain to exercise, the Company elected not to apply ASC 842 recognition requirements; and (ii) the Company elected to apply the package of practical expedients for existing arrangements entered into prior to January 1, 2021 to not reassess (a) whether an arrangement is or contains a lease, (b) the lease classification applied to existing leases, and (c) initial direct costs.

 

The accounting update also requires that for finance leases, a lessee recognize interest expense on the lease liability, separately from the amortization of the right-of-use asset in the statements of earnings, while for operating leases, such amounts should be recognized as a combined expense. In addition, this accounting update requires expanded disclosures about the nature and terms of lease agreements.

 

Related Parties

 

The Company follows the ASC Topic 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Commitments And Contingencies

 

The Company follows the ASC Topic 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair Value Measurement

 

The Company follows the guidance of the ASC Topic 820-10, Fair Value Measurements and Disclosures ("ASC Topic 820-10"), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 : Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets;

 

  Level 2 : Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. Black-Scholes Option-Pricing model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs; and

 

  Level 3 : Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the assets or liabilities. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models.

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, restricted cash, accounts receivable, deposits, prepayments, and others receivable, amounts due to the holding company, accounts payable and accrued liabilities, escrow liabilities and borrowings approximate at their fair values because of the short-term nature of these financial instruments.

 

Management believes, based on the current market prices or interest rates for similar debt instruments, the fair value of loans receivable and notes receivable approximate the carrying amount. They are accounted at amortized cost, subject to impairment testing.

 

The following table presents information about the Company’s assets that were measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

 

   June 30,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2023   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $524   $    524   $         -   $- 
Non-marketable equity securities  $33,946,542   $-   $-   $33,946,542 
                     
Liabilities:                    
Warrant liabilities  $2,173   $-   $-   $2,173 

 

   December 31,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2022   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $2,443,593   $2,443,593   $     -   $- 
Non-marketable equity securities  $34,589,767   $-   $-   $34,589,767 
                     
Liabilities:                    
Forward share purchase liability  $13,491,606   $-   $-   $13,491,606 
Warrant liabilities  $4,548   $-   $-   $4,548 

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recently Issued Accounting Pronouncements

 

There were no new standards or updates during the six months ended June 30, 2023 that had a material impact on the unaudited condensed consolidated financial statements.

v3.23.2
Liquidity and Going Concern
6 Months Ended
Jun. 30, 2023
Nature of Business and Basis of Presentation [Abstract]  
LIQUIDITY AND GOING CONCERN

NOTE 3 — LIQUIDITY AND GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements were prepared assuming the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

For the six months ended June 30, 2023, the Company reported $22,657,899 net loss and $19,265,823 net cash outflows from operating activities. As of June 30, 2023, the Company had an accumulated deficit of $62,053,032 and cash and cash equivalents of $3,783,780.

 

The ability to continue as a going concern is dependent on the Company’s ability to successfully implement its plans. The Company believes that it will be able to continue to grow the Company’s revenue base and control expenditures. In parallel, the Company continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance the Company’s business development activities, general and administrative expenses and growth strategy. These alternatives include external borrowings, raising funds through public equity or debt markets. Although there is no assurance that, if needed, the Company will be successful with its fundraising initiatives, the Company believes that the Business Combination transaction significantly increases its ability to access the capital going forward. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Without realization of additional capital, there is substantial doubt about the Company can continue as a going concern until such time, as the Company is able to secure adequate financial resources and capital that provides the required capital to continue to settle its debts as they fall due and sustain the operation through the next 12 months from the date that these unaudited condensed consolidated financial statements were made available to issue.

v3.23.2
Restricted Cash
6 Months Ended
Jun. 30, 2023
Restricted Cash [Abstract]  
RESTRICTED CASH

NOTE 4 — RESTRICTED CASH

 

Pursuant to the Meteora Backstop Agreement dated November 9, 2022, the fund held in the escrow account for the forward share purchase is restricted to the Company for the nine months following the consummation of the Business Combination in November 2022, unless the investors sell the shares in the market or redeems the shares. Notwithstanding the sale of shares by the investors, the restricted cash will be used to settle any of the Company’s repurchase obligations.

 

During the six months ended June 30, 2023, the investors sold 1,191,016 shares in the open market at a price ranging from $1.51 to $1.61 per share.

 

On June 29, 2023, the Company and the investors entered into an agreement to early terminate the Meteora Backstop Agreement.

 

Pursuant to the early termination clauses of Meteora Backstop Agreement, the Company released $14.0 million from restricted cash to settle the obligation to investors and retained $1.7 million which is reflected in the cash and cash equivalents on the unaudited condensed consolidated balance sheets.

 

Pursuant to the termination agreement, the Company is not obligated to purchase the remaining 124,949 shares (the “Shares”) from the investors and the investors shall have no obligation to sell the Shares to the Company. In addition, the investors may dispose the Shares at its discretion in the open market at a sales price not less than $2 per share within the first three months following the date of the termination agreement and there is no condition or restrictions on the sales price thereafter. As a result, the Company released the remaining $1.5 million from restricted cash to settle the obligation to investors.

 

With the early termination and sale of shares by investors, the forward share purchase liability (“FSP liability”) was fully settled as of June 30, 2023 and a loss on settlement of $378,895 was recorded in the unaudited condensed consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2023.

v3.23.2
Accounts Receivable, Net
6 Months Ended
Jun. 30, 2023
Accounts Receivable, Net [Abstract]  
ACCOUNTS RECEIVABLE, NET

NOTE 5 - ACCOUNTS RECEIVABLE, NET

 

Accounts receivable, net consisted of the following:

 

   As of 
   June 30,
2023
   December 31,
2022
 
Accounts receivable  $3,592,789   $2,916,609 
Accounts receivable – related parties   601,576    272,546 
Less: allowance for estimated credit losses   (162,009)   (94,447)
Accounts receivable, net  $4,032,356   $3,094,708 

 

The accounts receivable due from related parties represented the management service rendered to the portfolio assets of a related companies, which are controlled by the holding company, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers. The amount is unsecured, interest-free and with a credit term mutually agreed.

 

The Company generally conducts its business with creditworthy third parties. The Company determines, on a quarterly basis, the probable losses and an allowance for credit losses determined in accordance with the CECL model, based on historical losses, current economic conditions, forecasted future economic and market considerations, and in some cases, evaluating specific customer accounts for risk of loss. Accounts receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. In addition, receivable balances are monitored on an ongoing basis and its exposure to bad debts is not significant.

 

For the three and six months ended June 30, 2023, the Company has assessed the probable loss and made an allowance for estimated credit losses of $67,949 and $67,949 on accounts receivable, respectively.

 

For the three and six months ended June 30, 2022, there was no estimated credit losses to accounts receivable.

v3.23.2
Loans Receivables, Net
6 Months Ended
Jun. 30, 2023
Loans Receivables [Abstract]  
LOANS RECEIVABLES, NET

NOTE 6 - LOANS RECEIVABLE, NET

 

The Company’s loans receivable, net was as follows:

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Mortgage loans (residential)  $1,576,013   $1,589,871 
           
Reclassifying as:          
Current portion  $516,237   $517,479 
Non-current portion   1,059,776    1,072,392 
Loans receivable, net  $1,576,013   $1,589,871 

 

The interest rates on loans issued ranged between 9.00% and 10.50% per annum for the six months ended June 30, 2023 and 2022. Mortgage loans are secured by collateral in the pledge of the underlying real estate properties owned by the borrowers.

 

Mortgage loans are made to either business or individual customers in Hong Kong for a period of 1 to 25 years, which are fully collateralized and closely monitored for counterparty creditworthiness, with such collateral having a fair value in excess of the carrying amount of the loans as of June 30, 2023 and December 31, 2022.

 

Estimated allowance for credit losses is determined on quarterly basis, in accordance with the CECL model, for general credit risk of the overall portfolio, which is relied on an assessment of specific evidence indicating doubtful collection, historical loss experience, loan balance aging and prevailing economic conditions. If there is an unexpected deterioration of a customer’s financial condition or an unexpected change in economic conditions, including macroeconomic events, the Company will assess the need to adjust the allowance for credit losses. Any such resulting adjustments would affect earnings in the period that adjustments are made.

 

For the three and six months ended June 30, 2023 and 2022, the Company has evaluated the probable losses on the loans receivable and no estimated credit losses is determined.

v3.23.2
Assets Held For Sale
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment Assets Held-for-Sale Disclosure [Abstract]  
ASSETS HELD FOR SALE

NOTE 7 - ASSET HELD FOR SALE

 

On June 28, 2023, the Company entered into a provisional purchase and sale agreement with an independent third party to sell one of its office premises at a consideration of $6.15 million. The Company received a deposit of $0.3 million and the transaction is expected to be completed in October 2023. As of June 30, 2023, the carrying amount of the asset held for sale was $5.46 million which reclassified from the property and equipment, net.

v3.23.2
Notes Receivable
6 Months Ended
Jun. 30, 2023
Notes Receivable [Abstract]  
NOTES RECEIVABLE

NOTE 8 - NOTES RECEIVABLE, NET

 

On February 24, 2023, the Company entered into a Subscription Agreement and a Convertible Loan Note Instrument (the “Note”) (collectively the “Agreements”) with Investment A. Pursuant to the Agreements, the Company agrees to subscribe an aggregate amount of $1,673,525 notes, in batches, which are payable on or before January 31, 2024 and bears a fixed interest rate of 8% per annum. The maturity of the notes receivable is on April 30, 2024.

 

As of June 30, 2023, the carrying amount of the notes receivable was $601,490, including an interest receivable of $11,778.

 

In accordance with ASC Topic 326, the Company accounts for its allowance for credit losses on notes receivable using the CECL model. Periodic changes to the allowance for credit losses are recognized in the unaudited condensed consolidated statements of operations. For the three and six months ended June 30, 2023, the Company has evaluated the probable losses on the notes receivable and no estimated credit losses is determined.

v3.23.2
Long-Term Investments, Net
6 Months Ended
Jun. 30, 2023
Long-Term Investments, Net [Abstract]  
LONG-TERM INVESTMENTS, NET

NOTE 9 - LONG-TERM INVESTMENTS, NET

 

Long-term investments consisted of the following:

 

   As of 
   Ownership
interest
   June 30,
2023
   Ownership
interest
   December 31,
2022
 
                 
Marketable equity securities                
Investment C   0.00%*  $524    0.46%  $2,443,593 
                     
Non-marketable equity securities:                    
Investment A   8.37%   5,740,036    8.37%   5,717,678 
Investment B   3.63%   511,003    3.63%   513,000 
Investment D   4.49%   16,784,183    4.92%   16,030,943 
Investment E   4.00%   520,523    4.00%   522,557 
Investment F   4.00%   10,390,797    4.00%   11,805,589 
Total        33,946,542         34,589,767 
Net carrying value       $33,947,066        $37,033,360 

 

*Less than 0.001%

 

Investments in Marketable Equity Securities

 

Investments in marketable securities are accounted for at its current market value with the changes in fair value recognized in statements of operations. Investment C was listed and publicly traded on Nasdaq Stock Exchange.

 

During the six months ended June 30, 2023, the Company sold 993,108 shares of Investment C at the average market price of $4.01 per share, resulting with a realized gain of $1,541,736.

 

As of June 30, 2023 and December 31, 2022, Investment C was recorded at fair value of $524 and $2,443,593, which were traded at a closing price of $8.06 and $2.46 per share, respectively.

 

Investments in Non-Marketable Equity Securities

 

Investments in non-marketable equity securities consist of investments in limited liability companies in which the Company’s interests are deemed minor and long-term, strategic investments in companies that are in various stages of development, and investments in a close-ended partnership funds which concentrated in the healthcare sector. These investments do not have readily determinable fair values and, therefore, are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.

 

Management assesses each of these investments on an individual basis, subject to a periodic impairment review and considers qualitative and quantitative factors including the investee’s financial condition, the business outlook for its products and technology, its projected results and cash flow, financing transactions subsequent to the acquisition of the investment, the likelihood of obtaining subsequent rounds of financing and cash usage. The Company is not required to determine the fair value of these investments unless impairment indicators existed. When an impairment exists, the investment will be written down to its fair value by recording the corresponding charge as a component of other income (expense), net. Fair value is estimated using the best information available, which may include cash flow projections or other available market data.

 

The following table presents the changes in fair value of non-market equity securities which are measured using Level 3 inputs as of June 30, 2023 and December 31, 2022:

 

   As of 
   June 30,
2023
   December 31,
2022
 
Balance at beginning of period/year  $34,589,767   $25,496,534 
Additions   -    16,228,690 
Adjustments:          
Downward adjustments   (1,427,904)   (6,898,549)
Upward adjustments   -    2,137,021 
Foreign exchange adjustment   784,679    (2,373,929)
Balance at end of period/year  $33,946,542   $34,589,767 

 

Cumulative unrealized gains and losses, included in the carrying value of the Company’s non-marketable equity securities:

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Downward adjustments (including impairment)  $(28,682,504)  $(27,254,600)
Upward adjustments  $6,209,357   $6,209,357 

 

Investment income (loss) is recorded as other income (expense) and consisted of the following:

 

   For the three months ended
June 30,
 
   2023   2022 
Marketable equity securities:        
Unrealized loss from the changes in fair value – Investment C  $(168)  $(5,683,988)
Realized gain from sale of Investment C   -    - 
           
Non-marketable equity securities:          
Unrealized loss (including impairment) – Investment F   (1,000,119)   - 
Dividend income   558,719    - 
Investment loss, net  $(441,568)  $(5,683,988)

   For the six months ended
June 30,
 
   2023   2022 
Marketable equity securities:        
Unrealized gain (loss) from the changes in fair value – Investment C  $98   $(3,535,053)
Realized gain from sale of Investment C   1,541,736    - 
           
Non-marketable equity securities:          
Unrealized loss (including impairment) – Investment F   (1,427,771)   - 
Dividend income   1,167,433    - 
Investment income (loss), net  $1,281,496   $(3,535,053)
v3.23.2
Property and Equipment, Net
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

NOTE 10 - PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

   As of 
   June 30,
2023
   December 31,
2022
 
At cost:        
Land and building  $1,878,538   $7,881,202 
Furniture, fixtures and equipment   13,360    13,412 
Computer equipment   241,842    164,536 
Motor vehicles   108,570    108,994 
    2,242,310    8,168,144 
Less: accumulated depreciation   (508,846)   (808,728)
Property and equipment, net  $1,733,464   $7,359,416 

 

Depreciation expenses for the three months ended June 30, 2023 and 2022 were $114,322 and $95,673, respectively.

 

Depreciation expenses for the six months ended June 30, 2023 and 2022 were $215,494 and $192,352, respectively.

 

As of June 30, 2023, the carrying amount of an office premises of $5.46 million was reclassified to asset held for sale as the Company entered a provisional purchase and sale agreement with an independent third party to sale the office premises in October 2023 (see Note 7).

v3.23.2
Borrowings
6 Months Ended
Jun. 30, 2023
Borrowings [Abstract]  
BORROWINGS

NOTE 11 - BORROWINGS

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Mortgage borrowings  $6,255,238   $4,477,254 

 

In September 2022, the Company obtained a mortgage loan from a finance company in Hong Kong, which bears interest at a fixed rate of 10.85% per annum, is repayable in September 2023.

 

In February 2023, the Company obtained another mortgage loan from another finance company in Hong Kong, which bears an average interest rate at 13.75% per annum, is repayable in February 2024.

 

As of June 30, 2023, the mortgage loans are secured by the office premises of the Company, located in Hong Kong, with the aggregate carrying amount of $7.0 million (December 31, 2022: $5.7 million), of which $5.5 million (December 31, 2022: nil) is asset held for sale.

v3.23.2
Forward Share Purchase Liability
6 Months Ended
Jun. 30, 2023
Forward Share Purchase Liabilitiy [Abstract]  
FORWARD SHARE PURCHASE LIABILITY

NOTE 12 - FORWARD SHARE PURCHASE LIABILITY

 

For the three and six months ended June 30, 2023, subject to the sale of shares by investors and early termination of the Meteora Backshop Agreement, the forward share purchase liability (“FSP liability”) was fully settled and a loss on settlement of $378,895 was recorded in the unaudited condensed consolidated statements of operations and comprehensive loss.

 

The FSP liability under the Meteora Backstop Agreement is valued by an independent valuer using a Black-Scholes model, which is considered to be Level 3 fair value measurement. The following table present the quantitative information regarding Level 3 fair value measurement of the FSP liability:

 

Input   December 31,
2022
 
Share price   $1.54 
Risk-free interest rate    4.16%
Volatility    52.19%
Exercise price   $12.34 
Term    0.61 years 

 

For the three and six months ended June 30, 2023, the change in fair value of FSP liability was $0 and $82,182, respectively.

v3.23.2
Leases
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
LEASES

NOTE 13 - LEASES

 

Operating lease right-of-use (“ROU”) asset and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU asset represents the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest (“discount rate”) in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

 

During the six months ended June 30, 2023, the Company has entered into a commercial operating lease with an independent third party for the use of an office in Hong Kong. The lease has an original term exceeding 1 year, but not more than 3 years with an option to renew a further term of 3 years. The operating lease is included in “Right-of-use asset” on the unaudited condensed consolidated balance sheet and represents the Company’s right to use the underlying asset during the lease term. The Company’s obligation to make lease payments are included in “Lease liabilities” on the unaudited condensed consolidated balance sheet.

 

Supplemental balance sheet information related to the operating lease was as follows:

 

   June 30,
2023
 
Operating lease:    
Right-of-use asset, net  $12,361,125 
      
Lease liabilities:     
Current lease liabilities   1,186,200 
Non-current lease liabilities   11,227,185 
Total lease liabilities  $12,413,385 

 

Operating lease expense for the three and six months ended June 30, 2023 was $213,550 and $213,550, respectively. There was no operating lease for the three and six months ended June 30, 2022.

 

Other supplemental information about the Company’s operating lease as of June 30, 2023 are as follow:

 

Weighted average discount rate   6.58%
Weighted average remaining lease term (years)   5.92 

 

Maturities of operating lease liabilities as of June 30, 2023 were as follows:

 

For the period ending June 30,  Operating
lease
 
2024  $1,934,715 
2025   1,934,715 
2026   2,039,234 
2027   3,188,945 
2028   3,188,945 
Thereafter   2,923,199 
Total future minimum lease payments   15,209,753 
Less: imputed interest   (2,796,368)
Present value of operating lease liabilities  $12,413,385 
v3.23.2
Warrant Liabilities
6 Months Ended
Jun. 30, 2023
Warrant Liabilities [Abstract]  
WARRANT LIABILITIES

NOTE 14 - WARRANT LIABILITIES

 

The private warrants are accounted for as liabilities in accordance with ASC 480 and are presented as liabilities on the unaudited condensed consolidated balance sheets. As of June 30, 2023 and December 31, 2022, there were 225,000 private warrants outstanding.

 

The fair value of the private warrants are valued by an independent valuer using a Binominal pricing model. The warrants were classified as Level 3 due to the use of unobservable inputs.

 

The key inputs into the Binominal pricing model were as follows at their measurement dates:

 

Input  June 30,
2023
   December 31,
2022
 
Share price  $1.44   $1.54 
Risk-free interest rate   4.51%   4.16%
Volatility   51.83%   52.19%
Exercise price  $11.50   $11.50 
Term   4.4 years    4.9 years 

 

As of June 30, 2023 and December 31, 2022, the aggregate value of the private warrants was $2,173 and $4,548, respectively. The changes in fair value for the three and six months ended June 30, 2023 was $1,695 and $2,375, respectively.

v3.23.2
Shareholders’ Equity
6 Months Ended
Jun. 30, 2023
Shareholders’ Equity [Abstract]  
SHAREHOLDERS’ EQUITY

NOTE 15 - SHAREHOLDERS’ EQUITY

 

Ordinary shares

 

As of June 30, 2023 and December 31, 2022, the Company has authorized share of 200,000,000 ordinary shares with a par value $0.001.

 

On March 21, 2023, the Company issued 2,173,913 ordinary shares to Apex Twinkle Limited to partially settle the finder fee payable.

 

On May 22, 2023, the Company issued 946,100 ordinary shares to the directors and officers of the Company under the Share Award Scheme (the “Scheme”) for compensating the contributions of prior services and performance. The shares were approved and granted previously in December 2022.

 

On June 6, 2023, the holdback shares of 1,665,000 ordinary shares were fully released and issued.

 

During the six months ended June 30, 2023, pursuant to the Scheme, the Company issued in aggregate of 4,300,000 ordinary shares to certain consultants to compensate the services rendered.

 

As of June 30, 2023 and December 31, 2022, there were 67,461,998 and 58,376,985 ordinary shares issued and outstanding, respectively.

 

Public Warrants

 

Each public warrant entitles the holder thereof to purchase one-half (1/2) of one ordinary share at a price of $11.50 per full share, subject to adjustment as discussed herein. The warrants became exercisable 90 days after the Closing of the Business Combination and will expire five years after the Closing of the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares. This means that only an even number of warrants may be exercised at any given time by a warrant holder.

 

Once the warrants become exercisable, the Company may call the outstanding warrants (including any outstanding warrants issued upon exercise of the unit purchase option issued to Maxim Group LLC) for redemption:

 

  in whole and not in part;

 

  at a price of $0.01 per warrant;

 

  upon a minimum of 30 days’ prior written notice of redemption,

 

  if, and only if, the last sales price of the ordinary shares equals or exceeds $16.50 per share for any 20 trading days within a 30 trading day period ending three business days before the Company send the notice of redemption, and

 

  if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

 

If the Company calls the warrants for redemption as described above, the management of the Company will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Whether the Company will exercise our option to require all holders to exercise their warrants on a “cashless basis” will depend on a variety of factors including the price of our ordinary shares at the time the warrants are called for redemption, the Company’s cash needs at such time and concerns regarding dilutive share issuances.

 

Private Warrants

 

The private warrants are identical to the public warrants, except that the private warrants and the ordinary shares issuable upon the exercise of the private warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the private warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private warrants are held by someone other than the initial purchasers or their permitted transferees, the private warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.

 

The private warrants are accounted as liabilities, remeasured to fair value on a recurring basis, with changes in fair value recorded to the unaudited condensed consolidated statements of operations (see Note 14).

 

As of June 30, 2023 and December 31, 2022, there were 4,600,000 public warrants and 225,000 private warrants outstanding.

 

Share Award Scheme

 

On February 24, 2023, pursuant to the Scheme, the Company registered 11,675,397 ordinary shares to be issued. As of June 30, 2023, the Company issued 5,246,100 ordinary shares under the Scheme.

 

The fair value of the ordinary shares granted under the scheme is measured based on the closing price of the Company’s ordinary shares as reported by Nasdaq Exchange on the date of grant.

 

For those vested immediately on the date of grant, the fair value is recognized as share-based compensation expense in the consolidated statements of operations.

 

For the restricted share units (“RSUs”), the fair value is recognized over the period based on the derived service period (usually the vesting period), on a straight-line basis. The valuations assume no dividends will be paid. The Company has assumed 10% forfeitures.

 

During the three and six months ended June 30, 2023, the Company recorded $4,604,320 and $8,510,920 share-based compensation expense, respectively which is included in the operating expenses in the unaudited condensed consolidated statements of operations.

 

As of June 30, 2023, total unrecognized compensation remaining to be recognized in future periods for RSUs totaled $8.5 million. They are expected to be recognized over the weighted average period of 2.2 years.

 

A summary of the activities for the Company’s RSUs for the three and six months ended June 30, 2023 is as follow:

 

   As of 
   June 30, 2023   December 31, 2022 
   Number of
RSUs
   Weighted
Average
Grant Price
   Number of
RSUs
   Weighted
Average
Grant Price
 
                 
Outstanding, beginning of period/year   5,000,000   $2.47    -   $- 
Granted   -   $-    5,000,000   $2.47 
Outstanding, end of period/year   5,000,000   $2.47    5,000,000   $2.47 

 

Forgiveness of Amounts Due to the Holding Company

 

During the three and six months ended June 30, 2023, TAG agreed to forgive the Company $5.6 million and $8.6 million, in aggregate, respectively representing certain amount due to it and treat as additional paid-in capital.

v3.23.2
Operating Cost and Expenses
6 Months Ended
Jun. 30, 2023
Operating Cost and Expenses [Abstract]  
OPERATING COST AND EXPENSES

NOTE 16 - OPERATING COST AND EXPENSES

 

Commission Expense

 

Pursuant to the terms of respective contracts, commission expense represents certain premiums from insurance or investment products paid to agents. Commission rates vary by market due to local practice, competition, and regulations. The Company charged commission expense on a systematic basis that is consistent with the revenue recognition.

 

During the three months ended June 30, 2023 and 2022, the Company recorded $11,984,437 and $2,480,271 commission expenses, respectively.

 

During the six months ended June 30, 2023 and 2022, the Company recorded $19,279,929 and $3,181,313 commission expenses, respectively.

 

Personnel and Benefit Expense

 

Personnel and benefit expense mainly consisted of salaries and bonus paid and payable to the employees of the Company. During the six months ended June 30, 2023, the Company reversed the annual bonus of $3.8 million that was already accrued for the year ended December 31, 2022.

 

During the three months ended June 30, 2023 and 2022, the Company recorded $5,302,270 and $3,404,039 personnel and benefit expense, respectively.

 

During the six months ended June 30, 2023 and 2022, the Company recorded $14,907,460 and $5,409,018 personnel and benefit expense, respectively.

 

Other General and Administrative Expenses

 

The Company incurred different types of expenditures under other general and administrative expenses. They primarily consist of depreciation of property and equipment, legal and professional fees and management fee expenses which are allocated for certain corporate office expenses.

 

During the three months ended June 30, 2023 and 2022, the Company recorded $8,655,884 and $1,173,217 other general and administrative expenses, respectively.

 

During the six months ended June 30, 2023 and 2022, the Company recorded $14,511,705 and $2,081,618 other general and administrative expenses, respectively.

v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Taxes [Abstract]  
INCOME TAXES

NOTE 17 - INCOME TAXES

 

The provision for income taxes consisted of the following:

 

   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
Current tax (including over provision of income tax)  $26,368   $40,431   $(280)  $105,354 
Deferred tax   -    (354,574)   -    - 
Income tax expense (benefit)  $26,368   $(314,143)  $(280)  $105,354 

 

The Company’s subsidiaries mainly operate in Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

British Virgin Islands

 

The Company is incorporated in the British Virgin Islands and is not subject to taxation. In addition, upon payments of dividends by these entities to their shareholder, no British Virgin Islands withholding tax will be imposed.

 

Hong Kong

 

The Company’s subsidiaries operating in Hong Kong is subject to the Hong Kong Profits Tax at the income tax rates ranging from 8.25% to 16.5% on the assessable income arising in Hong Kong during its tax year. During the six months ended June 30, 2023, income tax benefit is primarily attributable to the over provision of income taxes for prior year of $40,151.   

 

The following table sets forth the significant components of the deferred tax liabilities and assets of the Company as of June 30, 2023 and December 31, 2022:

 

   June 30,
2023
   December 31,
2022
 
Deferred tax liabilities:        
- Accelerated depreciation  $45,680   $45,858 
    45,680    45,858 
           
Deferred tax assets, net:          
Net operating loss carryforwards   7,747,627    5,461,370 
Less: valuation allowance   (7,747,627)   (5,461,370)
    -    - 
           
Deferred tax liabilities, net  $45,680   $45,858 

 

As of June 30, 2023 and December 31, 2022, the operations incurred $47.0 million and $33.1 million, respectively of cumulative net operating losses which can be carried forward to offset future taxable income. Net operating loss can be carried forward indefinitely but cannot be carried back to prior years. There are no group relief provisions for losses or transfers of assets under Hong Kong tax regime. Each company within a corporate group is taxed as a separate entity. The Company has provided for a full valuation allowance against the deferred tax assets on the expected future tax benefits from the net operating loss carryforwards as the management believes that it is more likely than not that these assets will not be realized in the future. The valuation allowance is reviewed annually.

 

Uncertain tax positions

 

The Company evaluates the uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of June 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the six months ended June 30, 2023 and 2022 and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from June 30, 2023.

v3.23.2
Segment Information
6 Months Ended
Jun. 30, 2023
Segment Information [Abstract]  
SEGMENT INFORMATION

NOTE 18 - SEGMENT INFORMATION

 

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for detailing the Company’s business segments.

 

Currently, the Company has four business segments comprised of the following products and services:

 

Segments   Scope of Business Activities
Distribution Business   - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
     
Platform Business  

- Providing access to financial products and services to licensed brokers.

 

- Providing operational support for the submission and processing of product applications.

 

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

 

- Providing training resources and materials.

 

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

     
    - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
     
    - Solicitation of real estate sales for the developers, in exchange for commissions.
     
Fintech Business   Managing an ensemble of fintech investments.
     
Healthcare Business   Managing an ensemble of healthcare-related investments.

 

The four business segments were determined based primarily on how the chief operating decision maker views and evaluates the operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services are considered in determining the formation of these operating segments.

 

The following tables present the summary information by segment for the three and six months ended June 30, 2023 and 2022:

 

   For the three months ended June 30, 2023 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue                    
- Interest income  $-   $38,175   $-   $-   $38,175 
- Non-interest income   16,005,608    1,327,150    -    -    17,332,758 

Total revenue  

   16,005,608    1,365,325    -    -    17,370,933 
                          
Commission expense   11,628,412    356,025    -    -    11,984,437 
Depreciation on property and equipment   261    105,892    8,169    -    114,322 
Income (loss) from operations   2,734,753    6,785,460    (19,913,347)   -    (10,393,134)
Investment loss, net   -    -    (441,568)   -    (441,568)
Total assets  $18,065,731   $42,202,217   $34,513,786   $520,523   $95,302,257 

 

   For the three months ended June 30, 2022 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue, net                    
- Interest income  $-   $37,871   $-   $-   $37,871 
- Non-interest income   2,373,898    1,677,903    1,188    -    4,052,989 
Less: inter-segment   -    -    (1,188)   -    (1,188)

Total revenue, net  

   2,373,898    1,715,774    -    -    4,089,672 
                          
Commission expense   1,906,944    573,327    -    -    2,480,271 
Depreciation on property and equipment   239    95,342    92    -    95,673 
Income (loss) from operations   (1,321,333)   (2,591,456)   404,403    -    (3,508,386)
Investment loss, net   -    -    (5,683,988)   -    (5,683,988)
Total assets  $4,427,863   $52,241,241   $37,746,196   $522,557   $94,937,857 

 

   For the six months ended June 30, 2023 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue                    
- Interest income  $-   $76,333   $-   $-   $76,333 
- Non-interest income   25,693,427    2,674,853    -    -    28,368,280 

Total revenue  

   25,693,427    2,751,186    -    -    28,444,613 
                          
Commission expense   18,540,477    739,452    -    -    19,279,929 
Depreciation on property and equipment   522    201,514    13,458    -    215,494 
Income (loss) from operations   3,187,190    (4,401,856)   (23,762,276)   -    (24,976,942)
Investment income, net   -    -    1,281,496    -    1,281,496 
Total assets  $18,065,731   $42,202,217   $34,513,786   $520,523   $95,302,257 

 

   For the six months ended June 30, 2022 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue, net                    
- Interest income  $-   $99,194   $-   $-   $99,194 
- Non-interest income   2,553,829    3,512,972    2,767    -    6,069,568 
Less: inter-segment   -    -    (2,767)   -    (2,767)
Total revenue, net   2,553,829    3,612,166    -    -    6,165,995 
                          
Commission expense   1,975,138    1,206,175    -    -    3,181,313 
Depreciation on property and equipment   372    191,285    695    -    192,352 
Loss from operations   (2,768,395)   (2,045,873)   (606,435)   -    (5,420,703)
Investment loss, net   -    -    (3,535,053)   -    (3,535,053)
Total assets  $4,427,863   $52,241,241   $37,746,196   $522,557   $94,937,857 

 

All of the Company’s customers and operations are based in Hong Kong.

v3.23.2
Related Party Balances and Transactions
6 Months Ended
Jun. 30, 2023
Related Party Balances and Transactions [Abstract]  
RELATED PARTY BALANCES AND TRANSACTIONS

NOTE 19 - RELATED PARTY BALANCES AND TRANSACTIONS

 

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by the holding company. Amounts represent advances or amounts paid in satisfaction of liabilities.

 

Related party balances consisted of the following:

 

      As of 
      June 30,
2023
   December 31,
2022
 
            
Accounts receivable  (a)  $601,576   $272,546 
Amounts due to the holding company  (b)  $4,539,168   $6,289,743 

 

(a)Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the holding company.

 

(b) Amounts due to the holding company are those nontrade payables arising from transactions between the Company and the holding company, such as advances made by the holding company on behalf of the Company, advances made by the Company on behalf of the holding company, and allocated shared expenses paid by the holding company.

 

In the ordinary course of business, during the three and six months ended June 30, 2023 and 2022, the Company involved with transactions, either at cost or current market prices and on the normal commercial terms among related parties. The following table provides the transactions with these parties for the periods as presented (for the portion of such period that they were considered related):

 

      Three months ended
June 30,
   Six months ended
June 30,
 
      2023   2022   2023   2022 
Asset management service income  (c)  $241,688   $241,325   $480,621   $481,268 
Commission expenses  (d)       7,183        56,017 
Office and operating fee charge  (e)   1,742,332    499,161    3,772,045    1,004,307 
General and administrative expense allocated  (f)   1,722    272,190    1,722    545,836 
Purchase of investment from holding company  (g)       6,560,122        6,560,122 
Purchase of office building from holding company  (h)               5,896,301 
Payment of special dividends to holding company  (k)  $   $   $   $47,000,000 

 

(c) Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the holding company, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers.

 

(d)Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee.

 

(e)Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the holding company for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the holding company. Also, the holding company charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business.

 

(f)Certain amounts of general and administrative expenses were allocated by the holding company.

 

(g)The Company purchased 4,158,963 shares of Investment A from the holding company and the transaction was completed on April 20, 2022 based on the historical cost to the holding company.

 

(h)The Company purchased an office building from the holding company in January 2022, based on its historical carrying amount.

 

(i)On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from holding company and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021.

 

Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented.

v3.23.2
Concentrations of Risk
6 Months Ended
Jun. 30, 2023
Concentrations of Risk [Abstract]  
CONCENTRATIONS OF RISK

NOTE 20 - CONCENTRATIONS OF RISK

 

The Company is exposed to the following concentrations of risk:

 

(a)Major customers

 

For the three and six months ended June 30, 2023, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivable balances at period-end dates, are presented as follows:

 

   Three months ended
June 30, 2023
   Six months ended
June 30, 2023
   June 30,
2023
 
Customer  Revenues   Percentage
of revenues
   Revenues   Percentage
of revenues
   Accounts
receivable
 
Customer A  $3,849,161    22%  $6,566,059    23%  $- 
Customer B  $3,055,295    18%  $4,425,921    16%  $139 
Customer C  $1,874,473    11%  $3,105,629    11%  $- 
Customer D  $2,029,613    12%  $3,051,903    11%  $49,223 

 

For the three and six months ended June 30, 2022, there was no single customer who accounted for 10% or more of the Company’s revenues.

 

All of the Company’s major customers are located in Hong Kong.

 

(b)Credit risk

 

Financial instruments that potentially subject the Company to credit risk consist of cash equivalents, restricted cash, accounts receivable, loans receivable, and notes receivable. Cash equivalents are maintained with high credit quality institutions, the composition and maturities of which are regularly monitored by management. The Hong Kong Deposit Protection Board pays compensation up to a limit of HK$500,000 (approximately $63,805) if the bank with which an individual/a company hold its eligible deposit fails. As of June 30, 2023, cash balance of $3.8 million and fund held in escrow of $27.5 million were maintained at financial institutions in Hong Kong, of which approximately $28.7 million was subject to credit risk. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.

 

For accounts receivable, loans receivable, and notes receivable, the Company determines, on a continuing basis, the probable losses and sets up an allowance for doubtful accounts based on the estimated realizable value. Credit of money lending business is controlled by the application of credit approvals, limits and monitoring procedures.

 

The Company uses internally-assigned risk grades to estimate the capability of borrowers to repay the contractual obligations of their loan agreements as scheduled or at all. The Company’s internal risk grade system is based on experiences with similarly graded loans and the assessment of borrower credit quality, such as, credit risk scores, collateral and collection history. Individual credit scores are assessed by credit bureau, such as TransUnion. Internal risk grade ratings reflect the credit quality of the borrower, as well as the value of collateral held as security. To minimize credit risk, the Company requires collateral arrangements to all mortgage loans and has policies and procedures for validating the reasonableness of the collateral valuations on a regular basis. Management believes that these policies effectively manage the credit risk from advances.

 

The Company’s third-party customers that represent more than 10% of total combined loans receivable, and their related net loans receivable balance as a percentage of total combined loans receivable, as of June 30, 2023 and December 31, 2022 were as follows:

 

   As of 
   June 30,
2023
   December 31,
2022
 
         
Customer E   37.3%   37.4%
Customer F   31.6%   31.6%
Customer G   31.1%   31.0%

 

(c)Economic and political risk

 

The Company’s major operations are conducted in Hong Kong. Accordingly, the political, economic, and legal environments in Hong Kong, as well as the general state of Hong Kong’s economy may influence the Company’s business, financial condition, and results of operations.

 

(d)Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of HKD converted to US$ and Sterling on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

For the three months ended June 30, 2023 and 2022, the Company recorded the foreign exchange gain of $349,539 and exchange loss of $2,126,882, respectively, mainly attributable from the long-term investments which are mostly denominated in Sterling.

 

For the six months ended June 30, 2023 and 2022, the Company recorded the foreign exchange gain of $905,850 and exchange loss of $2,607,456, respectively, mainly attributable from the long-term investments which are mostly denominated in Sterling.

 

(e)Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company’s policy is to ensure that it has sufficient cash to meet its liabilities when they become due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation. A key risk in managing liquidity is the degree of uncertainty in the cash flow projections. If future cash flows are fairly uncertain, the liquidity risk increases.

v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 21 - COMMITMENTS AND CONTINGENCIES

 

Litigation — From time to time, the Company is involved in various legal proceedings and claims in the ordinary course of business. The Company currently is not aware of any legal proceedings or claims that it believes will have, individually or in the aggregate, a material adverse effect on its business, financial condition, operating results, or cash flows.

 

As at June 30, 2023, the Company involved with various legal proceedings:-

 

Action Case: HCA702/2018 On March 27, 2018, the writ of summons was issued against the Company and seven related companies of the former shareholder by the Plaintiff. This action alleged the infringement of certain registered trademarks currently registered under the Plaintiff. In February 2023, the Court granted leave for this action be set down for trial of 13 days. The trial will take place from November 25 to December 11, 2024. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

Action Case: HCA765/2019 On April 30, 2019, the writ of summons was issued against the Company’s subsidiary, three related companies and the former directors, shareholders and financial consultant by the Plaintiff. This action alleged the deceit and misrepresentation from an inducement of the fund subscription and claimed for compensatory damage of approximately $2 million (equal to HK$17.1 million). In April 2023, the Court fixed a case management conference with 30 minutes reserved. The conference will be held on November 2, 2023. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

Action Case: HCA2097 and 2098/2020 On December 15, 2020, the writs of summons were issued against the Company and the former consultant by the Plaintiff. This action alleged the misrepresentation and conspiracy causing the loss from the investment in corporate bond and claimed for compensatory damage of approximately $1.67 million (equal to HK$13 million). The Company previously made $0.84 million as contingency loss during the year ended December 31, 2021. In March 2022, parties participated in a mediation but no settlement reached. A case management summons will be held on February 5, 2024. Legal counsel of the Company will continue to handle this matter. At this stage in the proceedings, it is unable to determine the probability of the outcome of the matter or the range of reasonably possible loss, if any.

 

The Company makes a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least each fiscal quarter and adjusted to reflect the impacts of negotiations, estimate settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. Legal fees are expensed in the period in which they are incurred.

 

Notes Receivable Agreement — Pursuant to the Agreements, subject to demand, the Company is committed to subscribe the notes of Investment A with an aggregate amount of $1,673,525, in batches, which are payable on or before January 31, 2024. As of June 30, 2023, the remaining committed subscription amount was $1,084,439.

 

Capital Contribution in Investment F — As of June 30, 2023, the remaining committed capital amount in Investment F was $331,432.

 

Share-based Compensation — Pursuant to the Scheme, the Company is committed to issue 2,000,000 ordinary shares to a consultant to compensate the services rendered subsequently.

v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 22 - SUBSEQUENT EVENTS

 

On July 20, 2023, the Company entered into a purchase and sale agreement with an independent third party to sell one of its office premises for a consideration of $6.15 million. The transaction is expected to be completed in October 2023. As of June 30, 2023, the Company has accounted for the relevant office premises as asset held for sale in the unaudited condensed consolidated balance sheets. For the related disclosure, please refer to Note 7 of these financial statements.

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2023, up to August 11, 2023 that the unaudited condensed consolidated financial statements were available to be issued.

v3.23.2
Accounting Policies, by Policy (Policies)
6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Principal of Consolidation
Principal of Consolidation

The accompanying unaudited condensed consolidated financial statements include the financial statements of AGBA and its subsidiaries. A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. All intercompany transactions and balances between AGBA and its subsidiaries are eliminated upon consolidation.

 

Use of Estimates and Assumptions
Use of Estimates and Assumptions

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property and equipment, impairment of long-lived assets, allowance for doubtful accounts, notes receivable, share-based compensation, warrant liabilities, forward share purchase liability, provision for contingent liabilities, revenue recognition, income tax provision, deferred taxes and uncertain tax position, and allocation of expenses from holding company.

The inputs into the management’s judgments and estimates consider the economic implications of COVID-19 on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates.

Foreign Currency Translation and Transaction
Foreign Currency Translation and Transaction

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations.

The reporting currency of the Company is US$ and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company and subsidiaries are operating in Hong Kong maintain their books and record in their local currency, Hong Kong dollars (“HK$”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, Translation of Financial Statement, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component of accumulated other comprehensive income within the unaudited condensed consolidated statements of changes in shareholders’ equity.

Translation of amounts from HK$ into US$ has been made at the following exchange rates for the six months ended June 30, 2022 and 2021:

   June 30,
2023
   June 30,
2022
 
Period-end HK$:US$ exchange rate   0.12761    0.12744 
Period average HK$:US$ exchange rate   0.12757    0.12779 
Cash and Cash Equivalents
Cash and Cash Equivalents

Cash and cash equivalents consist primarily of cash in readily available checking and saving accounts. They consist of highly liquid investments that are readily convertible to cash and that mature within three months or less from the date of purchase. The carrying amounts approximate fair value due to the short maturities of these instruments. The Company maintains most of its bank accounts in Hong Kong.

Restricted Cash
Restricted Cash

Restricted cash consist of funds held in escrow accounts reflecting (i) the restricted cash and cash equivalents maintained in certain bank accounts that are held for the exclusive interest of the Company’s customers and (ii) the full obligation to an investor in connection with the Meteora Backstop Agreement (see Note 4).

The Company restricts the use of the assets underlying the funds held in escrow to meet with regulatory or contractual requirements and classifies the assets as current based on their purpose and availability to fulfill its direct obligation under current liabilities.

 

Accounts Receivable, net
Accounts Receivable, net

Accounts receivable include trade accounts due from customers in insurance brokerage and asset management businesses.

Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms. The normal settlement terms of accounts receivable from insurance companies in the provision of brokerage agency services are within 30 days upon the execution of the insurance policies. Credit terms with the products providers of investment, unit and mutual funds and asset portfolio are mainly 90 days or a credit period mutually agreed between the contracting parties. The Company seeks to maintain strict control over its outstanding receivables to minimize credit risk. Overdue balances are reviewed regularly by senior management. Management reviews its receivables on a regular basis to determine if the bad debt allowance is adequate, and provides allowance when necessary.

The Company does not hold any collateral or other credit enhancements over its accounts receivable balances.

Loans Receivables, net
Loans Receivable, net

Loans receivable are real estate mortgage loans that carried at unpaid principal balances, less the allowance for credit losses on loans receivable and charge-offs.

Loans are placed on nonaccrual status when they are past due 180 days or more as to contractual obligations or when other circumstances indicate that collection is not probable. When a loan is placed on nonaccrual status, any interest accrued but not received is reversed against interest income. Payments received on a nonaccrual loan are either applied to protective advances, the outstanding principal balance or recorded as interest income, depending on an assessment of the ability to collect the loan. A nonaccrual loan may be restored to accrual status when principal and interest payments have been brought current and the loan has performed in accordance with its contractual terms for a reasonable period (generally six months).

If the Company determines that a loan is impaired, the Company next determines the amount of the impairment. The amount of impairment on collateral dependent loans is charged off within the given fiscal quarter. Generally, the amount of the loan and negative escrow in excess of the appraised value less estimated selling costs, for the fair value of collateral valuation method, is charged off. For all other loans, impairment is measured as described below in Allowance for Credit Losses on Financial Instruments.

Allowance for Credit Losses on Financial Instruments
Allowance for Credit Losses on Financial Instruments

In accordance with ASC Topic 326 “Credit Losses – Measurement of Credit Losses on Financial Instruments” (ASC Topic 326), the Company utilizes the current expected credit losses (“CECL”) model to determine an allowance that reflects its best estimate of the lifetime expected credit losses on accounts receivable, loans receivable, notes receivable and deposits, prepayments, and others receivable which is recorded as a liability to offset the receivables. The CECL model is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Accounts receivable, loans receivable, notes receivables and deposits, prepayments, and others receivable are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded as a reduction of bad debt expense.

Long-Term Investments, net
Long-Term Investments, net

The Company invests in equity securities with readily determinable fair values and equity securities that do not have readily determinable fair values.

Equity securities with readily determinable fair values are carried at fair value with any unrealized gains or losses reported in earnings.

 

Equity securities that do not have readily determinable fair values mainly consist of investments in privately-held companies. They are accounted for, at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.

At each reporting period, the Company makes a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired.

Assets Held For Sale
Asset Held For Sale

Assets to be disposed of by sale are reported at the lower of the carrying value or fair value less cost to sell when the Company has committed to a sale agreement and would be reported separately as assets held for sale in the unaudited condensed consolidated balance sheets.  

Property and Equipment, net
Property and Equipment, net

Property and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational:

   Expected useful life
Land and building  Shorter of 50 years or lease term
Office improvement  3 years
Furniture, fixtures and equipment  5 years
Computer equipment  3 years
Motor vehicle  3 years

Expenditure for repairs and maintenance is expensed as incurred. When assets have retired or sold, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in the results of operations.

Impairment of Long-Lived Assets
Impairment of Long-Lived Assets

In accordance with the provisions of ASC Topic 360, Impairment or Disposal of Long-Lived Assets, all long-lived assets such as property and equipment owned and held by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. No impairment losses were recognized for the three and six months ended June 30, 2023 and 2022.

Revenue Recognition
Revenue Recognition

The Company receives certain portion of its non-interest income from contracts with customers, which are accounted for in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASC Topic 606").

ASC Topic 606 provided the following overview of how revenue is recognized from the Company’s contracts with customers. The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.

Step 1: Identify the contract(s) with a customer.

Step 2: Identify the performance obligations in the contract.

 

Step 3: Determine the transaction price – The transaction price is the amount of consideration in a contract to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer.

Step 4: Allocate the transaction price to the performance obligations in the contract – Any entity typically allocates the transaction price to each performance obligation on the basis of the relative standalone selling prices of each distinct good or service promised in the contract.

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation – An entity recognizes revenue when (or as) it satisfies a performance obligation by transferring a promised good or service to a customer (which is when the customer obtains control of that good or service). The amount of revenue recognized is the amount allocated to the satisfied performance obligation. A performance obligation may be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically for promises to transfer service to a customer).

Certain portion of the Company's income is derived from contracts with customers, and as such, the revenue recognized depicts the transfer of promised goods or services to its customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company considers the terms of the contract and all relevant facts and circumstances when applying this guidance. The Company’s revenue recognition policies are in compliance with ASC Topic 606, as follows:

Commissions

The Company earns commissions from the sale of investment products to customers. The Company enters into commission agreements with customers which specify the key terms and conditions of the arrangement. Commissions are separately negotiated for each transaction and generally do not include rights of return, credits or discounts, rebates, price protection or other similar privileges, and typically paid on or shortly after the transaction is completed. Upon the purchase of an investment product, the Company earns a commission from customers, calculated as a fixed percentage of the investment products acquired by its customers. The Company defines the “purchase of an investment product” for its revenue recognition purpose as the time when the customers referred by the Company has entered into a subscription contract with the relevant product provider and, if required, the customer has transferred a deposit to an escrow account designated by the Company to complete the purchase of the investment products. After the contract is established, there are no significant judgments made when determining the one-time commission price. Therefore, commissions are recorded at point in time when the investment product is purchased.

The Company also facilitates the arrangement between insurance providers and individuals or businesses by providing insurance placement services to the insureds, and is compensated in the form of one-time commissions from the respective insurance providers. The Company primarily facilitates the placement of life, general and MPF insurance products. The Company determines that insurance providers are the customers.

The Company primarily earns commission income arising from the facilitation of the placement of an effective insurance policy, which is recognized at a point in time when the performance obligation has been satisfied upon execution of the insurance policy as the Company has no future or ongoing obligation with respect to such policies. The commission fee rate, which is paid by the insurance providers, based on the terms specified in the service contract which are agreed between the Company and insurance providers for each insurance product being facilitated through the Company. The commission earned is equal to a percentage of the premium paid to the insurance provider. Commission from renewed policies is variable consideration and is recognized in subsequent periods when the uncertainty around variable consideration is subsequently resolved (e.g., when customer renews the policy).

In accordance with ASC Topic 606, Revenue Recognition: Principal Agent Considerations, the Company evaluates the terms in the agreements with its channels and independent contractors to determine whether or not the Company acts as the principal or as an agent in the arrangement with each party respectively. The determination of whether to record the revenue in a gross or net basis depends upon whether the Company has control over the services prior to transferring it. Control is demonstrated by the Company which is primarily responsible for fulfilling the provision of placement services through the Company’s licensed insurance brokers to provide agency services. The commissions from insurance providers are recorded on a gross basis and commission paid to independent contractors or channel costs are recorded as commission expense in the statements of operations.

 

The Company also offers the sale solicitation of real estate property to the final customers and is compensated in the form of commissions from the corresponding property developers pursuant to the service contracts. Commission income is recognized at a point of time upon the sale contracts of real estate property is signed and executed.

Recurring service fees

The Company provides asset management services to investment funds or investment product providers in exchange for recurring service fees. Recurring service fees are determined based on the types of investment products the Company distributes and are calculated as a fixed percentage of the fair value of the total investment of the investment products, calculated daily. These customer contracts require the Company to provide investment management services, which represents a performance obligation that the Company satisfies over time. After the contract is established, there are no significant judgments made when determining the transaction price. As the Company provides these services throughout the contract term, for the method of calculating recurring service fees, revenue is calculated on a daily basis over the contract term, quarterly billed and recognized. Recurring service agreements do not include rights of return, credits or discounts, rebates, price protection, performance component or other similar privileges and the circumstances under which the fixed percentage fees, before determined, could be not subject to clawback. Payment of recurring service fees are normally on a regular basis (typically monthly or quarterly).

Interest income

The Company offers money lending services from loan origination in form of mortgage and personal loans. Interest income is recognized monthly in accordance with their contractual terms and recorded as interest income in the unaudited condensed consolidated statement of operations. The Company does not charge prepayment penalties from its customers. Interest income on mortgage and personal loans is recognized as it accrued using the effective interest method. Accrual of interest income on mortgage loans is suspended at the earlier of the time at which collection of an account becomes doubtful or the account becomes 180 days delinquent.

Disaggregation of Revenue

The Company has disaggregated its revenue from contracts with customers into categories based on the nature of the revenue. The following table presents the revenue streams by segments, with the presentation revenue categories presented on the statements of operation for the periods indicated:

   For the three months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $38,175   $-   $38,175 
                          
Non-interest income:                         
Commissions   16,005,608    277,960    -    39,488    16,323,056 
Recurring service fees   -    1,009,702    -    -    1,009,702 
                          
   $16,005,608   $1,287,662   $38,175   $39,488   $17,370,933 

 

   For the three months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $37,871   $-   $37,871 
                          
Non-interest income:                         
Commissions   2,373,898    518,277    -    44,905    2,937,080 
Recurring service fees   -    1,114,721    -    -    1,114,721 
                          
   $2,373,898   $1,632,998   $37,871   $44,905   $4,089,672 
   For the six months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $76,333   $-   $76,333 
                          
Non-interest income:                         
Commissions   25,693,427    601,722    -    43,534    26,338,683 
Recurring service fees   -    2,029,597    -    -    2,029,597 
                          
   $25,693,427   $2,631,319   $76,333   $43,534   $28,444,613 
   For the six months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $99,194   $-   $99,194 
                          
Non-interest income:                         
Commissions   2,553,829    1,094,812    -    115,516    3,764,157 
Recurring service fees   -    2,302,644    -    -    2,302,644 
                          
   $2,553,829   $3,397,456   $99,194   $115,516   $6,165,995 
Rental Income
Rental income

Rental income represents monthly rental received from the Company’s tenants. The Company recognizes rental income on a straight-line basis over the lease term in accordance with the lease agreement.

 

Comprehensive Loss
Comprehensive Loss

ASC Topic 220, Comprehensive Income, establishes standards for reporting and display of comprehensive income, its components and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated other comprehensive income (loss), as presented in the accompanying statement of shareholder’s equity, consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive loss is not included in the computation of income tax expense or benefit.

Income Taxes
Income Taxes

Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

ASC Topic 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC Topic 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

For the three and six months ended June 30, 2023 and 2022, the Company did not have any interest and penalties associated with tax positions. As of June 30, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions.

The Company is subject to tax in local and foreign jurisdictions. As a result of its business activities, the Company files tax returns that are subject to examination by the relevant tax authorities.

Share-Based Compensation
Share-Based Compensation

The Company accounts for share-based compensation in accordance with the fair value recognition provision of ASC Topic 718, Stock Compensation. The Company grants share awards, including ordinary shares and restricted share units, to eligible participants. Share-based compensation expense for share awards is measured at fair value on the grant date. The fair value of restricted stock with either solely a service requirement or with the combination of service and performance requirements is based on the closing fair market value of the ordinary shares on the date of grant. Share-based compensation expense is recognized over the awards requisite service period. For awards with graded vesting that are subject only to a service condition, the expense is recognized on a straight-line basis over the service period for the entire award.

Net Loss Per Share
Net Loss Per Share

The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, Earnings per Share (“ASC Topic 260”). ASC Topic 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net (loss) income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

Segment Reporting
Segment Reporting

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about geographical areas, business segments and major customers in financial statements for details on the Company’s business segments.

 

The Company uses the management approach to determine reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making decisions, allocating resources and assessing performance. The Company’s CODM has been identified as the CEO, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. Based on management’s assessment, the Company determined that it has the following operating segments:

Segments   Scope of Service   Business Activities
Distribution Business   Insurance Brokerage
Business
  - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
         
Platform Business   - Asset Management Business  

- Providing access to financial products and services to licensed brokers.

- Providing operational support for the submission and processing of product applications.

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

- Providing training resources and materials.

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

         
    - Money Lending Service   - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
         
    - Real Estate Agency Service   - Solicitation of real estate sales for the developers, in exchange for commissions.
         
Fintech Business   Investment Holding   Managing an ensemble of fintech investments.
         
Healthcare Business   Investment Holding   Managing an ensemble of healthcare-related investments.

All of the Company’s revenues were generated in Hong Kong.

Leases
Leases

The Company follows ASC Topic 842, Leases (“ASC Topic 842”), utilizing the modified retrospective transition method with no adjustments to comparative periods presented. On February 25, 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (ASC Topic 842), to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. ASC Topic 842 requires that lessees recognize right-of-use asset and lease liabilities calculated based on the present value of lease payments for all lease agreements with terms that are greater than twelve months. It requires for leases longer than one year, a lessee to recognize in the statement of financial condition a right-of-use asset, representing the right to use the underlying asset for the lease term, and a lease liability, representing the liability to make lease payments. ASC Topic 842 distinguishes leases as either a finance lease or an operating lease that affects how the leases are measured and presented in the statement of operations and statement of cash flows. ASC Topic 842 supersedes nearly all existing lease accounting guidance under GAAP issued by the Financial Accounting Standards Board (“FASB”) including ASC Topic 840, Leases.

When determining the lease term, the Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option, if any. As the Company’s leases do not provide an implicit rate, the Company used an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected to adopt the following lease policies in conjunction with the adoption of ASU 2016-02: (i) for leases that have lease terms of 12 months or less and does not include a purchase option that is reasonably certain to exercise, the Company elected not to apply ASC 842 recognition requirements; and (ii) the Company elected to apply the package of practical expedients for existing arrangements entered into prior to January 1, 2021 to not reassess (a) whether an arrangement is or contains a lease, (b) the lease classification applied to existing leases, and (c) initial direct costs.

 

The accounting update also requires that for finance leases, a lessee recognize interest expense on the lease liability, separately from the amortization of the right-of-use asset in the statements of earnings, while for operating leases, such amounts should be recognized as a combined expense. In addition, this accounting update requires expanded disclosures about the nature and terms of lease agreements.

Related Parties
Related Parties

The Company follows the ASC Topic 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

Pursuant to section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Commitments and Contingencies
Commitments And Contingencies

The Company follows the ASC Topic 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Fair Value Measurement
Fair Value Measurement

The Company follows the guidance of the ASC Topic 820-10, Fair Value Measurements and Disclosures ("ASC Topic 820-10"), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

  Level 1 : Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets;
  Level 2 : Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. Black-Scholes Option-Pricing model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs; and
  Level 3 : Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the assets or liabilities. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models.

The carrying value of the Company’s financial instruments: cash and cash equivalents, restricted cash, accounts receivable, deposits, prepayments, and others receivable, amounts due to the holding company, accounts payable and accrued liabilities, escrow liabilities and borrowings approximate at their fair values because of the short-term nature of these financial instruments.

Management believes, based on the current market prices or interest rates for similar debt instruments, the fair value of loans receivable and notes receivable approximate the carrying amount. They are accounted at amortized cost, subject to impairment testing.

The following table presents information about the Company’s assets that were measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

   June 30,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2023   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $524   $    524   $         -   $- 
Non-marketable equity securities  $33,946,542   $-   $-   $33,946,542 
                     
Liabilities:                    
Warrant liabilities  $2,173   $-   $-   $2,173 
   December 31,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2022   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $2,443,593   $2,443,593   $     -   $- 
Non-marketable equity securities  $34,589,767   $-   $-   $34,589,767 
                     
Liabilities:                    
Forward share purchase liability  $13,491,606   $-   $-   $13,491,606 
Warrant liabilities  $4,548   $-   $-   $4,548 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements

There were no new standards or updates during the six months ended June 30, 2023 that had a material impact on the unaudited condensed consolidated financial statements.

v3.23.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Exchange Rates Translation of amounts from HK$ into US$ has been made at the following exchange rates for the six months ended June 30, 2022 and 2021:
   June 30,
2023
   June 30,
2022
 
Period-end HK$:US$ exchange rate   0.12761    0.12744 
Period average HK$:US$ exchange rate   0.12757    0.12779 
Schedule of Estimated Residual Values Property and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated on the straight-line basis over the following expected useful lives from the date on which they become fully operational:
   Expected useful life
Land and building  Shorter of 50 years or lease term
Office improvement  3 years
Furniture, fixtures and equipment  5 years
Computer equipment  3 years
Motor vehicle  3 years
Schedule of Revenue Streams by Segments The Company has disaggregated its revenue from contracts with customers into categories based on the nature of the revenue. The following table presents the revenue streams by segments, with the presentation revenue categories presented on the statements of operation for the periods indicated:
   For the three months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $38,175   $-   $38,175 
                          
Non-interest income:                         
Commissions   16,005,608    277,960    -    39,488    16,323,056 
Recurring service fees   -    1,009,702    -    -    1,009,702 
                          
   $16,005,608   $1,287,662   $38,175   $39,488   $17,370,933 

 

   For the three months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $37,871   $-   $37,871 
                          
Non-interest income:                         
Commissions   2,373,898    518,277    -    44,905    2,937,080 
Recurring service fees   -    1,114,721    -    -    1,114,721 
                          
   $2,373,898   $1,632,998   $37,871   $44,905   $4,089,672 
   For the six months ended June 30, 2023 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $76,333   $-   $76,333 
                          
Non-interest income:                         
Commissions   25,693,427    601,722    -    43,534    26,338,683 
Recurring service fees   -    2,029,597    -    -    2,029,597 
                          
   $25,693,427   $2,631,319   $76,333   $43,534   $28,444,613 
   For the six months ended June 30, 2022 
   Distribution Business   Platform Business     
   Insurance brokerage service   Asset management service   Money lending service   Real estate agency service   Total 
Interest income:                    
Loans  $-   $-   $99,194   $-   $99,194 
                          
Non-interest income:                         
Commissions   2,553,829    1,094,812    -    115,516    3,764,157 
Recurring service fees   -    2,302,644    -    -    2,302,644 
                          
   $2,553,829   $3,397,456   $99,194   $115,516   $6,165,995 
Schedule of Operating Segments Based on management’s assessment, the Company determined that it has the following operating segments:
Segments   Scope of Service   Business Activities
Distribution Business   Insurance Brokerage
Business
  - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
         
Platform Business   - Asset Management Business  

- Providing access to financial products and services to licensed brokers.

- Providing operational support for the submission and processing of product applications.

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

- Providing training resources and materials.

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

         
    - Money Lending Service   - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
         
    - Real Estate Agency Service   - Solicitation of real estate sales for the developers, in exchange for commissions.
         
Fintech Business   Investment Holding   Managing an ensemble of fintech investments.
         
Healthcare Business   Investment Holding   Managing an ensemble of healthcare-related investments.
Schedule of Fair Value Hierarchy of the Valuation Techniques The following table presents information about the Company’s assets that were measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
   June 30,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2023   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $524   $    524   $         -   $- 
Non-marketable equity securities  $33,946,542   $-   $-   $33,946,542 
                     
Liabilities:                    
Warrant liabilities  $2,173   $-   $-   $2,173 
   December 31,   Quoted
Prices In
Active
Markets
   Significant
Other
Observable
Inputs
   Significant
Other
Unobservable
Inputs
 
Description  2022   (Level 1)   (Level 2)   (Level 3) 
                 
Assets:                
Marketable equity securities  $2,443,593   $2,443,593   $     -   $- 
Non-marketable equity securities  $34,589,767   $-   $-   $34,589,767 
                     
Liabilities:                    
Forward share purchase liability  $13,491,606   $-   $-   $13,491,606 
Warrant liabilities  $4,548   $-   $-   $4,548 
v3.23.2
Accounts Receivable, Net (Tables)
6 Months Ended
Jun. 30, 2023
Accounts Receivable, Net [Abstract]  
Schedule of Accounts Receivable, Net Accounts receivable, net consisted of the following:
   As of 
   June 30,
2023
   December 31,
2022
 
Accounts receivable  $3,592,789   $2,916,609 
Accounts receivable – related parties   601,576    272,546 
Less: allowance for estimated credit losses   (162,009)   (94,447)
Accounts receivable, net  $4,032,356   $3,094,708 
v3.23.2
Loans Receivables, Net (Tables)
6 Months Ended
Jun. 30, 2023
Loans Receivables [Abstract]  
Schedule of Loans Receivables, Net The Company’s loans receivable, net was as follows:
   As of 
   June 30,
2023
   December 31,
2022
 
         
Mortgage loans (residential)  $1,576,013   $1,589,871 
           
Reclassifying as:          
Current portion  $516,237   $517,479 
Non-current portion   1,059,776    1,072,392 
Loans receivable, net  $1,576,013   $1,589,871 
v3.23.2
Long-Term Investments, Net (Tables)
6 Months Ended
Jun. 30, 2023
Long-Term Investments, Net [Abstract]  
Schedule of Long-Term Investments Long-term investments consisted of the following:
   As of 
   Ownership
interest
   June 30,
2023
   Ownership
interest
   December 31,
2022
 
                 
Marketable equity securities                
Investment C   0.00%*  $524    0.46%  $2,443,593 
                     
Non-marketable equity securities:                    
Investment A   8.37%   5,740,036    8.37%   5,717,678 
Investment B   3.63%   511,003    3.63%   513,000 
Investment D   4.49%   16,784,183    4.92%   16,030,943 
Investment E   4.00%   520,523    4.00%   522,557 
Investment F   4.00%   10,390,797    4.00%   11,805,589 
Total        33,946,542         34,589,767 
Net carrying value       $33,947,066        $37,033,360 
*Less than 0.001%
Schedule of Changes in Fair Value of Non-Marketable Equity Securities The following table presents the changes in fair value of non-market equity securities which are measured using Level 3 inputs as of June 30, 2023 and December 31, 2022:
   As of 
   June 30,
2023
   December 31,
2022
 
Balance at beginning of period/year  $34,589,767   $25,496,534 
Additions   -    16,228,690 
Adjustments:          
Downward adjustments   (1,427,904)   (6,898,549)
Upward adjustments   -    2,137,021 
Foreign exchange adjustment   784,679    (2,373,929)
Balance at end of period/year  $33,946,542   $34,589,767 
Schedule of Cumulative Unrealized Gains and Losses, Included In the Carrying Value Cumulative unrealized gains and losses, included in the carrying value of the Company’s non-marketable equity securities:
   As of 
   June 30,
2023
   December 31,
2022
 
         
Downward adjustments (including impairment)  $(28,682,504)  $(27,254,600)
Upward adjustments  $6,209,357   $6,209,357 
Schedule of Investment Income Is Recorded As Other Income Investment income (loss) is recorded as other income (expense) and consisted of the following:
   For the three months ended
June 30,
 
   2023   2022 
Marketable equity securities:        
Unrealized loss from the changes in fair value – Investment C  $(168)  $(5,683,988)
Realized gain from sale of Investment C   -    - 
           
Non-marketable equity securities:          
Unrealized loss (including impairment) – Investment F   (1,000,119)   - 
Dividend income   558,719    - 
Investment loss, net  $(441,568)  $(5,683,988)

   For the six months ended
June 30,
 
   2023   2022 
Marketable equity securities:        
Unrealized gain (loss) from the changes in fair value – Investment C  $98   $(3,535,053)
Realized gain from sale of Investment C   1,541,736    - 
           
Non-marketable equity securities:          
Unrealized loss (including impairment) – Investment F   (1,427,771)   - 
Dividend income   1,167,433    - 
Investment income (loss), net  $1,281,496   $(3,535,053)
v3.23.2
Property and Equipment, Net (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment Property and equipment, net consisted of the following:
   As of 
   June 30,
2023
   December 31,
2022
 
At cost:        
Land and building  $1,878,538   $7,881,202 
Furniture, fixtures and equipment   13,360    13,412 
Computer equipment   241,842    164,536 
Motor vehicles   108,570    108,994 
    2,242,310    8,168,144 
Less: accumulated depreciation   (508,846)   (808,728)
Property and equipment, net  $1,733,464   $7,359,416 
v3.23.2
Borrowings (Tables)
6 Months Ended
Jun. 30, 2023
Borrowings [Abstract]  
Schedule of Borrowings
   As of 
   June 30,
2023
   December 31,
2022
 
         
Mortgage borrowings  $6,255,238   $4,477,254 
v3.23.2
Forward Share Purchase Liability (Tables)
6 Months Ended
Jun. 30, 2023
Forward Share Purchase Liabilitiy [Abstract]  
Schedule of Level 3 Fair Value Measurements of the FSP Liability The following table present the quantitative information regarding Level 3 fair value measurement of the FSP liability:
Input   December 31,
2022
 
Share price   $1.54 
Risk-free interest rate    4.16%
Volatility    52.19%
Exercise price   $12.34 
Term    0.61 years 
v3.23.2
Leases (Tables)
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Schedule of Supplemental Balance Sheet Information Related To Operating Leases Supplemental balance sheet information related to the operating lease was as follows:
   June 30,
2023
 
Operating lease:    
Right-of-use asset, net  $12,361,125 
      
Lease liabilities:     
Current lease liabilities   1,186,200 
Non-current lease liabilities   11,227,185 
Total lease liabilities  $12,413,385 
Schedule of Other Supplemental Information of Operating Lease Other supplemental information about the Company’s operating lease as of June 30, 2023 are as follow:
Weighted average discount rate   6.58%
Weighted average remaining lease term (years)   5.92 

 

Schedule of Future Minimum Lease Payments Maturities of operating lease liabilities as of June 30, 2023 were as follows:
For the period ending June 30,  Operating
lease
 
2024  $1,934,715 
2025   1,934,715 
2026   2,039,234 
2027   3,188,945 
2028   3,188,945 
Thereafter   2,923,199 
Total future minimum lease payments   15,209,753 
Less: imputed interest   (2,796,368)
Present value of operating lease liabilities  $12,413,385 
v3.23.2
Warrant Liabilities (Tables)
6 Months Ended
Jun. 30, 2023
Warrant Liabilities [Abstract]  
Schedule of Binominal Pricing Model The key inputs into the Binominal pricing model were as follows at their measurement dates:
Input  June 30,
2023
   December 31,
2022
 
Share price  $1.44   $1.54 
Risk-free interest rate   4.51%   4.16%
Volatility   51.83%   52.19%
Exercise price  $11.50   $11.50 
Term   4.4 years    4.9 years 
v3.23.2
Shareholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2023
Shareholders’ Equity [Abstract]  
Schedule of Activities for the Company’s RSUs A summary of the activities for the Company’s RSUs for the three and six months ended June 30, 2023 is as follow:
   As of 
   June 30, 2023   December 31, 2022 
   Number of
RSUs
   Weighted
Average
Grant Price
   Number of
RSUs
   Weighted
Average
Grant Price
 
                 
Outstanding, beginning of period/year   5,000,000   $2.47    -   $- 
Granted   -   $-    5,000,000   $2.47 
Outstanding, end of period/year   5,000,000   $2.47    5,000,000   $2.47 
v3.23.2
Income Taxes (Tables)
6 Months Ended
Jun. 30, 2023
Income Taxes [Abstract]  
Schedule of Provision for Income Taxes The provision for income taxes consisted of the following:
   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
Current tax (including over provision of income tax)  $26,368   $40,431   $(280)  $105,354 
Deferred tax   -    (354,574)   -    - 
Income tax expense (benefit)  $26,368   $(314,143)  $(280)  $105,354 
Schedule of Deferred Tax Liabilities and Assets The following table sets forth the significant components of the deferred tax liabilities and assets of the Company as of June 30, 2023 and December 31, 2022:
   June 30,
2023
   December 31,
2022
 
Deferred tax liabilities:        
- Accelerated depreciation  $45,680   $45,858 
    45,680    45,858 
           
Deferred tax assets, net:          
Net operating loss carryforwards   7,747,627    5,461,370 
Less: valuation allowance   (7,747,627)   (5,461,370)
    -    - 
           
Deferred tax liabilities, net  $45,680   $45,858 

 

v3.23.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2023
Segment Information [Abstract]  
Schedule of Business Segments Comprised of the Related Products and Services Currently, the Company has four business segments comprised of the following products and services:
Segments   Scope of Business Activities
Distribution Business   - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
     
Platform Business  

- Providing access to financial products and services to licensed brokers.

 

- Providing operational support for the submission and processing of product applications.

 

- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.

 

- Providing training resources and materials.

 

- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.

     
    - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
     
    - Solicitation of real estate sales for the developers, in exchange for commissions.
     
Fintech Business   Managing an ensemble of fintech investments.
     
Healthcare Business   Managing an ensemble of healthcare-related investments.
Schedule of Information by Segment for the Years The following tables present the summary information by segment for the three and six months ended June 30, 2023 and 2022:
   For the three months ended June 30, 2023 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue                    
- Interest income  $-   $38,175   $-   $-   $38,175 
- Non-interest income   16,005,608    1,327,150    -    -    17,332,758 

Total revenue  

   16,005,608    1,365,325    -    -    17,370,933 
                          
Commission expense   11,628,412    356,025    -    -    11,984,437 
Depreciation on property and equipment   261    105,892    8,169    -    114,322 
Income (loss) from operations   2,734,753    6,785,460    (19,913,347)   -    (10,393,134)
Investment loss, net   -    -    (441,568)   -    (441,568)
Total assets  $18,065,731   $42,202,217   $34,513,786   $520,523   $95,302,257 
   For the three months ended June 30, 2022 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue, net                    
- Interest income  $-   $37,871   $-   $-   $37,871 
- Non-interest income   2,373,898    1,677,903    1,188    -    4,052,989 
Less: inter-segment   -    -    (1,188)   -    (1,188)

Total revenue, net  

   2,373,898    1,715,774    -    -    4,089,672 
                          
Commission expense   1,906,944    573,327    -    -    2,480,271 
Depreciation on property and equipment   239    95,342    92    -    95,673 
Income (loss) from operations   (1,321,333)   (2,591,456)   404,403    -    (3,508,386)
Investment loss, net   -    -    (5,683,988)   -    (5,683,988)
Total assets  $4,427,863   $52,241,241   $37,746,196   $522,557   $94,937,857 
   For the six months ended June 30, 2023 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue                    
- Interest income  $-   $76,333   $-   $-   $76,333 
- Non-interest income   25,693,427    2,674,853    -    -    28,368,280 

Total revenue  

   25,693,427    2,751,186    -    -    28,444,613 
                          
Commission expense   18,540,477    739,452    -    -    19,279,929 
Depreciation on property and equipment   522    201,514    13,458    -    215,494 
Income (loss) from operations   3,187,190    (4,401,856)   (23,762,276)   -    (24,976,942)
Investment income, net   -    -    1,281,496    -    1,281,496 
Total assets  $18,065,731   $42,202,217   $34,513,786   $520,523   $95,302,257 

 

   For the six months ended June 30, 2022 
   Distribution
Business
   Platform
Business
   Fintech
Business
   Healthcare
Business
   Total 
                     
Revenue, net                    
- Interest income  $-   $99,194   $-   $-   $99,194 
- Non-interest income   2,553,829    3,512,972    2,767    -    6,069,568 
Less: inter-segment   -    -    (2,767)   -    (2,767)
Total revenue, net   2,553,829    3,612,166    -    -    6,165,995 
                          
Commission expense   1,975,138    1,206,175    -    -    3,181,313 
Depreciation on property and equipment   372    191,285    695    -    192,352 
Loss from operations   (2,768,395)   (2,045,873)   (606,435)   -    (5,420,703)
Investment loss, net   -    -    (3,535,053)   -    (3,535,053)
Total assets  $4,427,863   $52,241,241   $37,746,196   $522,557   $94,937,857 
v3.23.2
Related Party Balances and Transactions (Tables)
6 Months Ended
Jun. 30, 2023
Related Party Balances and Transactions [Abstract]  
Schedule of Related Party Balances Related party balances consisted of the following:
      As of 
      June 30,
2023
   December 31,
2022
 
            
Accounts receivable  (a)  $601,576   $272,546 
Amounts due to the holding company  (b)  $4,539,168   $6,289,743 
(a)Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the holding company.
(b) Amounts due to the holding company are those nontrade payables arising from transactions between the Company and the holding company, such as advances made by the holding company on behalf of the Company, advances made by the Company on behalf of the holding company, and allocated shared expenses paid by the holding company.

 

Schedule of Ordinary Course of Business The following table provides the transactions with these parties for the periods as presented (for the portion of such period that they were considered related):
      Three months ended
June 30,
   Six months ended
June 30,
 
      2023   2022   2023   2022 
Asset management service income  (c)  $241,688   $241,325   $480,621   $481,268 
Commission expenses  (d)       7,183        56,017 
Office and operating fee charge  (e)   1,742,332    499,161    3,772,045    1,004,307 
General and administrative expense allocated  (f)   1,722    272,190    1,722    545,836 
Purchase of investment from holding company  (g)       6,560,122        6,560,122 
Purchase of office building from holding company  (h)               5,896,301 
Payment of special dividends to holding company  (k)  $   $   $   $47,000,000 
(c) Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the holding company, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers.
(d)Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee.
(e)Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the holding company for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the holding company. Also, the holding company charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business.
(f)Certain amounts of general and administrative expenses were allocated by the holding company.
(g)The Company purchased 4,158,963 shares of Investment A from the holding company and the transaction was completed on April 20, 2022 based on the historical cost to the holding company.
(h)The Company purchased an office building from the holding company in January 2022, based on its historical carrying amount.
(i)On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from holding company and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021.
v3.23.2
Concentrations of Risk (Tables)
6 Months Ended
Jun. 30, 2023
Concentrations of Risk [Abstract]  
Schedule of Revenue and Outstanding Receivable For the three and six months ended June 30, 2023, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivable balances at period-end dates, are presented as follows:
   Three months ended
June 30, 2023
   Six months ended
June 30, 2023
   June 30,
2023
 
Customer  Revenues   Percentage
of revenues
   Revenues   Percentage
of revenues
   Accounts
receivable
 
Customer A  $3,849,161    22%  $6,566,059    23%  $- 
Customer B  $3,055,295    18%  $4,425,921    16%  $139 
Customer C  $1,874,473    11%  $3,105,629    11%  $- 
Customer D  $2,029,613    12%  $3,051,903    11%  $49,223 
Schedule of Related Net Loans Receivable Balance as a Percentage of Total Loans Receivable The Company’s third-party customers that represent more than 10% of total combined loans receivable, and their related net loans receivable balance as a percentage of total combined loans receivable, as of June 30, 2023 and December 31, 2022 were as follows:
   As of 
   June 30,
2023
   December 31,
2022
 
         
Customer E   37.3%   37.4%
Customer F   31.6%   31.6%
Customer G   31.1%   31.0%
v3.23.2
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Summary of Significant Accounting Policies [Abstract]        
Impairment losses
Tax benefit, percentage     50.00%  
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Exchange Rates - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Schedule of exchange rates [Abstract]    
Period-end HK$:US$ exchange rate $ 0.12761 $ 0.12744
Period average HK$:US$ exchange rate $ 0.12757 $ 0.12779
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Estimated Residual Values
6 Months Ended
Jun. 30, 2023
Land and building [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Expected useful life Shorter of 50 years or lease term
Office improvement [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Expected useful life 3 years
Furniture, fixtures and equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Expected useful life 5 years
Computer equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Expected useful life 3 years
Motor vehicle [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Expected useful life 3 years
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Revenue Streams by Segments - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]        
Distribution Business, Insurance brokerage service $ 16,005,608 $ 2,373,898 $ 25,693,427 $ 2,553,829
Platform Business, Asset management service 1,287,662 1,632,998 2,631,319 3,397,456
Platform Business, Money lending service 38,175 37,871 76,333 99,194
Platform Business, Real estate agency service 39,488 44,905 43,534 115,516
Total 17,370,933 4,089,672 28,444,613 6,165,995
Recurring service fees [Member]        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Distribution Business, Insurance brokerage service
Platform Business, Asset management service 1,009,702 1,114,721 2,029,597 2,302,644
Platform Business, Money lending service
Platform Business, Real estate agency service
Total 1,009,702 1,114,721 2,029,597 2,302,644
Loans [Member]        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Distribution Business, Insurance brokerage service
Platform Business, Asset management service
Platform Business, Money lending service 38,175 37,871 76,333 99,194
Platform Business, Real estate agency service
Total 38,175 37,871 76,333 99,194
Commissions [Member]        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Distribution Business, Insurance brokerage service 16,005,608 2,373,898 25,693,427 2,553,829
Platform Business, Asset management service 277,960 518,277 601,722 1,094,812
Platform Business, Money lending service
Platform Business, Real estate agency service 39,488 44,905 43,534 115,516
Total $ 16,323,056 $ 2,937,080 $ 26,338,683 $ 3,764,157
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Operating Segments - Business Acquisition [Member]
6 Months Ended
Jun. 30, 2023
Distribution Business [Member]  
Segment Reporting Information [Line Items]  
Scope of Service Insurance Brokerage Business
Business Activities - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
Platform Business [Member]  
Segment Reporting Information [Line Items]  
Scope of Service - Asset Management Business
Business Activities - Providing access to financial products and services to licensed brokers. - Providing operational support for the submission and processing of product applications. - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc. - Providing training resources and materials. - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.
Platform Business Two [Member]  
Segment Reporting Information [Line Items]  
Scope of Service - Money Lending Service
Business Activities - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
Platform Business Three [Member]  
Segment Reporting Information [Line Items]  
Scope of Service - Real Estate Agency Service
Business Activities - Solicitation of real estate sales for the developers, in exchange for commissions.
Fintech Business [Member]  
Segment Reporting Information [Line Items]  
Scope of Service Investment Holding
Business Activities Managing an ensemble of fintech investments.
Healthcare Business [Member]  
Segment Reporting Information [Line Items]  
Scope of Service Investment Holding
Business Activities Managing an ensemble of healthcare-related investments.
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Fair Value Hierarchy of the Valuation Techniques - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Assets:    
Marketable equity securities $ 524 $ 2,443,593
Non-marketable equity securities 33,946,542 34,589,767
Liabilities:    
Forward share purchase liability 13,491,606
Warrant liabilities 2,173 4,548
Quoted Prices in Active Markets (Level 1) [Member]    
Assets:    
Marketable equity securities 524 2,443,593
Non-marketable equity securities
Liabilities:    
Forward share purchase liability  
Warrant liabilities
Significant Other Observable Inputs (Level 2) [Member]    
Assets:    
Marketable equity securities
Non-marketable equity securities
Liabilities:    
Forward share purchase liability  
Warrant liabilities
Significant Other Unobservable Inputs (Level 3) [Member]    
Assets:    
Marketable equity securities
Non-marketable equity securities 33,946,542 34,589,767
Liabilities:    
Forward share purchase liability   13,491,606
Warrant liabilities $ 2,173 $ 4,548
v3.23.2
Liquidity and Going Concern (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Nature of Business and Basis of Presentation [Abstract]    
Net loss $ 22,657,899  
Net cash outflows from operating activities 19,265,823  
Accumulated losses 62,053,032  
Cash and cash equivalents $ 3,783,780 $ 6,449,876
v3.23.2
Restricted Cash (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 29, 2023
Dec. 31, 2022
Restricted Cash (Details) [Line Items]        
Investors sold shares (in Shares) 1,191,016 1,191,016 124,949  
Restricted cash released $ 14,000,000 $ 14,000,000    
Cash and cash equivalents $ 1,700,000 $ 1,700,000    
Sales price per share (in Dollars per share) $ 8.06 $ 8.06 $ 2 $ 2.46
Restricted cash $ 1,500,000 $ 1,500,000    
Loss on settlement $ 378,895 $ 378,895    
Minimum [Member]        
Restricted Cash (Details) [Line Items]        
Price ranging per share (in Dollars per share) $ 1.51 $ 1.51    
Maximum [Member]        
Restricted Cash (Details) [Line Items]        
Price ranging per share (in Dollars per share) $ 1.61 $ 1.61    
v3.23.2
Accounts Receivable, Net (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Accounts Receivable, Net [Abstract]        
Allowance for estimated credit losses on accounts receivable $ 67,949 $ 67,949
v3.23.2
Accounts Receivable, Net (Details) - Schedule of Accounts Receivable, Net - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Schedule of Accounts Receivable Net [Abstract]    
Accounts receivable $ 3,592,789 $ 2,916,609
Accounts receivable – related parties 601,576 272,546
Less: allowance for estimated credit losses (162,009) (94,447)
Accounts receivable, net $ 4,032,356 $ 3,094,708
v3.23.2
Loans Receivables, Net (Details)
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Minimum [Member]      
Loans Receivables, Net (Details) [Line Items]      
Interest rates on loans issued 9.00%    
Term loans 1 year    
Maximum [Member]      
Loans Receivables, Net (Details) [Line Items]      
Interest rates on loans issued     10.50%
Maximum [Member] | Hong Kong [Member]      
Loans Receivables, Net (Details) [Line Items]      
Term loans   25 years  
v3.23.2
Loans Receivables, Net (Details) - Schedule of Loans Receivables, Net - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Loan Portfolio [Abstract]    
Mortgage loans (residential) $ 1,576,013 $ 1,589,871
Reclassifying as:    
Current portion 516,237 517,479
Non-current portion 1,059,776 1,072,392
Loans receivable, net $ 1,576,013 $ 1,589,871
v3.23.2
Assets Held For Sale (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Jun. 28, 2023
Property, Plant and Equipment Assets Held-for-Sale Disclosure [Abstract]    
Office premises with a consideration   $ 6,150
Deposit received $ 300  
Assets held for sale $ 5,460  
v3.23.2
Notes Receivable (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Feb. 24, 2023
Notes Receivable [Abstract]      
Note payable     $ 1,673,525
Fixed interest rate     8.00%
Note receivable $ 601,490    
Interest receivable $ 11,778  
v3.23.2
Long-Term Investments, Net (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 29, 2023
Dec. 31, 2022
Apr. 20, 2022
Long-Term Investments, Net [Abstract]              
Investment shares 993,108   993,108       4,158,963
Per share $ 4.01   $ 4.01        
Realized gain (loss) $ 1,541,736      
Fair value $ 524   $ 524     $ 2,443,593  
Closing price $ 8.06   $ 8.06   $ 2 $ 2.46  
v3.23.2
Long-Term Investments, Net (Details) - Schedule of Long-Term Investments - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Marketable equity securities    
Long term investment balance $ 33,946,542 $ 34,589,767
Net carrying value $ 33,947,066 $ 37,033,360
Investment C [Member]    
Marketable equity securities    
Ownership interest 0.00% [1] 0.46%
Long term investment balance $ 524 $ 2,443,593
Investment A [Member]    
Marketable equity securities    
Ownership interest 8.37% 8.37%
Long term investment balance $ 5,740,036 $ 5,717,678
Investment B [Member]    
Marketable equity securities    
Ownership interest 3.63% 3.63%
Long term investment balance $ 511,003 $ 513,000
Investment D [Member]    
Marketable equity securities    
Ownership interest 4.49% 4.92%
Long term investment balance $ 16,784,183 $ 16,030,943
Investment E [Member]    
Marketable equity securities    
Ownership interest 4.00% 4.00%
Long term investment balance $ 520,523 $ 522,557
Investment F [Member]    
Marketable equity securities    
Ownership interest 4.00% 4.00%
Long term investment balance $ 10,390,797 $ 11,805,589
[1] Less than 0.001%
v3.23.2
Long-Term Investments, Net (Details) - Schedule of Changes in Fair Value of Non-Marketable Equity Securities - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Changes in Fair Value of Non Marketable Equity Securities [Abstract]    
Balance at beginning of period/year $ 34,589,767 $ 25,496,534
Additions 16,228,690
Downward adjustments (1,427,904) (6,898,549)
Upward adjustments 2,137,021
Foreign exchange adjustment 784,679 (2,373,929)
Balance at end of period/year $ 33,946,542 $ 34,589,767
v3.23.2
Long-Term Investments, Net (Details) - Schedule of Cumulative Unrealized Gains and Losses, Included In the Carrying Value - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Cumulative Unrealized Gains and Losses Included in the Carrying Value [Abstract]    
Downward adjustments (including impairment) $ (28,682,504) $ (27,254,600)
Upward adjustments $ 6,209,357 $ 6,209,357
v3.23.2
Long-Term Investments, Net (Details) - Schedule of Investment Income Is Recorded As Other Income - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Schedule Of Investment Income Is Recorded As Other Income Abstract        
Unrealized loss from the changes in fair value – Investment C $ (168) $ (5,683,988) $ 98 $ (3,535,053)
Realized gain from sale of Investment C 1,541,736
Unrealized loss (including impairment) – Investment F (1,000,119) (1,427,771)
Dividend income 558,719 1,167,433
Investment loss, net $ (441,568) $ (5,683,988) $ 1,281,496 $ (3,535,053)
v3.23.2
Property and Equipment, Net (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Abstract]        
Depreciation expenses $ 114,322 $ 95,673 $ 215,494 $ 192,352
Reclassified to asset held for sale     $ 5,460,000  
v3.23.2
Property and Equipment, Net (Details) - Schedule of Property and Equipment - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 2,242,310 $ 8,168,144
Less: accumulated depreciation (508,846) (808,728)
Property and equipment, net 1,733,464 7,359,416
Land and building [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,878,538 7,881,202
Furniture, fixtures and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 13,360 13,412
Computer equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 241,842 164,536
Motor vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 108,570 $ 108,994
v3.23.2
Borrowings (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Feb. 28, 2023
Feb. 24, 2023
Dec. 31, 2022
Sep. 30, 2022
Borrowings (Details) [Line Items]          
Fixed interest rate, percentage     8.00%    
Aggregate carrying amount $ 7.0     $ 5.7  
Asset held for sale $ 5.5      
Hong Kong [Member]          
Borrowings (Details) [Line Items]          
Fixed interest rate, percentage         10.85%
Interest rate   13.75%      
v3.23.2
Borrowings (Details) - Schedule of Borrowings - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Schedule of Borrowings [Abstract]    
Mortgage borrowings $ 6,255,238 $ 4,477,254
v3.23.2
Forward Share Purchase Liability (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Forward Share Purchase Liabilitiy [Abstract]        
Loss on settlement $ (378,895) $ (378,895)
Change in fair value of FSP liability $ 0   $ 82,182  
v3.23.2
Forward Share Purchase Liability (Details) - Schedule of Level 3 Fair Value Measurements of the FSP Liability - Level 3 [Member]
6 Months Ended
Jun. 30, 2023
$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Share price $ 1.54
Risk-free interest rate 4.16%
Volatility 52.19%
Exercise price $ 12.34
Term 7 months 9 days
v3.23.2
Leases (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Leases [Abstract]    
Operating lease expense $ 213,550 $ 213,550
v3.23.2
Leases (Details) - Schedule of Supplemental Balance Sheet Information Related To Operating Leases - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Schedule of Supplemental Balance Sheet Information Related To Operating Leases [Abstract]    
Right-of-use asset, net $ 12,361,125
Current lease liabilities 1,186,200
Non-current lease liabilities 11,227,185
Total lease liabilities $ 12,413,385  
v3.23.2
Leases (Details) - Schedule of Other Supplemental Information of Operating Lease
Jun. 30, 2023
Schedule of Other Supplemental Information of Operating Lease [Abstract]  
Weighted average discount rate 6.58%
Weighted average remaining lease term (years) 5 years 11 months 1 day
v3.23.2
Leases (Details) - Schedule of Future Minimum Lease Payments
Jun. 30, 2023
USD ($)
Schedule of Future Minimum Lease Payments [Abstract]  
2024 $ 1,934,715
2025 1,934,715
2026 2,039,234
2027 3,188,945
2028 3,188,945
Thereafter 2,923,199
Total future minimum lease payments 15,209,753
Less: imputed interest (2,796,368)
Present value of operating lease liabilities $ 12,413,385
v3.23.2
Warrant Liabilities (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Warrant Liabilities (Details) [Line Items]          
Changes in fair value of warrant $ (1,695) $ (2,375)  
Private Warrants [Member]          
Warrant Liabilities (Details) [Line Items]          
Warrants outstanding (in Shares) 225,000   225,000   225,000
Aggregate value $ 2,173   $ 2,173   $ 4,548
v3.23.2
Warrant Liabilities (Details) - Schedule of Binominal Pricing Model - $ / shares
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Binominal Pricing Model [Abstract]    
Share price $ 1.44 $ 1.54
Risk-free interest rate 4.51% 4.16%
Volatility 51.83% 52.19%
Exercise price $ 11.5 $ 11.5
Term 4 years 4 months 24 days 4 years 10 months 24 days
v3.23.2
Shareholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 03, 2023
Mar. 21, 2023
Jun. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Jun. 06, 2023
Feb. 24, 2023
Shareholders’ Equity (Details) [Line Items]              
Ordinary shares, authorized     200,000,000 200,000,000 200,000,000    
Ordinary shares, par value (in Dollars per share)     $ 0.001 $ 0.001 $ 0.001    
Ordinary shares issued 946,100            
Hold back ordinary shares issued           1,665,000  
Aggregate shares issued       4,300,000      
Ordinary shares, issued     67,461,998 67,461,998 58,376,985    
Ordinary shares, outstanding     67,461,998 67,461,998 58,376,985    
Exercisable warrants term     90 days 90 days      
Expire date       5 years      
Description of exercisable warrants       Once the warrants become exercisable, the Company may call the outstanding warrants (including any outstanding warrants issued upon exercise of the unit purchase option issued to Maxim Group LLC) for redemption:   ●in whole and not in part;   ●at a price of $0.01 per warrant;   ●upon a minimum of 30 days’ prior written notice of redemption,   ●if, and only if, the last sales price of the ordinary shares equals or exceeds $16.50 per share for any 20 trading days within a 30 trading day period ending three business days before the Company send the notice of redemption, and   ●if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.      
Shares of public warrants       4,600,000      
Shares of private warrants outstanding         225,000    
Ordinary shares, issued     5,246,100 5,246,100     11,675,397
Percentage of forfeitures       10.00%      
Share based compensation expenses (in Dollars)     $ 4,604,320 $ 8,510,920      
Recognized future periods RSUs (in Dollars)       $ 8,500,000      
Weighted average period       2 years 2 months 12 days      
Additional paid-in capital (in Dollars)     $ 5,600,000 $ 8,600,000      
Public Warrants [Member]              
Shareholders’ Equity (Details) [Line Items]              
Ordinary share price per share (in Dollars per share)     $ 11.5 $ 11.5      
Apex Twinkle Limited [Member]              
Shareholders’ Equity (Details) [Line Items]              
Ordinary shares issued   2,173,913          
v3.23.2
Shareholders’ Equity (Details) - Schedule of Activities for the Company’s RSUs - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Activities for the Company RSUs [Abstract]    
Number of RSUs, Outstanding, beginning of period 5,000,000
Outstanding, beginning of period $ 2.47
Number of RSUs, Granted 5,000,000
Weighted Average Grant Price Granted $ 2.47
Number of RSUs, Outstanding, end of period 5,000,000 5,000,000
Weighted Average Grant Price, Outstanding, end of period $ 2.47 $ 2.47
v3.23.2
Operating Cost and Expenses (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating Cost And Expenses Abstract        
Commission expenses $ 11,984,437 $ 2,480,271 $ 19,279,929 $ 3,181,313
Annual bonus 3,800,000   3,800,000  
Personnel and benefit expense 5,302,270 3,404,039 14,907,460 5,409,018
Other general and administrative expenses $ 8,655,884 $ 1,173,217 $ 14,511,705 $ 2,081,618
v3.23.2
Income Taxes (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Income Taxes (Details) [Line Items]    
Income taxes amount $ 40,151  
Net operating losses carryforward $ 47,000,000 $ 33,100,000
Minimum [Member] | Hong Kong [Member]    
Income Taxes (Details) [Line Items]    
Income tax rate 8.25%  
Maximum [Member] | Hong Kong [Member]    
Income Taxes (Details) [Line Items]    
Income tax rate 16.50%  
v3.23.2
Income Taxes (Details) - Schedule of Provision for Income Taxes - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Schedule of Provision for Income Taxes [Abstract]        
Current tax (including over provision of income tax) $ 26,368 $ 40,431 $ (280) $ 105,354
Deferred tax (354,574)
Income tax expense (benefit) $ 26,368 $ (314,143) $ (280) $ 105,354
v3.23.2
Income Taxes (Details) - Schedule of Deferred Tax Liabilities and Assets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Deferred tax liabilities:    
Accelerated depreciation $ 45,680 $ 45,858
Deferred tax liabilities total 45,680 45,858
Deferred tax assets, net:    
Net operating loss carryforwards 7,747,627 5,461,370
Less: valuation allowance (7,747,627) (5,461,370)
Deferred tax assets, net
Deferred tax liabilities, net $ 45,680 $ 45,858
v3.23.2
Segment Information (Details) - Schedule of Business Segments Comprised of the Related Products and Services
6 Months Ended
Jun. 30, 2023
Distribution Business [Member]  
Revenue, Major Customer [Line Items]  
Scope of Business Activities - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
Platform Business [Member]  
Revenue, Major Customer [Line Items]  
Scope of Business Activities - Providing access to financial products and services to licensed brokers.   - Providing operational support for the submission and processing of product applications.   - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.   - Providing training resources and materials.   - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.
Platform Business Two [Member]  
Revenue, Major Customer [Line Items]  
Scope of Business Activities - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
Platform Business Three [Member]  
Revenue, Major Customer [Line Items]  
Scope of Business Activities - Solicitation of real estate sales for the developers, in exchange for commissions.
Fintech Business [Member]  
Revenue, Major Customer [Line Items]  
Scope of Business Activities Managing an ensemble of fintech investments.
Healthcare Business [Member]  
Revenue, Major Customer [Line Items]  
Scope of Business Activities Managing an ensemble of healthcare-related investments.
v3.23.2
Segment Information (Details) - Schedule of Information by Segment for the Years - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Distribution Business [Member]        
Revenue        
Interest income
Non-interest income 16,005,608 2,373,898 25,693,427 2,553,829
Total 16,005,608 2,373,898 25,693,427 2,553,829
Less: inter-segment    
Commission expense 11,628,412 1,906,944 18,540,477 1,975,138
Depreciation 261 239 522 372
Income (loss) from operations 2,734,753 (1,321,333) 3,187,190 (2,768,395)
Investment income (loss) net
Total assets 18,065,731 4,427,863 18,065,731 4,427,863
Platform Business [Member]        
Revenue        
Interest income 38,175 37,871 76,333 99,194
Non-interest income 1,327,150 1,677,903 2,674,853 3,512,972
Total 1,365,325 1,715,774 2,751,186 3,612,166
Less: inter-segment    
Commission expense 356,025 573,327 739,452 1,206,175
Depreciation 105,892 95,342 201,514 191,285
Income (loss) from operations 6,785,460 (2,591,456) (4,401,856) (2,045,873)
Investment income (loss) net
Total assets 42,202,217 52,241,241 42,202,217 52,241,241
Fintech Business [Member]        
Revenue        
Interest income
Non-interest income 1,188 2,767
Total
Less: inter-segment   (1,188)   (2,767)
Commission expense
Depreciation 8,169 92 13,458 695
Income (loss) from operations (19,913,347) 404,403 (23,762,276) (606,435)
Investment income (loss) net (441,568) (5,683,988) 1,281,496 (3,535,053)
Total assets 34,513,786 37,746,196 34,513,786 37,746,196
Healthcare Business [Member]        
Revenue        
Interest income
Non-interest income
Total
Less: inter-segment    
Commission expense
Depreciation
Income (loss) from operations
Investment income (loss) net
Total assets 520,523 522,557 520,523 522,557
Total [Member]        
Revenue        
Interest income 38,175 37,871 76,333 99,194
Non-interest income 17,332,758 4,052,989 28,368,280 6,069,568
Total 17,370,933 4,089,672 28,444,613 6,165,995
Less: inter-segment   (1,188)   (2,767)
Commission expense 11,984,437 2,480,271 19,279,929 3,181,313
Depreciation 114,322 95,673 215,494 192,352
Income (loss) from operations (10,393,134) (3,508,386) (24,976,942) (5,420,703)
Investment income (loss) net (441,568) (5,683,988) 1,281,496 (3,535,053)
Total assets $ 95,302,257 $ 94,937,857 $ 95,302,257 $ 94,937,857
v3.23.2
Related Party Balances and Transactions (Details) - USD ($)
$ in Millions
Jan. 18, 2022
Jun. 30, 2023
Apr. 20, 2022
Related Party Balances and Transactions [Abstract]      
Investment of shares   993,108 4,158,963
Dividend $ 47    
v3.23.2
Related Party Balances and Transactions (Details) - Schedule of Related Party Balances - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Schedule of Related Party Balances [Abstract]    
Accounts receivable [1] $ 601,576 $ 272,546
Amounts due to the holding company [2] $ 4,539,168 $ 6,289,743
[1] Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the holding company.
[2] Amounts due to the holding company are those nontrade payables arising from transactions between the Company and the holding company, such as advances made by the holding company on behalf of the Company, advances made by the Company on behalf of the holding company, and allocated shared expenses paid by the holding company.
v3.23.2
Related Party Balances and Transactions (Details) - Schedule of Ordinary Course of Business - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Schedule of Ordinary Course of Business [Abstract]        
Asset management service income [1] $ 241,688 $ 241,325 $ 480,621 $ 481,268
Commission expenses [2] 7,183 56,017
Office and operating fee charge [3] 1,742,332 499,161 3,772,045 1,004,307
General and administrative expense allocated [4] 1,722 272,190 1,722 545,836
Purchase of investment from holding company [5] 6,560,122 6,560,122
Purchase of office building from holding company [6] 5,896,301
Payment of special dividends to holding company [7] $ 47,000,000
[1] Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the holding company, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers.
[2] Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee.
[3] Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the holding company for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the holding company. Also, the holding company charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business.
[4] Certain amounts of general and administrative expenses were allocated by the holding company.
[5] The Company purchased 4,158,963 shares of Investment A from the holding company and the transaction was completed on April 20, 2022 based on the historical cost to the holding company.
[6] The Company purchased an office building from the holding company in January 2022, based on its historical carrying amount.
[7] On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from holding company and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021.
v3.23.2
Concentrations of Risk (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2023
HKD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
Concentrations of Risk [Abstract]            
Revenue outstanding receivable percentage 10.00%   10.00% 10.00%    
Revenue percentage   10.00%     10.00%  
Deposit protection     $ 63,805 $ 500,000    
Cash and cash equivalents $ 3,800,000   3,800,000      
Fund held in escrow 27,500,000   27,500,000      
Maintained financial institutions amount 28,700,000   $ 28,700,000      
Combined loans receivables percentage     10.00% 10.00%   10.00%
Foreign exchange gain (loss) $ 349,539 $ (2,126,882) $ 905,850   $ (2,607,456)  
v3.23.2
Concentrations of Risk (Details) - Schedule of Revenue and Outstanding Receivable
3 Months Ended 6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Customer A [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 3,849,161 $ 6,566,059
Percentage of revenues 22% 23%
Accounts receivable
Customer B [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 3,055,295 $ 4,425,921
Percentage of revenues 18% 16%
Accounts receivable $ 139 $ 139
Customer C [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 1,874,473 $ 3,105,629
Percentage of revenues 11% 11%
Accounts receivable
Customer D [Member]    
Disaggregation of Revenue [Line Items]    
Revenues $ 2,029,613 $ 3,051,903
Percentage of revenues 12% 11%
Accounts receivable $ 49,223 $ 49,223
v3.23.2
Concentrations of Risk (Details) - Schedule of Related Net Loans Receivable Balance as a Percentage of Total Loans Receivable
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Concentrations of Risk (Details) - Schedule of Related Net Loans Receivable Balance as a Percentage of Total Loans Receivable [Line Items]    
Percentage of total combined loans receivables 31.10% 31.00%
Customer E [Member]    
Concentrations of Risk (Details) - Schedule of Related Net Loans Receivable Balance as a Percentage of Total Loans Receivable [Line Items]    
Percentage of total combined loans receivables 37.30% 37.40%
Customer F [Member]    
Concentrations of Risk (Details) - Schedule of Related Net Loans Receivable Balance as a Percentage of Total Loans Receivable [Line Items]    
Percentage of total combined loans receivables 31.60% 31.60%
v3.23.2
Commitments and Contingencies (Details)
$ in Millions
1 Months Ended 6 Months Ended
Dec. 15, 2020
USD ($)
Dec. 15, 2020
HKD ($)
Jan. 31, 2024
USD ($)
Apr. 30, 2019
USD ($)
Apr. 30, 2019
HKD ($)
Jun. 30, 2023
USD ($)
shares
Dec. 31, 2021
USD ($)
Commitments and Contingencies (Details) [Line Items]              
Subscription and claimed damage $ 1,670,000 $ 13.0   $ 2,000,000 $ 17.1    
Contingency loss             $ 840,000
Committed subscription amount           $ 1,084,439  
Capital amount           $ 331,432  
Compensation shares issued (in Shares) | shares           2,000,000  
Forecast [Member]              
Commitments and Contingencies (Details) [Line Items]              
Aggregated amount     $ 1,673,525        
v3.23.2
Subsequent Events (Details)
$ in Thousands
Jul. 20, 2023
USD ($)
Subsequent Events [Abstract]  
Office premises consideration $ 6,150

AGBA (NASDAQ:AGBA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 AGBA 차트를 더 보려면 여기를 클릭.
AGBA (NASDAQ:AGBA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 AGBA 차트를 더 보려면 여기를 클릭.